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Executive Summary
This technical report presents results of the baseline Behavioral Sentinel Surveillance (BSS) 
survey undertaken by Breakthrough RESEARCH/Nigeria between September and October 
2019. From 2019 to 2021, baseline, midline, and endline waves of the BSS will be used to 
assess the effectiveness of the Breakthrough ACTION/Nigeria integrated social and behav-
ior change (SBC) activities for malaria; family planning; and maternal, newborn, and child 
health plus nutrition (MNCH+N) in Kebbi and Sokoto states relative to Breakthrough ACTION/
Nigeria’s malaria-only SBC activities in Zamfara State. 
Breakthrough ACTION/Nigeria uses three primary SBC approaches that span across societal 
levels including: 1) advocacy outreach to opinion leaders and community influencers at state 
and local government area (LGA) level, 2) direct engagement of community members through 
community dialogues and group meetings that includes referrals for services, and 3) comple-
mentary SBC messaging through mass and mid-media. The official launch of integrated SBC 
activities in Kebbi and Sokoto occurred on 19 September 2019, although staged implementa-
tion rolled out across these states between early and late September, which coincided with 
BSS baseline survey fieldwork. The Albishirin Ku! radio program began airing in integrated 
states at the end of August 2019. Malaria-only SBC activities were initiated in Zamfara in 
October 2019. 
This technical report presents detailed baseline results, including comparisons of results for 
the Breakthrough ACTION/Nigeria integrated (Kebbi/Sokoto) versus malaria-only program 
areas (Zamfara). The report also presents findings regarding the contextual factors and driv-
ers that influence health behavior and service utilization outcomes, as these results have 
important and direct implications for Breakthrough ACTION/Nigeria SBC program adaption 
and scale-up. 
About the BSS
The BSS is unique in its focus on the drivers of behav-
ioral outcomes in the areas of family planning, malaria, 
and MNCH+N. Measures of these drivers are reflected 
in questions about the psychosocial influences—across 
cognitive, emotional, and social domains—that have been 
posited by various theories as intermediate determinants 
of behavioral outcomes. Indeed, as these theories sug-
gest, a person’s actions are strongly influenced by their 
beliefs, feelings, and sense of self-efficacy, and changing 
these perceptions may lead to future positive behavioral 
change. 
The BSS focuses on women aged 15 to 49 years who are 
currently pregnant or with a child under 2 years living 
in areas targeted for integrated (Kebbi/Sokoto) and 
malaria-only (Zamfara) Breakthrough ACTION/Nigeria 
SBC programming. This subset of women is the primary 
target audience for Breakthrough ACTION/Nigeria’s 
programming. A total of 3,026 pregnant women and 
3,040 women with a child under 2 years from randomly 
selected locations in the Breakthrough ACTION/Nigeria 
program areas were included in the BSS baseline survey. 
Study populations are referred to as “respondents” 
throughout this report. Female interviewers used a 
structured questionnaire to collect information across a 
wide variety of health areas. The BSS asks respondents 
about current health behaviors and key behavioral 
determinants, including: (cognitive) knowledge, attitudes, 
beliefs, and perceived risk; (emotional) empathy, self-ef-
ficacy, and emotional response; and (social) subjective 
BR E A K THROUGH R ESE A RCH  |  JUNE 2020     1 
norms, social support, social influence, and interpersonal 
communication. By understanding these key behavioral 
determinants, the BSS provides new and important 
evidence that will directly inform programs in Nigeria to 
tailor messaging and promote activities that address the 
psychosocial influences that promote behavior change. 
Such evidence is critical to inform Breakthrough ACTION/
Nigeria’s SBC program, which works across multiple soci-
etal levels and through various communication channels 
to promote positive normative and behavioral change 
across family planning, malaria, and MNCH+N. The BSS 
results also complement findings from the recent Nigeria 
Demographic and Health Survey (NDHS) 2018. While 
the NDHS 2018 reports on a wide range of health and 
demographic outcomes across Nigeria, the BSS collects 
additional program-relevant evidence on behavioral 
determinants. Such evidence will inform programs about 
pregnant women’s and mothers of young children’s 
beliefs or perceptions that must be addressed to help 
improve outcomes by the next NDHS survey round.
Specifically, the BSS results presented in this report—
and highlighted in this Executive Summary—answer 
the following unique and important program-relevant 
questions:
• Are respondents aware of the health behaviors that 
are being promoted, e.g., how to prevent or treat 
certain diseases?
• Are certain myths or beliefs held by respondents that 
could impede progress across health areas? 
• How do respondents view health services in their 
communities and what are their main reasons for 
choosing certain treatment locations or for not 
seeking care at all? What types of difficulties, if any, 
have they had accessing services? 
• How do health decisions get made in the household? 
Who mainly influences decisions and practices across 
health areas? How much autonomy or influence do 
respondents have in making family health decisions? 
• What are key social norms around certain health 
behaviors? How prevalent are certain practices and 
how do respondents feel they would be perceived 
in their community if they took up the promoted 
practice? 
• Do respondents feel confident in their ability to take 
up the promoted practice, or to negotiate with their 
husband/spouse about initiating the new practice?  
Key Findings and Recommendations
Albishirin Ku! 
Awareness of Breakthrough ACTION/Nigeria’s Albishirin 
Ku! radio programming is already apparent even at this 
baseline period. In Kebbi/Sokoto, 24 percent of respon-
dents have heard the Albishirin Ku! radio slogan, as have 
13 percent in Zamfara. Albishirin Ku! radio program 
awareness in Kebbi and Sokoto is significantly lower 
among respondents in the poorest households (12%) 
than in the wealthiest households (42%), which is likely 
due to lower radio ownership in the poorest households 
and thus fewer opportunities to listen to radio program-
ming. This result suggests that Breakthrough ACTION/
Nigeria radio programming may not reach the poorest 
households that are shown to have demonstrably worse 
health outcomes described in this report (see below 
sections). Going forward, Breakthrough ACTION/Nigeria 
should ensure that ongoing SBC outreach efforts (e.g., 
household visits or community events) are targeting this 
population as a priority in order to raise overall rates. 
Family planning
Modern contraceptive use: Non-pregnant respondents 
reported low modern contraceptive use, with higher use 
in Zamfara (15%) than in Kebbi (9%) and Sokoto (12%). 
Modern contraceptive use was lower among respon-
dents in the poorest households (6% in Kebbi/Sokoto 
and 7% in Zamfara) than in wealthiest households (24% 
in Kebbi/Sokoto and 34% in Zamfara). Most respondents 
had heard of at least one modern method, with the most 
recognized methods being injectables, implants, and daily 
pills. Higher recall of methods was noted in Kebbi/Sokoto 
(30% for injectables, 38% for implants, and 33% for 
daily pills) than in Zamfara (16% for injectables, 23% for 
implants, and 19% for daily pills). Consistent with existing 
evidence/literature, the most common methods used 
were injectables (48%) and implants (25%), with similar 
proportions across study areas. Finally, among non-users, 
15 percent intended to start contraceptive use in the 
next six months, which presents an opportunity to fill 
this latent demand among current non-users who have a 
stated intention to act. 
Reasons for non-use, attitudes, and social norms: The 
most common reasons non-pregnant respondents stated 
for not currently using contraception were fatalism (“It’s 
up to God”) (25%), currently breastfeeding (23%), partner 
opposition (21%), and respondent opposition (18%). In 
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line with this result, approximately 
half (52%) of respondents agreed that 
they do not personally approve of 
using contraception for birth spac-
ing, underscoring a critical hurdle 
to Breakthrough ACTION/Nigeria 
SBC messaging for changing family 
planning practices. In addition, one in 
five respondents believed that people 
in their community would call them 
bad names or avoid their company if 
others knew they were using con-
traception for birth spacing, which 
further highlights the importance 
of addressing social norms in family 
planning. About half of the respon-
dents agreed that religious leaders 
should speak publicly about using 
modern contraceptives, which under-
scores an important pillar of Breakthrough ACTION/
Nigeria programming. 
Contraceptive myths: Common contraceptive myths 
also persist across study areas, with firmer belief in these 
myths in Kebbi/Sokoto than in Zamfara. About one in 
three respondents in Kebbi/Sokoto agreed that contra-
ception could make a woman permanently infertile, harm 
a woman’s womb, or lead to health problems, compared 
with about one-quarter of respondents in Zamfara. 
About one in five respondents in Kebbi/Sokoto believed 
that contraceptives cause cancer, result in deformed 
babies, increase promiscuity, or reduce sexual urges of 
women and men. SBC programming needs to actively 
work to dispel these specific myths going forward to help 
promote behavior change. 
Spousal communication and decision-making: There 
were low rates of spousal communication about contra-
ceptive use, although rates of spouse communication 
were higher in Zamfara (22%) than in Kebbi/Sokoto 
(6%). While approximately half of respondents across 
study areas reported that contraceptive use decisions 
were made jointly with their partner, a significant 
proportion—30 percent in Kebbi/Sokoto and 17 percent 
in Zamfara—noted that contraceptive decisions were 
mainly made by their partners. When respondents were 
asked who else influences a woman’s decision about 
contraceptive use, the most commonly mentioned 
influencers were no one else (61%) and partners/spouses 
(30%). Self-efficacy for negotiating contraceptive use with 
a partner was low. Only about half of respondents across 
study areas were confident in their ability to convince 
their partner to use modern contraception for spacing 
births. These findings further underscore the need for 
SBC activities to engage couples in decision-making about 
birth spacing and to support women’s agency in health 
decision-making to help raise contraceptive use rates.
Malaria
Malaria prevention: Overall, ownership of long-lasting 
insecticide nets (LLIN) was high. Approximately 75 per-
cent and 69 percent of households surveyed in Zamfara 
and Kebbi/Sokoto, respectively, owned at least one LLIN. 
However, fewer households had the recommended ratio 
of at least one LLIN for every two household members, 
with slightly higher proportions in Kebbi/Sokoto (25%) 
than in Zamfara (18%). In households where there were 
sufficient nets (at least one LLIN for every two house-
hold members), 81 percent and 88 percent of pregnant 
respondents slept under an LLIN the previous night in 
Kebbi/Sokoto and Zamfara, with little difference across 
wealth quintiles or maternal education. Similarly, in 
households with sufficient nets, over 90 percent of 
children under 2 years slept under an LLIN the previous 
night in integrated and malaria-only areas, with limited 
differences across sociodemographics. 
There was also extremely high overall awareness about 
the importance of LLINs in malaria prevention. Almost all 
respondents agreed that malaria was caused by mosquito 
bites (97%), and that sleeping under mosquito nets was 
an effective malaria prevention method (93%). In addi-
tion, nearly all respondents stated they were expected 
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to be able to get all their children under 5 years sleeping 
under a mosquito net every night of the year (93%). The 
results suggest that SBC programming to raise awareness 
about malaria prevention measures is not needed, but 
improving access, acceptability, and efficacy to use LLINs 
as directed may be a useful programmatic focus.
Malaria during pregnancy: Less than one in five 
respondents in study areas took intermittent preven-
tive treatment as directed (three or more sulfadoxine/
pyrimethamine(SP)/Fansidar doses) during their last 
pregnancy, with lower rates among respondents in the 
poorest households (10% and 12%) compared with the 
wealthiest (33% and 34%). Lower percentages were 
also observed among the less educated (15% and 14%) 
compared to respondents who attended at least some 
primary school (36% and 25%). The most common rea-
sons for not taking SP/Fansidar during the last pregnancy 
were opposition by the respondent (34%) or spouse 
(33%), and further research is needed to understand 
this opposition. Moreover, the “other” category was 
disproportionately high and largely included the following 
responses: did not attend antenatal care (ANC) or facility 
to obtain medicines, not sick or did not have pregnancy 
complications, and not necessary or customary to take 
medications. In addition, more frequent ANC visits is also 
associated with a higher likelihood of IPTp uptake. BSS 
baseline results show that women who attended ANC 
four or more times during the last pregnancy were about 
six times more likely to receive IPTp than those attending 
ANC only one time.
Taken together, these responses underscore the need for 
SBC messaging to reinforce the importance of intermit-
tent preventive treatment for malaria during pregnancy 
(IPTp) as a key component of essential antenatal care 
services. In addition, while 91 percent of respondents 
agreed that malaria in pregnancy can affect the fetus, 
far fewer could state the specific risks to the baby. Only 
about half reported fetal death (45%) or miscarriage 
(44%) as specific risks from malaria in pregnancy, while 
far fewer reported premature birth (26%) and low birth 
weight (17%) as specific risks. Building knowledge of 
malaria risks and specific health consequences for the 
fetus may be a driver toward greater adoption of preven-
tion behaviors. 
Malaria treatment: While there were high rates of 
care-seeking for children under 2 years of age with fever, 
33 percent and 54 percent of those who were taken to 
care in Kebbi/Sokoto and Zamfara, respectively, went to 
a pharmacy where poor-quality care persists. The most 
important reasons for choosing the treatment location 
for pediatric fever care were trust (36%), nearby location 
(33%), and effective treatment (28%). These findings 
underscore the importance to women of convenient, 
trusted, and high-quality health services provision. 
Importantly, respondents also reported that few of their 
febrile children were tested for malaria (19% and 24%), 
and few of their febrile children were given artemisi-
nin-based combination therapies (ACT) (22% and 36%) in 
Kebbi/Sokoto and Zamfara. The low prevalence of testing 
may be due in large part to care-seeking from pharma-
cies. Nearly all respondents reported intentions to take 
a child with a fever to care the same/next day (92%) and 
to make sure the child takes the entire treatment course 
(92%). This finding suggests that while respondents know 
the recommendation and have stated intentions to act, 
such knowledge and intentions may still not translate to 
behavioral action. However, while 74 percent agreed that 
a blood test is the only way to know whether a person 
has malaria, most respondents (61%) agreed that they 
still worry the illness could be malaria even if the test 
result is negative. This implies some lack of confidence in 
negative malaria test results that reinforces Breakthrough 
ACTION/Nigeria’s ongoing efforts to change malaria 
diagnosis perceptions and practices. 
MNCH+N
Antenatal care: There is low ANC attendance across 
Breakthrough ACTION program areas, with approxi-
mately one-third (32% and 38%) and one-quarter (20% 
and 26%) of respondents attending ANC one or more or 
four or more times during the last pregnancy in Kebbi/
Sokoto and Zamfara, respectively. The most common 
reasons for not attending ANC were lack of perceived 
need (42%), spousal opposition (25%), fatalism (“It’s up to 
God”) (20%), and perceptions that ANC is not the norm 
(13%). This finding suggests lack of information, poor risk 
perceptions, and lack of awareness about the benefits 
of ANC to a mother and her newborn. In addition, more 
than two-thirds (67%) of respondents said their spouses 
influence their decision to go to ANC four or more times, 
making spousal support or opposition a critical facilitator 
or barrier to uptake. The data suggest that capturing 
husband ideations may be important to inform future 
spousal communications interventions. There are also 
common ANC myths that persist among respondents. 
Overall, 48 percent and 35 percent of respondents 
agreed that pregnant women need ANC only when sick, 
and 25 percent agreed that only first-time mothers 
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need ANC. A significant percentage of respondents—40 
percent and 30 percent in Kebbi/Sokoto and Zamfara, 
respectively—noted that it is better to use a traditional 
provider than a health facility for ANC. These perceptions 
point to areas for SBC messaging to improve awareness 
of the benefits of ANC even for healthy pregnancies 
that could lead to additional ANC uptake going forward. 
Finally, birth planning with a health worker during ANC 
does not appear to be standard practice, although one in 
three respondents reported having discussed birth plans. 
This suggests a strong starting point for making further 
inroads in this important area. 
Facility delivery: Facility delivery was an uncommon 
practice in Kebbi/Sokoto (14%) and Zamfara (16%) 
among respondents during their last pregnancy. More 
than 80 percent of respondents delivered at their own 
or another home, and births are commonly assisted by 
family members (36%) or traditional birth attendants 
(29%). The most common reasons for not delivering at a 
facility were that they did not feel it was necessary (75% 
and 61%) followed by spousal opposition (15% and 36%) 
in Kebbi/Sokoto and Zamfara, respectively. Similar to 
ANC results, this finding suggests there is a critical lack of 
information, poor risk perceptions, and lack of awareness 
about the benefits of facility-based delivery to make this 
service feel necessary to both women and their spouses. 
When respondents were asked who influences the deci-
sion to have a facility delivery, partner/spouse (57%) was 
the most common response, making spousal opposition 
another critical barrier to service utilization. About half 
(54%) of respondents agreed that the health facility is the 
best place to deliver a baby, but fewer (44%) felt confi-
dent that they could get to a health facility for delivery. 
About half (55%) were confident that they could start a 
conversation with their husband about facility delivery, 
and a similar proportion (51%) intended to deliver their 
next child at a health facility. These positive intentions 
around facility-based delivery represent an opportunity 
for SBC programs to support women with interventions 
to make it easier for them to act in accordance with their 
beliefs and intentions. 
Breastfeeding: Nearly all respondents (96%) reported 
ever breastfeeding their last-born child under 2 years. 
Yet initiating breastfeeding within one hour of birth was 
low across study areas, although the rate was higher 
in Zamfara (46%) than in Kebbi/Sokoto (36%). Exclusive 
breastfeeding for the first six months of life was low 
overall, with higher rates in Zamfara (46%) than in Kebbi/
Sokoto (26%). This low coverage is in large part due to 
high rates of giving non-breastmilk liquids to a child in 
the first three days after birth, with much higher practice 
rates in Kebbi/Sokoto (73%) than in Zamfara (50%). In 
relation to this practice, 23 percent of respondents also 
agreed that mother’s breastmilk after birth (colostrum) is 
bad, suggesting an area for future SBC messaging. Taken 
together, these responses suggest ways SBC messaging 
may help promote exclusive breastfeeding in this area. In 
addition, while there was high awareness of breastfeed-
ing and its benefits among respondents, only 55 percent 
of respondents felt confident to exclusively breastfeed 
their child for the first six months, with higher confidence 
in Zamfara (64%) than Kebbi/Sokoto (42%). Forty-one 
percent of respondents believed that most other women 
in their communities gave breastmilk exclusively to 
their infants, suggesting perceived social norms about 
breastfeeding. There was also higher intent to exclusively 
breastfeed their next child in Zamfara (59%) and Kebbi/
Sokoto (46%) compared to current exclusive breastfeed-
ing rates, indicating an opportunity to support mothers 
with their breastfeeding intentions, such as increasing 
family or social supports.
Vaccination: There was very low vaccination coverage, 
with only 4 percent and 8 percent of children aged 12 to 
23 months in Kebbi/Sokoto and Zamfara, respectively, 
who were fully vaccinated (bacilli Calmette-Guerin or 
BCG, measles, diphtheria-tetanus-pertussis or DTP3, and 
polio3) by the survey interview. The most important rea-
son for not vaccinating the child was spousal opposition 
(33%) followed by distance to the health facility (14%) 
and fear of needles (11%). Across study areas, 73 percent 
of respondents reported that their spouses influence 
their decision about child vaccinations, making spousal 
opposition an important barrier to vaccine uptake. The 
result suggests that capturing husband ideations may 
be important to inform future SBC interventions. While 
respondents generally gave positive reports about their 
own vaccine knowledge and attitudes, more specific 
questions elicited a less rosy picture. Specifically, only 
about half (52%) of respondents in Kebbi/Sokoto believed 
that health facilities frequently had vaccines available, 
compared with 61 percent in Zamfara. Only 47 percent of 
respondents in Kebbi/Sokoto and 66 percent in Zamfara 
believed most women in their communities took chil-
dren to facilities for routine vaccination. Approximately 
one in four respondents (26%) agreed that vaccines 
contain dangerous chemicals that could harm a child’s 
health. Few respondents knew when a child should first 
be vaccinated and the number of vaccinations children 
should receive by their first birthdays. Taken together, 
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results suggest relatively low vaccine knowledge, com-
mon perceptions of frequent vaccine stockouts at health 
facilities, spousal opposition to vaccine uptake, and the 
persistence of vaccine myths across the study area.
Acute respiratory infections: While there were high 
rates of care-seeking for children under 2 years with 
cough, rapid breathing, or other chest-related problems, 
only 49 percent and 33 percent of those who sought 
care were taken to a formal medical source in Kebbi/
Sokoto and Zamfara. Even fewer children with these 
respiratory symptoms were given antibiotics (41% and 
26%). The most common reasons for choosing the source 
of care across study areas were nearby location (40%), 
provider trust (36%), family/friend recommendation 
(30%), and effective treatment (27%), which underscores 
the importance to women of convenient, trusted, and 
high-quality health care providers in their communi-
ties. The most important reasons for not seeking care 
were expense/cost (33%) and symptoms not perceived 
as severe or home care was provided (25%). Pediatric 
pneumonia knowledge is low across study areas. Only 28 
percent and 37 percent of respondents reported rapid 
or difficult breathing as a symptom of pediatric pneu-
monia; 45 percent and 31 percent could not report any 
way to help prevent a child from getting pneumonia; and 
62 percent and 56 percent could not report any effec-
tive medicine to treat pneumonia in Kebbi/Sokoto and 
Zamfara, respectively. These results point to the need 
to shift care-seeking from pharmacies to formal medical 
sources and to improve overall pneumonia knowledge in 
study areas.
Diarrhea: Few children with diarrhea were given both 
oral rehydration solutions (ORS) and zinc, although this 
proportion was higher in Zamfara (27%) than in Kebbi/
Sokoto (13%). Among children with diarrhea, 36 percent 
and 56 percent were given ORS alone in Kebbi/Sokoto 
and Zamfara, respectively. While there were high rates of 
care-seeking for children under 2 years with diarrhea, 34 
percent and 56 percent of these children were taken to a 
pharmacy instead of the formal medical sector. The most 
important reasons for choosing the source of care were 
provider trust (39%), nearby location (29%), and effective 
treatment (24%), which underscores the importance to 
women of convenient, trusted, and high-quality health 
care provision in their communities. The most important 
reasons for not seeking care were expense/cost (32%), 
fatalism (“It’s up to God”) (29%), and symptoms not 
perceived as severe or care was provided at home (25%). 
Approximately one in four respondents (24%) had never 
heard of zinc across study areas. Across study areas, 63 
percent of respondents reported that ORS replaces lost 
water in a child with diarrhea, while 44 percent incor-
rectly noted that it stops diarrhea. These results point to 
the need to shift care-seeking from pharmacies to formal 
medical sources in the study areas.
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Background 
United States Agency for International Development 
(USAID)/Nigeria works to increase the utilization of 
quality primary health care services in targeted areas and 
population groups. Working with the Nigerian govern-
ment, USAID/Nigeria aims to improve human resources 
for health, deliver high-impact services, and strengthen 
leadership, management, governance, and accountabil-
ity in order to improve a wide set of health outcomes 
related to family planning, malaria, and maternal, 
newborn, and child health plus nutrition (MNCH+N) in 
Nigeria.1
Family planning in Nigeria
Modern contraceptive use in Nigeria has been histori-
cally low, without significant increases in the past two 
decades.2 In the three States of this study (Kebbi, Sokoto, 
and Zamfara), these indicators tend to be lower than 
national estimates. The 2018 Nigeria Demographic and 
Health Survey (NDHS) reported a persistently high total 
fertility rate (TFR) of 5.3 births per woman, which has 
been attributed to high rates of teenage pregnancy 
(19%), early marriage, low modern contraceptive prev-
alence among married women (12%), and high unmet 
need for family planning.3 A high fertility rate not only 
affects women and children’s health and survival, but 
also their long-term education and employment pros-
pects. Early childbearing is common among the poor; 
almost 60 percent of 20- to 24-year-olds living in the 
poorest households have had a child before the age of 
18.4
Misconceptions and negative perceptions about family 
planning use, such as beliefs that contraceptives are 
dangerous to a woman’s health or that they can harm a 
woman’s womb,5,6 are common. Opposition to use and 
wanting more children are also the predominant reasons 
women typically do not use modern contraceptives.4 
Spousal communication about contraceptive use is also 
low: The Nigerian Urban Reproductive Health Initiative 
(NURHI) reported that less than 20 percent of married 
women discussed family planning and fertility options 
with their spouses within the past six months.6
There is ample opportunity to effect change through 
social and behavior change (SBC) programming since 
few women have heard family planning SBC messaging. 
Nationwide, less than one-quarter of women and less 
than one-third of men aged 15 to 19 years reported hav-
ing heard any messages regarding family planning in the 
past few months, although 60 percent of young women 
in Lagos had heard such messages.3 In the six cities where 
NURHI conducted their endline survey, nearly two out of 
three women reported exposure to NURHI family plan-
ning television programs, and approximately three out of 
four had heard NURHI family planning radio programs.6
MNCH+N in Nigeria
Nigeria has one of the highest child mortality rates 
in the world.7 NDHS 2018 reported that the under-5 
mortality rate (U5MR) was estimated at 132 deaths 
per 1,000 live births in the five-year period before the 
survey, making Nigeria the largest contributor to child 
deaths in the African region.8 Moreover, the highest 
U5MR was found in the northern States, including 
Sokoto, Kebbi, and Zamfara. The leading causes of child 
©CRERD
BR E A K THROUGH R ESE A RCH  |  M A RCH 2020     7 
deaths include neonatal conditions, pneumonia, diar-
rhea, and malaria. Routine immunization rates remain 
low in Nigeria, with only approximately 50 percent of 
one-year-old children receiving measles and diphthe-
ria-tetanus-pertussis (DPT3) vaccines in 2018, with far 
lower rates in the northwestern region.
Appropriate treatment for common causes of child-
hood morbidity and mortality is low. Only 23 percent 
of children under 5 years with diarrhea received the 
recommended treatment of ORS and zinc, while only 
37 percent with symptoms of pneumonia were taken to 
a public sector provider for care. In terms of nutrition, 
one-third (37%) of children under 5 years were stunted 
in 2018. In addition, only 29 percent of infants were 
exclusively breastfed for the first six months of their life 
in 2018.3 
According to NDHS 2018, the Nigerian maternal mortality 
ratio remains among the highest in the world, at 512 
maternal deaths per 100,000 live births in the seven-year 
period before the 2018 survey.3 The main causes of 
maternal deaths include hemorrhage, hypertension, and 
indirect causes. In 2018, 57 percent of women attended 
antenatal care (ANC) at least four times during their last 
pregnancies, and only 39 percent of births took place 
in a facility, while 43 percent were attended by a skilled 
health professional. 
Malaria in Nigeria
Based on NDHS 2018, four Nigerian States are consid-
ered high-transmission zones, including Jigawa, Kebbi, 
Zamfara, and Sokoto. The latter three states are the 
setting for the Behavioral Sentinel Surveillance (BSS) 
study. In the north, transmission is year-round with 
seasonal peaks within a four-month window from June 
to September. Plasmodium falciparum is the principal 
malaria species, and Anopheles (An.) gambiae is the 
predominant mosquito vector.
While there has been great progress over the past 
decade in malaria control activities, the availability of 
key prevention tools and engagement in malaria preven-
tive behaviors remains sub-optimal. Only 61 percent of 
households owned at least one long-lasting insecticidal 
net (LLIN), although this represents significant improve-
ments, given that only 8 percent reported the same in 
NDHS 2008 and 50 percent in NDHS 2013. Approximately 
58 percent of pregnant women reported sleeping under 
an LLIN in 2018, and only 17 percent received intermit-
tent preventive treatment during pregnancy (IPTp) to 
prevent malaria.9 Exposure to malaria messaging—gener-
ally through radio, community drama, printed materials, 
community and religious leaders, community support 
groups, and household visits—has led to high levels of 
knowledge of malaria interventions, but misconceptions 
about the causes of and ways to manage malaria still 
remain.10
©CRERD
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Breakthrough ACTION in Nigeria
Breakthrough ACTION/Nigeria is the follow-up project to 
the Johns Hopkins Center for Communications Programs 
(JHU CCP) Health Communication Capacity Collaborative 
(HC3) project (2014–2018), which operated in three 
northern states (Bauchi, Ebonyi, and Sokoto). HC3 used 
a selection of SBC approaches to promote positive birth 
spacing and use of family planning methods by women 
of reproductive age. In the states supported by the 
President's Malaria Initiative (PMI), HC3 also used SBC 
approaches to support the government of Nigeria’s goal 
of attaining 80 percent of the population practicing 
appropriate malaria prevention and management by 
2020. 
Under HC3, an ideational theory of change for birth 
spacing was posited (see next section for a full descrip-
tion of this theory).11 Three primary SBC approaches were 
implemented across socio-ecological levels: 1) advocacy 
outreach to opinion leaders and community influencers 
at state and local government area (LGA) level, 2) direct 
engagement of community members through community 
dialogues and group meetings that included referrals for 
services, and 3) complementary SBC messaging through 
mass and mid-media.12 The reported impact of HC3 
efforts was positive normative change supporting birth 
spacing, acceptability of contraception to achieve optimal 
birth spacing, and sizable increases in the utilization of 
family planning methods reported by health facilities in 
program areas. For malaria, the 
combination of advocacy visits, 
community dialogues, and training 
of community health workers 
allowed HC3 to reach more than 
8,000 opinion leaders in Zamfara 
State alone. Furthermore, in an 
analysis in four of the five states 
in which HC3 malaria SBC activi-
ties were undertaken, exposure 
to malaria SBC messaging was 
associated with an approximately 
two-fold increase in the percent of 
respondents who slept under an 
LLIN.
Breakthrough ACTION/Nigeria, led 
by JHU CCP, leverages and expands 
the HC3 activities in Nigeria (Figure 
A-1). In particular, advocacy 
outreach expanded from state to LGA levels, and inte-
grated MNCH+N and malaria messaging using a life-stage 
approach is embedded with family planning SBC messag-
ing and expanded to additional wards and LGAs in three 
targeted states (Bauchi, Sokoto, and Kebbi). The official 
launch of these expanded, integrated SBC activities in 
the targeted states occurred on 19 September 2019, 
in Abuja, although staged implementation rolled out 
between early and late September in LGAs/wards across 
the three states. 
Table A-1 describes the key objectives of each life stage 
messaging within the Breakthrough ACTION/Nigeria 
approach used in those three states. This approach was 
based on extensive formative research conducted by 
Breakthrough ACTION/Nigeria to develop messaging 
materials for communities within these states. Based on 
this formative research, Breakthrough ACTION/Nigeria 
MNCH+N messaging has focused on gateway and/or 
multiplier effect behaviors, such as ANC and routine 
immunization. In addition, Breakthrough ACTION/Nigeria 
continues to support SBC messaging that promotes the 
use of malaria control interventions, including IPTp, LLINs, 
and seasonal malaria chemoprevention. Breakthrough 
ACTION/Nigeria also continues to implement SBC pro-
gramming in support of USAID PMI malaria programming, 
service delivery partners, and commodities distribution.
FIGURE A-1. MAP OF BREAKTHROUGH ACTION/NIGERIA AREAS 
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TABLE A-1. KEY OBJECTIVES OF LIFE STAGE APPROACH FOR INTEGRATED SBC PROGRAMMING 
                    AREAS
LIFE STAGE OBJECTIVE






those in early 
pregnancy
Increase proportion of pregnant women who attend first ANC as soon as they become aware of pregnancy and at least 
four times during pregnancy and up to eight times
Increase proportion of pregnant women taking three or more doses of IPTp as prescribed by health worker during ANC 
Increase proportion of pregnant women who adhere to nutrition counseling to improve dietary intake during pregnancy
Increase proportion of pregnant women who sleep inside an insecticide-treated net 
Increase proportion of pregnant women/partners who develop a birth plan to increase intention to deliver at a health 
facility
Increase proportion of pregnant women who deliver at a health facility and/or with a skilled birth attendant





women in late 
pregnancy and 
those with a 
newborn (first 4 
weeks of life)
Increase proportion of pregnant women and their partners who develop a birth plan to increase intention to deliver at a 
health facility
Increase proportion of new mothers placing their baby on their abdomen for warmth immediately after birth
Increase proportion of new mothers who start breastfeeding within 30 minutes of giving birth
Increase proportion of new mothers who use chlorhexidine to cleanse their baby's umbilical cord for seven days
Increase proportion of mothers who complete all immunizations scheduled at birth per Nigerian policy
Increase proportion of new mothers who use misoprostol to stop bleeding for post-partum hemorrhage 
Increase proportion of new mothers who adhere to nutrition counseling to improve dietary intake post-partum
Increase proportion of new mothers and babies who sleep inside an insecticide-treated net
Increase proportion of new mothers who attend postnatal care check-ups







Increase proportion of children between 12 and 23 months who are fully immunized per Nigerian policy
Increase proportion of children under 6 months who are exclusively breastfed
Increase proportion of children six months to 2 years whose caregivers follow recommended infant and young child 
feeding practices
Increase proportion of children under 5 years who sleep inside an insecticide-treated net 
Increase proportion of children under 5 years with fever promptly taken for care and tested for malaria before treatment
Increase proportion of malaria-positive cases that take a full course of ACT
Increase proportion of children under 5 years with diarrhea promptly taken for care and given appropriate treatment





Increase proportion of men and women who use modern contraceptive methods
Increase proportion of women who receive nutrition counseling to improve dietary intake
Increase proportion of women, men, youth, and children who sleep inside an insecticide-treated net 
Increase proportion of women who intend to attend ANC early in their next pregnancy
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Theory of Strategic Communication 
and Behavior Change
The BSS questionnaire was largely informed by Kincaid’s 
Theory of Strategic Communication and Behavior Change 
(Figure A-2).12 In this model, ideations consist of three 
main domains—cognitive, emotional, and social. The 
two defining elements of attitude are beliefs and values, 
which indicate the perception of either the positive or 
negative consequence of a health behavior. Subjective 
norms involve an individual’s thoughts around what 
other individuals within their communities are doing or 
what they think they are expected by others to do. Self-
image refers to an individual’s belief about themselves 
in relation to a behavior, and self-efficacy measures how 
confident a person feels to perform a certain behavior. 
The social component involves interpersonal processes 
aimed at persuasion to adopt a behavior.
Furthermore, in this model, communication is consid-
ered an external factor impacting other variables in the 
model and shows how and why it impacts both intention 
and behavior. Communication has an indirect impact 
on behavior through its effect on skills and knowledge, 
ideations, and environmental support and constraints. 
Thus, the components in this model can be described 
as the “cognitive, emotional, and social outcomes of com-
munication and determinants of intention and behavior.” 
Because these components of ideation are regarded as 
intermediate outcome variables impacting intention and 
behavior, the Kincaid model represents a causal chain of 
the determinants of behavior where change is interde-
pendent, simultaneous, and interactive. 
The Breakthrough ACTION Integrated Health SBC 
Strategy (January 2019) was informed by this theory 
of change model, which was used to develop the SBC 
multi-level approach for influencing sociocultural and 
environmental determinants, as well as relationships 
and structural factors that affect MNCH+N, malaria, 
and family planning behaviors. Within these domains, 
Breakthrough ACTION’s programming expicitly recog-
nizes the centrality of community, household, and service 
delivery systems to effect desired change given the 
strong influence of social norms on behaviors and the 
critical role of health providers. Breakthrough ACTION 
also places a strong emphasis on the supportive environ-
ment as the foundational support to behavior change. 
Ideational factors are central to Breakthrough ACTION’s 
FIGURE A-2. THEORY OF STRATEGIC COMMUNICATION AND BEHAVIOR CHANGE 
Kincaid DL, Delate R, Storey JD & Figueroa ME. (2013). Closing the gaps in practice and in theory: evaluation of the Scrutinize HIV Campaign in South 
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SBC programming to help guide priorities and messaging, 
including knowledge, beliefs, values, risk perceptions, 
self-efficacy, social norms, perceived social support from 
key influencers, and spousal communication, among 
others. The more positive ideational factors held by 
a person about a given behavior, the more likely they 
are to engage in that behavior. Breakthrough ACTION 
has prioritized messages and activities to shift specific, 
actionable ideational factors for low prevalence behav-
iors, such as spousal communication about contraceptive 
use, as detailed in their strategy document.
Integrated versus health-area-
specific SBC messaging
There has been recent and growing interest in and 
implementation of integrated, multi-component SBC 
programming. These programs often operate at multiple 
levels of the socio-ecosystem (individual, household, and 
community) and span multiple health components (e.g., 
family planning, MNCH+N, and malaria), or may even 
address cross-sectoral outcomes (e.g., agriculture, health, 
and education). This shift has been partly motivated by 
the desire to meet the complex and multi-faceted needs 
of target populations, to effectively address underlying 
common causes and determinants of closely related 
health outcomes, and to increase cost-efficiencies. Yet 
there have been few systematic evaluations of integrated 
SBC programs and limited robust evidence on the effec-
tiveness of integrated SBC programs in improving target 
health and development outcomes.13 
Study rationale
The partnership of Breakthrough ACTION/Nigeria and 
Breakthrough RESEARCH/Nigeria  presents a unique 
opportunity to dovetail rigorous research design with 
state-of-the-art SBC programming to identify whether or 
not integrated SBC programming is more effective than 
vertical programming in promoting select healthy family 
behaviors. The study focused on pregnant women and 
women within the 1,000-day window of opportunity, 
and is closely tied to the primary Breakthrough ACTION/
Nigeria objective of improving key behaviors and ide-
ations related to MNCH+N, malaria, and family planning 
among this target group in order to improve the lives and 
well-being of women and families. 
Study objectives
This research exploited Breakthrough ACTION/Nigeria’s 
variation in integrated programming in Nigeria to 
assess the effectiveness of integrated SBC approaches 
to improve healthy behaviors and ideations across the 
Breakthrough ACTION/Nigeria project life cycle. To date, 
there has been little research on best practices in SBC 
integration methods to promote a wide range of healthy 
family behaviors and outcomes. Key study objectives 
include:
• Objective 1: Assess the effectiveness of integrated 
SBC programming relative to malaria-only SBC pro-
gramming focusing on pregnant women and women 
with a child under 2 years of age.
• Objective 2: Collect and report on a selection of 
ideational and priority behavioral indicators across 
MNCH+N, malaria, and family planning to inform 
Breakthrough ACTION/Nigeria implementation and 
scale-up.
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Methodology
Tulane University and Population Council, in collaboration 
with the Center for Research, Evaluation Resources, and 
Development (CRERD), conducted the BSS baseline sur-
vey in September 2019. Table A-2 provides an overview 
of the research activities, methods, and study instru-
ments with a detailed discussion of these methods in the 
following sub-sections.
Study location
Three states were identified, in collaboration with USAID/
Nigeria and JHU CCP, for the study setting: Kebbi and 
Sokoto States targeted by Breakthrough ACTION/Nigeria 
for integrated SBC programming and Zamfara State tar-
geted by Breakthrough ACTION/Nigeria for malaria-only 
SBC programming. These three states, located in north-
western Nigeria, are contiguous and share a border with 
Niger Republic, while Kebbi also borders Benin to the 
west. The dominant religion and ethnicity in these states 
are Islam and Hausa, respectively. The total populations 
are 5.4 million (Sokoto), 3.5 million (Kebbi), and 4.1 mil-
lion (Zamfara). The northwestern region has among the 
highest poverty rates and poorest health outcomes in 
Nigeria, including under-5 mortality rates of 119 (Sokoto), 
174 (Kebbi), and 210 (Zamfara) per 1,000 live births. Addi-
tionally, the maternal mortality ratio (MMR) in Nigeria 
was estimated at 917 maternal deaths per 100,000 live 
births in 2017, and is likely much higher in the northwest 
region.14–16 Agriculture is the main source of income for 
people living in this region.13,17–21 
TABLE A-2. STUDY OVERVIEW 
Study design A quasi-experimental and dose-response study. Women in the 1,000-day window in Breakthrough ACTION/Nigeria in-
tegrated areas (Sokoto, Kebbi) will be compared with women in Breakthrough ACTION/Nigeria vertical areas (Zamfara). 
Furthermore, the study will include dose-response design to compare women in high-dose integrated messaging areas 
(e.g., additional household visits) with women in standard-dose messaging areas. Community screening will be used 
to identify pregnant women to form a cohort to be followed over the life of the Breakthrough ACTION/Nigeria project. 
Women within the 1,000-day window will also be identified and interviewed cross-sectionally over the life of the Break-
through ACTION/Nigeria project.
Study location Breakthrough ACTION/Nigeria integrated implementation LGAs/wards in Kebbi and Sokoto States; LGA/wards with 
vertical malaria-only Breakthrough ACTION/Nigeria implementation in Zamfara State
Study  
population
Pregnant women and women with a child under 2 years old living within Breakthrough ACTION/Nigeria programming 
wards in Kebbi, Sokoto, and Zamfara States. For the purpose of this report, the study population is referred to as 
respondents.
Study period June 2019 to March 2022
Sample size 6,034 respondents
Annex  
materials
Annex 1-a: Adult consent form
Annex 1-b: Guardian consent form
Annex 1-c: Adolescent consent form
Annex 1-d: Adult caregiver consent form for orphaned and vulnerable children (OVC) interview
Annex 2: Community screening instrument
Annex 3-a: Household questionnaire
Annex 3-b: Female questionnaire
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Study design
The BSS survey targets pregnant women and women 
with a child under 2 years living in Breakthrough ACTION/
Nigeria programming areas targeted for integrated SBC 
messaging (Kebbi/Sokoto) and targeted for malaria-only 
SBC messaging (Zamfara). Since Breakthrough ACTION/
Nigeria covers only parts of these states, the data are 
representative of these populations within Breakthrough 
ACTION/Nigeria programming areas but not across the 
states at large. The BSS aims to measure changes in 
behaviors and ideations across family planning, malaria, 
and MNCH+N among this study population at base-
line, midline, and endline periods of the Breakthrough 
ACTION/Nigeria project cycle. 
The BSS will include both quasi-experimental and 
dose-response study design components. For the 
quasi-experimental design, ideational factors, behaviors, 
and outcomes among women in the 1,000-day window 
of opportunity in the integrated programming states of 
Kebbi and Sokoto will be measured and compared across 
time with those indicators for similar women in Zamfara 
State, which has been targeted for malaria-only SBC mes-
saging. For the dose-response design, and to measure 
the effect of more intensive integrated programming 
in terms of household visits, wards within a subsample 
of Breakthrough ACTION/Nigeria program areas will 
be purposefully chosen with Breakthrough ACTION/
Nigeria’s assistance to receive additional programming 
(e.g., additional household visits). In previous studies, 
the effectiveness of SBC interventions has been shown 
to hinge upon the intensity of interventions.22 Table A-3 
highlights the three study comparison arms in terms of 
household visit activities. 
Study population
The study population includes currently pregnant women 
aged 15 to 49 years and women aged 15 to 49 years 
with a child under 2 years who are living in Breakthrough 
ACTION/Nigeria program areas targeted for integrated 
SBC messaging (Kebbi/Sokoto) and for malaria-only SBC 
messaging (Zamfara). The study was powered to assess 
Breakthrough ACTION/Nigeria SBC program impact for 
these two population groups, as described in the next 
section.
Sampling frame
The sampling frame for the study population was gen-
erated through community screening conducted in 108 
clusters/wards across the three states (36 wards/clusters 
per state), which were selected using digital maps and 
grid sampling methodology (Figure A-3). Within each 
sampled cluster/ward, the community screening tool was 
used to identify all pregnant women and a random selec-
tion of women with a child under 2 years for inclusion in 
the BSS baseline survey using the following criteria: 
1. The household must include at least one currently 
pregnant woman or at least one woman with a child 





36 randomly selected wards in Kebbi/Sokoto: 
• Women currently in one life stage receive one household visit (with one life stage dialogue)




36 randomly selected wards in Kebbi/Sokoto: 
• Women currently in one life stage receive two household visits (with one life stage dialogue and a 
second visit as a follow-up within seven days to reinforce key messages from the previous life stage 
dialogue and to follow-up on referrals)
• Women in two life stages receive three household visits (with two different life stage dialogues given 
within seven days of each other, and a third visit as a follow-up within 10 to 14 days to reinforce key 
messages from the previous two life stage dialogues and for referral follow-up)
Malaria-only SBC 
program
All wards in Zamfara:
• Women receive one household visit with standard malaria-only dialogue 
TABLE A-3. STUDY COMPARISON ARMS
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2. The woman must be between the ages of 15 and 49 
years.
3. The woman must be willing and able to provide 
informed consent to participate.
Importantly, since only a quarter of women in the 
northern states attend ANC in the formal health sector, 
a community screening approach was necessary to 
prevent the omission of pregnant women who do not use 
formal sector care. Recruiting only women who present 
for ANC at health facilities would not reach all women 
targeted by Breakthrough ACTION/Nigeria programming 
and would introduce biases for understanding program 
effectiveness. 
Sample size estimation
The sample size was estimated based on the quasi-ex-
perimental study design that contains three comparison 
arms: (1) high-dose intervention in integrated SBC areas, 
(2) standard-dose intervention in integrated SBC areas, 
and (3) malaria-only SBC programming. The sample was 
chosen to ensure the detection of expected changes 
in priority behavioral outcomes across integrated and 
malaria-only SBC areas in the quasi-experimental design, 
to allow for assessment of the impact of variations in 
Breakthrough ACTION/Nigeria programming, and to 
account for potential attrition from the BSS cohort. To 
reduce attrition, pregnant women selected for the BSS 
cohort will be tracked across time by collecting detailed 
contact information, including name, address, GPS coor-
dinates of dwelling, and phone numbers.
To determine the required sample size for the baseline 
survey, a Stata 15.0 sample size routine for cluster 
sampling was used.23 The parameters specified for the 
sample size estimation included a power criterion of 0.80, 
alpha coefficient of 0.05, and intra-cluster correlations 
that varied by key outcomes as shown below. Table A-4 
presents the minimal detectable differences for priority 
outcomes. Based on this estimation, a sample size of 
approximately 3,000 pregnant women and 3,000 women 
with a child under 2 years were targeted for inclusion in 
the baseline survey, with similar sample sizes expected in 
future BSS rounds.
FIGURE A-3. DISTRIBUTION OF BSS SAMPLING WARDS IN KEBBI, SOKOTO, AND ZAMFARA STATES 
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Sampling strategy
We used the following sampling strategy to obtain the 
estimated sample size. We selected all pregnant women 
in a cluster based on a community screening tool. If the 
average cluster size is 150 households, this would yield 
approximately 25 pregnant women per cluster. With 36 
clusters per group, this yields 900 pregnant women per 
group. The total sample size would be 2,700 pregnant 
women, or 3,000 to account for 10 percent attrition. 
We further estimated the need to select 25 women per 
cluster with a child under 2 years. Again, with 36 clusters 
per group, this yields 900 women with a child under 2 per 
group, or 2,700. As before, it was planned to sample an 
additional 300 women with a child under 2 years to allow 
for 10 percent attrition.
Data collection and questionnaires
All eligible women were asked to respond to an inter-
viewer-directed BSS questionnaire. Development of the 
questionnaire was done through a collaborative process 
involving relevant stakeholders, including: Breakthrough 
ACTION/Nigeria, JHU CCP, USAID Headquarters and 
Nigeria Mission, and PMI. The household questionnaire 
collected information on usual resident household mem-
bers, bed net ownership and use, and household assets 
and characteristics. The female questionnaire asked all 
respondents about their demographics, reproductive 
history, contraceptive use, media exposure, gender 
norms, and ideations related to family planning, malaria, 
and MNCH+N. All pregnant women were specifically 
asked about current pregnancy behaviors, including 
ANC, malaria prevention in pregnancy, and nutritional 
practices. All women with a child under 2 years were 
specifically asked about behaviors for their last-born 
child within the past two years, including antenatal and 
delivery care, newborn care, breastfeeding, routine 
vaccination, malaria prevention and treatment, child and 
maternal nutrition, and childhood illness care-seeking 
and treatment, including for pneumonia symptoms. 
Training, pre-testing and fieldwork
Fieldwork was conducted simultaneously across the 
three states over a four-week period from 4 September 
2019 to 7 October 2019. All 168 fieldworkers (144 female 
interviewers and 24 supervisors) were trained together 
in Sokoto during a one-week period from 29 August 2019 
to 2 September 2019. A training manual was produced 
for each fieldworker to facilitate training sessions on the 
study objectives and survey instruments, ethical consid-
erations, and fieldwork procedures, with participation 
in a questionnaire pilot exercise. The questionnaire 
was translated into Hausa and pre-tested to confirm 
translations and skip patterns, and to assess question 
appropriateness and sequencing. 
Fieldwork supervision and teams
CRERD supervised and managed the BSS baseline survey 
implementation, as described in these sections. The 
fieldwork team in each state consisted of a state coor-
dinator who oversaw all the activities in the state and 
reported to the CRERD management team, as well as 168 
fieldworkers (144 female interviewers and 24 super-
visors). There were data quality assurance personnel 
in each state who monitored the data for each upload 
and who flagged any issues of concern immediately for 
discussion and resolution. There were five supervisors in 
each state, with a minimum of five and maximum of eight 
data collectors to one supervisor in line with the sample 
distribution. The management team traveled around 
TABLE A-4. PRIORITY INDICATORS AND  





ANC four or more 17.5% 0.29473 12–16 pp (a)
Facility delivery 6.0% 0.15223 5–9 pp (b)
Pregnant women 




5.2% 0.1234 4–8 pp (d)
DPT3 vaccination 
(12–23 months) 3.9% 0.07575 3–6 pp (e)
Modern contra-
ceptive use <1.0% 0.03894 pp (f)
Notes: (a) clustersampsi, binomial detectable difference p1(0.1749) k(36) 
m(25) rho(0.28064); (b) clustersampsi, binomial detectable difference 
p1(0.0599) k(36) m(25) rho(0.15223); (c) clustersampsi, binomial detect-
able difference p1(0.1768) k(36) m(25) rho(0.30883); (d) clustersampsi, 
binomial detectable difference p1(0.052) k(36) m(25) rho(0.12304); (e) 
clustersampsi, binomial detectable difference p1(.0389) k(36) m(25) 
rho(0.07575)
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the states to monitor the fieldwork as it was being 
conducted.  
Data entry and management
Survey questions were administered face-to-face by 
trained interviewers who entered responses into a 
secured handheld device (tablet). The handheld device 
was password-protected and the password was pro-
vided only to designated staff. Data from the handheld 
devices were removed from the device when uploaded 
to the central database. The completed data files on the 
handheld devices were encrypted after being completed. 
They were transmitted to the centralized storage in their 
encrypted format. Skips and data-entry checks were 
in place during the interview to prevent illogical data 
values. Survey data were uniquely identified through 
a numeric ID and were stored in central databases on 
password-protected computers that were transmitted 
regularly to the study investigators. All data were kept 
confidential and stored in a safe and secure place at 
Tulane and CRERD project offices. 
Data quality assurance
CRERD selected the field teams based on proven integrity 
in data collection during a previous performance. More 
than 90 percent of the field team participated in previous 
CRERD survey activities or with their close collaborators. 
The following quality assurance checks were also con-
ducted during data collection:
• Use of spatial data to ensure that the interviewer 
went to the assigned location for the interview. This 
was done based on geolocated household position-
ing and Google Earth maps, which show key visual 
features to determine whether the location of the 
interview was correct.
• The use of time stamps in the data (at the beginning 
and end of each interview) provided two import-
ant pieces of information to evaluate data quality: 
interview start time and duration. A typical interview 
should occur between 7:30am and 8pm. Any inter-
view outside these times was flagged as suspicious. 
If the interview was too long or too short (and if this 
happened in consecutive or frequent interviews), the 
supervisor or interviewer was asked to explain.
• Interviewer performance dashboard allowed the 
CRERD management team to monitor interviewer 
errors, time taken for interviews, and the number 
of interviews completed. All of the information 
consolidated on a dashboard was used to monitor 
the progress of each interviewer. The dashboard 
helped the survey management team to check on 
field workers’ productivity. It was also a tool for 
identifying top-performing individuals and teams for 
recognition.
• Field inspection allowed CRERD management and 
field supervisory teams to monitor all aspects 
of fieldwork activities. These teams inspected 
interviews to ensure the respondents had enough 
privacy, consent was obtained, and questions were 
clearly asked. They also ensured that interviewers 
behaved in a culturally sensitive way during fieldwork 
activities.
Uploaded data files were also reviewed for complete-
ness, clarity, and consistency of reporting:
• Completeness: All data files were checked to ensure 
that all planned interviews were conducted. This 
was done by matching the number of interviews 
documented in the field report with what was found 
in the uploaded files. If there were any discrepan-
cies, this was flagged by the data auditors, and field 
supervisors were asked to explain the difference 
and resolve the problem. We checked that the same 
interview was not uploaded twice, and, if duplicates 
occurred, the interviewer was asked to identify the 
correct version for upload. We also checked that all 
variables were properly captured, and we performed 
a skip analysis to ensure no incorrect skip patterns 
occurred within the data. 
• Clarity: We ensured that the data variables followed 
the questionnaire sequence. All value and variable 
labels were clearly worded in a concise manner in 
the final dataset for ease of analysis. 
• Consistency: To ensure that the data files made 
logical sense, the following checks were conducted:
  Review of outliers: Using central tendency, all 
continuous variables were evaluated for outliers. 
Numbers that seemed too low or too high were 
communicated to the teams. These were most 
often typographical errors (e.g., double digits 
instead of a single digit). 
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  Population pyramid: We looked at the population 
pyramids across all three states to determine if 
the age and sex distributions we obtained from 
the household roster were realistic. 
  Average household size: Since we knew the 
average household size of each state, we were 
able to flag fieldworkers who returned household 
rosters with too few household members. In these 
cases, field supervisors were asked to verify data 
collected and to correct any issues if found. 
  Skip pattern analysis: We checked whether 
the skips were enforced before and after data 
cleaning.
Response rates
Tables A-5 and A-6 present the response rates across 
states for pregnant women and women with a child 
under 2 years, respectively.
Study sample
Table A-7 presents the final study sample in the BSS 
baseline survey by Breakthrough ACTION/Nigeria pro-
gram areas with either integrated (Kebbi/Sokoto) or 
malaria-only (Zamfara) SBC programming.
Ethical approval
Ethical approval for this study was obtained from the 
National Health Research Ethics Committee (NHREC) 
in Nigeria (NHREC/01/01/2007-02/09/2019) and the 
Tulane University Institutional Review Board (IRB) in 
Louisiana, USA (2019-1047). Written informed consent 
to participate in the survey was obtained from all willing 
participants for the household and female question-
naires. Each participant signed or marked her thumbprint 
on the consent form to signify willingness to participate.. 











SELECTED INTERVIEWED RESPONSE 
RATE
Kebbi   35   6,347 1,279 1,336     980     980 100%
Sokoto   37   6,987 1,443 1,527 1,036 1,035   99%
Zamfara   36   6,931 1,722 1,833 1,008 1,007   99%
All 108 20,265 4,444 4,696 3,024 3,022   99%











SELECTED INTERVIEWED RESPONSE 
RATE
Kebbi 35 6,347 2,510 3,288    980    980 100%
Sokoto 37 6,987 3,249 4,018 1,036 1,032 99%
Zamfara 36 6,931 2,989 4,112 1,008 1,008 100%
All 108 20,265 8,748 11,418 3,024 3,020 99%
TABLE A-7. STUDY SAMPLE
SAMPLE









N (%) currently  








N (%) women 15 to 49 
years old with a child 
under 2 years, or ob-
servations of last-born 
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Data analysis and results 
dissemination
The primary statistical comparison in the quasi-exper-
imental study is between respondents who have been 
exposed to integrated SBC programming and those who 
have been exposed to malaria-only SBC programming. 
Final results, as presented in this baseline report, evalu-
ate whether the characteristics of the samples across the 
study arms are statistically equivalent. All point estimates 
were tabulated using weights to account for unequal 
probabilities of selection due to over- and under-sam-
pling. Standard error estimation accounted for data 
clustering in the complex survey design. All analyses were 
conducted in Stata 16 (STATA Corp, College Station, TX).
Information generated from the study will be shared 
with research communities through well-established 
relationships with Obafemi Awolowo University, Ile-Ife 
(where our research partner CRERD is housed), and other 
academic institutions in Nigeria and internationally. We 
will also present the study findings to key stakeholders 
including Breakthrough ACTION/Nigeria and other USAID 
implementing partners, governmental decision-mak-
ers, and other stakeholders. Finally, results will feed 
into regional presentations where applicable, and we 
anticipate that the rigor of this study design will evoke 
substantial interest in these findings from the global SBC 
community. 
Comparison between NDHS and BSS results
Table A-8 summarizes some issues to keep in mind 
when comparing results from the NDHS 2018 and the 
BSS baseline survey. For most BSS and NDHS indicators, 
confidence intervals around estimates overlap, indicating 
no real difference in results. 
TABLE A-8. NOTES ON COMPARING NDHS AND BSS BASELINE RESULTS
BSS BASELINE NDHS 2018 COMMENTS
Survey timing September 2019 August–December 2018 Differences in some results may be due to program-
matic activities at the time of survey collection that 
lead to rapid increases in coverage estimates that 
then could wane in subsequent months or years, e.g., 
LLIN distribution campaigns
Representation Representative of wards tar-
geted by Breakthrough  
ACTION for integrated SBC 
(Kebbi/Sokoto) and  
malaria-only SBC (Zamfara) 
programming
Representative at state level 
(Kebbi, Sokoto, Zamfara)
Differences in some results may be due to differences 
in the representativeness of BSS and NDHS estimates. 




Women 15 to 49 years who are 
currently pregnant or have a 
child under 2 years
Women 15 to 49 years Differences in some results may be due to different 
target populations from which the samples were 
drawn. Women 15 to 49 years old who are currently 
pregnant or have a child under 2 years may be differ-
ent in systematic ways than the overall women 15- to 
49-year-old population that is sampled for NDHS.
Confidence 
intervals (CI)
All point estimates have associated confidence intervals within which the “true” population value lies (if samples are 
repeatedly drawn from a target population, the true population value will lie within the 95% CI range in 95 of 100 times 




Most indicators in BSS and NDHS are measured using the same methods and definitions. For some indicators, there 
are differences in indicator definitions based on how data were collected that could lead to differences in results (e.g., 
exclusive breastfeeding)
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Demographics
Key findings
Study sample: The BSS included 6,034 households, with 
4,022 (67%) in Kebbi/Sokoto and 2,012 (33%) in Zamfara. 
There were 3,026 currently pregnant women 15 to 49 
years old, including 2,023 (67%) in Kebbi/Sokoto and 
1,003 (33%) in Zamfara. There were 3,040 women 15 to 
49 years old with a child under 2 years, or observations of 
last-born children in the past two years, including 1,971 
(65%) in Kebbi/Sokoto and 1,069 (35%) in Zamfara. 
Household characteristics: Among sampled house-
holds, a statistically significant higher percentage had an 
improved drinking water source in Zamfara (75%) than 
in Kebbi/Sokoto (34%). Zamfara also had a statistically sig-
nificant higher percentage of households with improved 
sanitation facilities (48%) compared with Kebbi/Sokoto 
(27%). There were important differences in household 
wealth and assets across Kebbi/Sokoto and Zamfara. 
In Kebbi/Sokoto, 29 percent of households were in the 
poorest wealth quintile, compared with 10 percent in 
Zamfara. Similarly, 17 percent of households were in the 
wealthiest quintile in Kebbi/Sokoto, compared with 28 
percent in Zamfara. 
Radio ownership was statistically significant higher in 
Zamfara (41%) than in Kebbi/Sokoto (28%), which has 
important implications for Breakthrough ACTION/Nigeria 
radio programming going forward as a means to dissem-
inate health messages to populations. As discussed in 
Chapter 9 (Media Exposure), radio listening was the most 
common form of media exposure among respondents 
compared to television, newspapers, internet, or other 
media forms. Mobile phone ownership was similarly 
higher in Zamfara (57%) and Kebbi/Sokoto (48%), 
which again may have implications for Breakthrough 
ACTION/Nigeria programming of health messages. 
About three-quarters of households across study areas 
were reported to lie within 30 minutes’ travel time of a 
school, health center, road, or market. Less than half of 
households (46%) were reportedly within 30 minutes’ 
travel time of a general hospital, which has important 
implications for health services utilization promoted by 
Breakthrough ACTION/Nigeria SBC activities.
Respondent characteristics: There were no real dif-
ferences in respondents’ ages across Kebbi/Sokoto and 
Zamfara, with more than half of respondents (55%) aged 
20 to 29 years across study areas. Nearly all respondents 
(98%) across study areas were married, and most respon-
dents (73%) never attended school or received Islamic 
education (11%), with a slightly higher proportion with no 
education in Kebbi/Sokoto (78%) than in Zamfara (69%). 
As a result, there was also high illiteracy among respon-
dents across all areas (79%). Nearly all respondents were 
Muslim (>99%), and Hausa was the main ethnic group 
(88%) across study areas. In terms of spouse character-
istics, more than half (55%) of spouses never attended 
school, with higher proportions in Kebbi/Sokoto (63%) 
than in Zamfara (51%). Spouses tended to be older, with 
nearly half (45%) reported to be 40 years or older across 
study areas. Across study areas, 66 percent of spouses 
had no other wife, while 24 percent had two other wives. 
TABLE 1.1.1. STUDY SAMPLE
Percentage of households, pregnant women and women 15 to 49 years with a child under 2 years in the BSS baseline 
study sample, September–October 2019
SAMPLE BREAKTHROUGH ACTION/NIGERIA PROGRAM AREA
KEBBI SOKOTO ZAMFARA TOTAL
N (%) households 1,960 (32.5%) 2,062 (34.2%) 2,012 (33.3%) 6,034 (100.0%)
N (%) currently pregnant women 15 to 49 years 984 (32.5%) 1,040 (34.3%) 1,004 (33.2%) 3,028 (100.0%)
N (%) women 15 to 49 years with a child under 2 years (or observa-
tions of last-born children in the past 2 years)
893 (29.4%) 1,078 (35.4%) 1,069 (35.2%) 3,040 (100.0%)
1
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TABLE 1.1.2. HOUSEHOLD CHARACTERISTICS








% % % %  N
Main source of  
drinking water       
Improved source 44.9 23.6 74.6 33.5 3,035 1122.209
Unimproved source 55.1 76.4 25.4 66.5 2,997 17.663
Total 100.0 100.0 100.0 100.0 6,032 ***
N 1,960 2,061 2,011 4,021   
Main sanitation 
facility       
Improved 26.1 27.0 48.0 26.6 2,340 280.414
Unimproved 73.9 73.0 52.0 73.4 3,689 5.444
Total 100.0 100.0 100.0 100.0 6,029 **
N 1,959 2,061 2,009 4,020   
Main flooring  
material       
Earth/sand 67.7 67.0 55.0 67.3 3,490 170.903
Ceramic tiles 2.6 3.3 6.0 3.0 297 2.190
Cement 29.6 28.3 38.4 28.9 2,188 .
Parquet/Polished 
wood 0.1 0.1 0.5 0.1 12  
Other 0.0 1.5 0.1 0.8 47  
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
Main roofing material       
Thatched/Palm leaf 16.4 23.0 11.1 20.0 978 134.733
Metal/Iron sheets 83.5 74.8 87.5 78.8 4,986 1.733
Calamine/Cement 
fiber 0.1 1.3 0.8 0.8 42 .
Other 0.0 0.9 0.6 0.5 28  
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
Improved drinking water sources include piped supplies and non-piped supplies (boreholes/tube wells, protected wells and springs, rainwater, pack-
aged water, and delivered water); unimproved drinking water sources include unprotected wells and springs.
Improved sanitation facilities include network sanitation and on-site sanitation (flush or pour flush toilets or latrines connected to septic tanks or pits, 
ventilated improved pit latrines, pit latrines with slabs, composting toilets including twin pit latrines, and container-based systems; unimproved sanita-
tion facilities include on-site sanitation (pit latrines without slabs, hanging latrines, bucket latrines).
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TABLE 1.1.3. HOUSEHOLD WEALTH AND ASSETS








% % % % N
Household wealth index       
Lowest 29.4 34.2 11.8 32.0 1,367 470.004
Second 21.8 20.4 19.3 21.1 1,167 5.319
Middle 18.7 20.0 20.4 19.4 1,178 ***
Fourth 13.9 12.2 24.8 13.0 1,050  
Highest 16.2 13.2 23.7 14.6 1,272  
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Household owns
Livestock, other farm animals, 
or poultry       
No 29.9 28.2 34.9 29.0 1,962 23.425
Yes 70.1 71.8 65.1 71.0 4,072 0.857
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Any agricultural land       
No 15.2 11.5 25.6 13.2 1,236 144.819
Yes 84.5 87.8 74.1 86.3 4,773 3.561
Don't know 0.3 0.7 0.3 0.5 25 *
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Radio       
No 76.5 71.0 59.3 73.5 4,090 137.896
Yes 23.6 29.0 40.7 26.5 1,944 5.937
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Television       
No 87.2 89.0 85.3 88.1 5,071 11.928
Yes 12.8 11.0 14.7 11.9 963 0.390
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Mobile phone       
No 51.3 56.0 45.0 53.8 2,965 50.904
Yes 48.8 44.0 55.0 46.2 3,069 1.538
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Computer       
No 99.0 97.6 97.9 98.3 5,902 7.580
Yes 1.0 2.4 2.1 1.7 132 1.325
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Household owns bicycle       
No 88.6 86.9 81.8 87.7 5,170 38.948
Yes 11.4 13.1 18.2 12.4 864 1.844
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Motorcycle or motor scooter       
No 67.7 72.0 65.8 70.0 4,129 17.002
Yes 32.3 28.0 34.2 30.0 1,905 0.965
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Car or truck       
No 95.2 94.3 92.9 94.7 5,625 8.680
Yes 4.8 5.7 7.1 5.3 409 0.726
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 1.1.4. HOUSEHOLD DISTANCES TO EDUCATION, HEALTH, AND ECONOMIC CENTERS
















(N= 4,022)  (N=6,034)
School       
0–30 minutes 75.2 58.3 75.6 66.1 4,245 392.410
31–60 minutes 15.0 15.2 8.1 15.1 770 2.110
>60 minutes 2.2 6.4 0.0 4.5 165 .
Don't know 7.6 20.0 16.3 14.3 854  
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Health center       
0–30 minutes 73.4 74.3 86.2 73.9 4,672 250.750
31–60 minutes 16.0 12.7 7.1 14.2 775 1.686
>60 minutes 4.9 1.1 0.9 2.9 130 .
Don't know 5.7 11.9 5.8 9.0 457  
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
General hospital       
0–30 minutes 40.1 42.3 46.4 41.3 2,776 218.741
31–60 minutes 35.2 29.1 37.6 31.9 2,030 1.095
>60 minutes 16.5 11.7 5.1 13.9 553 .
Don't know 8.3 16.9 11.0 12.9 675  
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Bank       
0–30 minutes 32.2 15.6 31.6 23.3 1,788 656.162
31–60 minutes 24.7 17.6 35.8 20.9 1,529 3.263
>60 minutes 15.9 14.0 2.9 14.9 598 **
Don't know 27.2 52.8 29.7 41.0 2,119  
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Tarred road       
0–30 minutes 73.3 65.7 71.0 69.2 4,526 49.014
31–60 minutes 19.2 19.9 16.9 19.6 930 0.184
>60 minutes 1.5 6.3 5.3 4.1 182 .
Don't know 6.0 8.1 6.8 7.1 396  
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Local market       
0–30 minutes 83.4 79.2 79.4 81.1 4,891 119.425
31–60 minutes 5.9 9.1 10.5 7.6 478 0.596
>60 minutes 4.7 2.6 0.6 3.5 153 .
Don't know 6.0 9.2 9.5 7.7 512  
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
State capital       
0–30 minutes 10.7 12.1 26.5 11.4 1,146 448.449
31–60 minutes 10.5 24.7 25.0 18.1 1,320 2.001
>60 minutes 63.5 42.3 37.0 52.1 2,628 .
Don't know 15.4 21.0 11.6 18.4 940  
Total 100.0 100.0 100.0 100.0 6,034
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas. Note: While respondents must decide for 
themselves how to interpret health center and general hospital in this question, we believe health center would mainly be interpreted by respondents as 
PHC while general hospital would be interpreted as nearest referral or general hospital. 
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TABLE 1.1.5. RESPONDENT CHARACTERISTICS









% % % %  
Education (highest level attended)       
None 75.4 80.2 69.4 78.0 4,411 81.408
Primary 4.8 4.8 5.2 4.8 319 1.133
Secondary or higher 9.4 4.6 13.8 6.8 692 .
Islamic 10.5 10.3 11.6 10.4 611  
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Age (in years)       
15–24 years 41.0 46.8 41.8 44.1 2,715 3.688
25–34 years 45.0 41.7 44.4 43.2 2,575 0.436
35–49 years 14.0 11.6 13.8 12.7 743 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Ethnicity       
Hausa 72.9 91.1 92.2 82.7 5,067 188.541
Fulani 10.3 5.7 5.6 7.8 466 4.061
Badakare/Dakarkari 4.2 0.0 0.0 1.9 101 **
Other 12.6 3.2 2.2 7.5 399  
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Literacy       
Cannot read at all 84.9 75.2 78.8 79.7 4,668 138.322
Able to read only parts of sentence 6.4 4.7 9.9 5.5 489 3.169
Able to read whole sentence 6.1 4.6 7.7 5.3 473 *
Blind/visually impaired 0.1 0.0 0.2 0.1 8  
Unable to read the language of the card 2.4 15.5 3.4 9.4 395  
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Religion       
Islam 99.4 99.8 99.8 99.6 6,013 3.069
Christianity 0.6 0.2 0.2 0.4 19 1.184
Traditional religion 0.0 0.0 0.0 0.0 1 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Occupation       
No work outside home 42.4 52.2 42.8 47.6 2,726 26.298
Work outside home 54.4 44.1 51.3 48.9 2,966 0.401
Student 0.4 0.9 0.9 0.6 51 .
Other 2.9 2.8 5.0 2.8 218  
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
Marital status       
Married or living together to one person 96.6 95.2 91.8 95.8 5,765 55.561
Married to more than one person 2.7 4.0 5.8 3.4 196 1.875
Divorced/separated 0.6 0.5 0.5 0.5 32 .
Widowed 0.2 0.3 1.9 0.2 37  
Never married and never lived together 0.1 0.0 0.0 0.0 3  
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indicates 
p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 1.1.6. SPOUSE/PARTNER CHARACTERISTICS
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years by partner/spouse sociode-








% % % %  
Age       
<20 years 0.5 0.6 0.9 0.5 42 4.023
20–24 years 3.0 2.3 2.1 2.7 163 ***
25–29 years 9.8 12.2 9.3 11.1 715  
30–34 years 17.7 20.3 18.8 19.1 1,182  
35–39 years 17.6 17.0 14.6 17.3 990  
40–44 years 16.0 19.4 20.0 17.8 1,075  
45+ years 20.5 20.7 30.1 20.6 1,348  
No spousal information 0.8 0.8 2.5 0.8 73  
Don't know 14.1 6.6 1.8 10.1 446 366.304
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
Education, highest school level attended       
No education 60.2 64.9 51.3 62.7 3,390 144.893
Primary 5.9 6.0 5.8 5.9 360 1.154
Secondary or higher 21.5 16.4 30.3 18.7 1,571 .
Islamic education 11.7 12.0 10.2 11.8 640  
No spousal information 0.8 0.8 2.5 0.8 73  
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
Occupation       
No work outside home 4.6 4.0 4.4 4.2 265 61.192
Works outside home 93.6 91.1 88.2 92.2 5,457 1.330
Student 0.2 0.7 0.5 0.5 35 .
No spousal information 0.8 0.8 2.5 0.8 73  
Other 0.9 3.4 4.5 2.3 204  
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
Total wives       
No other wife 68.8 75.1 61.6 72.2 4,324 171.543
Yes, 1 other wife 1.5 1.6 2.1 1.6 92 3.306
Yes, 2 other wives 22.8 19.6 26.5 21.1 1,247 **
 Yes, 3 other wives 3.5 2.1 6.1 2.8 200  
Yes, 4 other wives 0.3 0.1 0.9 0.2 26  
No spousal information 0.8 0.8 2.5 0.8 73  
Don't know 2.3 0.7 0.3 1.4 69  
Total 100.0 100.0 100.0 100.0 6,031  
N 1,960 2,062 2,009 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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Malaria 
Key findings
Malaria prevention: Overall, ownership of long-lasting 
insecticide nets (LLIN) was high. Approximately 75 per-
cent and 69 percent of households in Zamfara and Kebbi/
Sokoto, respectively, own at least one LLIN. However, 
fewer households had the recommended ratio of at least 
one LLIN for every two household members, with slightly 
higher proportions in Kebbi/Sokoto (25%) than in Zamfara 
(18%). In households where there were sufficient nets 
(at least one LLIN for every two household members), 81 
percent and 88 percent of pregnant respondents slept 
under an LLIN the previous night in Kebbi/Sokoto and 
Zamfara, with little difference across wealth quintiles 
or maternal education. Similarly, in households with 
sufficient nets, over 90 percent of children under 2 years 
slept under an LLIN the previous night in integrated and 
malaria-only areas, with limited differences across socio-
demographic characteristics. 
There was also extremely high overall awareness about 
the importance of LLINs in malaria prevention. Almost all 
respondents agreed that malaria was caused by mos-
quito bites (97%), and that sleeping under mosquito nets 
was an effective malaria prevention method (93%). In 
addition, nearly all respondents stated they were likely to 
get all their children under 5 sleeping under a mosquito 
net every night of the year (93%). The results suggest that 
SBC programming to raise awareness about malaria pre-
vention measures is not needed, but improving access, 
acceptability, and efficacy to use LLINs as directed may 
be a useful programmatic focus.
Malaria during pregnancy: Less than one in five respon-
dents in study areas who attended any ANC visit received 
intermittent preventive treatment (three or more doses 
of SP/Fansidar) to protect against malaria during their 
last pregnancy, with significantly lower rates among 
respondents in the poorest households (10% and 12%) 
and among less-educated respondents (15% and 14%) 
in Kebbi/Sokoto and in Zamfara compared with their 
wealthiest counterparts (33% and 34%) and those with 
at least primary education (36% and 25%). Doses of 
sulfadoxine/pyrimethamine (SP/Fansidar) were adminis-
tered almost exclusively during ANC visits (74% in Kebbi/
Sokoto and 84% in Zamfara). In addition, more frequent 
ANC visits is also associated with a higher likelihood of 
IPTp uptake. BSS baseline results show that women who 
attended ANC four or more times during the last preg-
nancy were about six times more likely to receive IPTp 
than those attending ANC only one time.
The most common reasons for not taking SP/Fansidar 
during pregnancy were opposition by respondent (27%) 
or spouse (22%). There were also many “other” responses 
that largely consisted of the following responses: did not 
attend ANC or facility to collect medicines, did not get 
sick during pregnancy or have pregnancy complications, 
not customary or not necessary to take medications. 
Among respondents attending any ANC visit, few (21% in 
Kebbi/Sokoto and 36% in Zamfara) were given a mosquito 
net during ANC. While 91 percent reported that malaria 
in pregnancy can affect the fetus, few respondents were 
able to report specific risks to the baby, with only about 
half reporting fetal death (45%) or miscarriage (44%), 
and even fewer reporting premature birth (26%) and low 
birth weight (17%). This suggests areas for future SBC 
programming to raise awareness about the specific and 
serious risks of malaria in pregnancy to the unborn child. 
Pediatric fever prevalence and care-seeking: Among 
last-born children in the past two years, one in five were 
reported to have had a fever in the previous two weeks. 
Among these children, 68 percent and 74 percent were 
taken for advice or treatment from any source in Kebbi/
Sokoto and Zamfara, and most respondents who sought 
advice from any source for the febrile child went the 
same or next day. However, 32 percent and 54 percent of 
febrile children who were taken to any care were brought 
to a pharmacy in Kebbi/Sokoto and Zamfara instead of 
formal medical care.
Reasons for source of care or not seeking care for pediat-
ric fevers: The most important reasons for choosing the 
source of care were trust in provider (36%), nearby loca-
tion (33%), and effective treatment (28%) across study 
areas. This result underscores the importance to respon-
dents in this community of convenient, trusted, and 
high-quality health care provision for effective treatment 
of their sick children. The most important reasons for not 
seeking care included fatalism (“It’s up to God”) (33%), 
2
26    BS S IN NIGER IA: BASELINE TECHNICA L R EPORT
expense or cost (31%), and symptoms were not perceived 
as severe or home care was provided (21%). 
Diagnosis and treatment of pediatric fevers: Among 
febrile children under 2 years, few were tested for 
malaria (19% and 24%) and few were given artemisi-
nin-based combination therapies (ACT) treatment (22% 
and 36%) in Kebbi/Sokoto and Zamfara, respectively. 
Similar to other priority behavioral outcomes, there was 
lower testing and ACT treatment among febrile children 
living in the poorest households and with less-educated 
mothers as compared with their wealthier and better-ed-
ucated counterparts. There was strong intent to take a 
child with a fever to care the same/next day (92%) and 
to make sure the child takes the entire treatment course 
(92%). However, while 74 percent agreed that a blood 
test is the only way to know if a person has malaria, 
most respondents (61%) said they still worry the illness 
could be malaria even if the test result is negative, which 
implies a lack of confidence in negative malaria test 
results.
2.1 Malaria prevention
TABLE 2.1.A. LLIN AVAILABILITY IN HOUSEHOLD (AT LEAST ONE) BY SOCIODEMOGRAPHIC  
                       CHARACTERISTICS
Percentage of households with at least one LLIN, September–October 2019




% N % N % N % N
Total 68.0 1,960 68.9 2,062 74.8 2,012 68.5 4,022
Household wealth        
Lowest 67.1 541 67.3 618 62.9 208 67.2 1,159
Second 60.8 419 70.1 407 74.7 341 65.7 826
Middle 68.8 363 71.5 408 75.5 407 70.4 771
Fourth 72.9 276 76.6 286 74.1 488 74.8 562
Highest 74.3 361 60.2 343 81.1 568 68.5 704
Maternal age (in years)         
15–24 years 63.9 866 70.4 1015 78.5 834 67.6 1,881
25–34 years 70.3 850 67.9 837 74.2 888 69.0 1,687
35–49 years 73.3 244 66.5 210 65.6 289 69.9 454
Maternal education (high-
est level attended)         
None 65.9 1,487 69.3 1624 71.8 1,300 67.8 3,111
Primary 76.0 99 74.6 101 82.6 119 75.2 200
Secondary or higher 82.3 210 46.9 141 80.7 341 69.4 351
Islamic 66.5 164 73.9 196 81.5 251 70.5 360
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.1.B. LLIN AVAILABILITY IN HOUSEHOLD (AT LEAST ONE FOR EVERY TWO HOUSEHOLD 
                       MEMBERS) BY SOCIODEMOGRAPHIC CHARACTERISTICS
Percentage of households with at least one LLIN for every two household members, September–October 2019




% N % N % N % N
Total 26.4 1,960 23.6 2,062 24.9 4,022 17.7 2,012
Household wealth         
Lowest 25.7 541 29.1 618 27.7 1,159 8.8 208
Second 19.9 419 21.8 407 20.9 826 18.8 341
Middle 24.0 363 19.5 408 21.4 771 15.0 407
Fourth 29.7 276 26.0 286 27.8 562 20.3 488
Highest 36.3 361 17.3 343 27.1 704 21.2 568
Maternal age (in years)         
15–24 years 31.5 866 29.4 1015 30.3 1,881 25.6 834
25–34 years 23.6 850 19.5 837 21.5 1,687 14.0 888
35–49 years 19.8 244 5.2 210 17.2 454 5.2 289
Maternal education (highest level 
attended)         
None 24.1 1,487 22.1 1,624 23.0 3,111 16.5 1,300
Primary 33.1 99 23.4 101 27.8 200 19.2 119
Secondary or higher 42.0 210 20.3 141 34.0 351 23.5 341
Islamic 26.2 164 37.8 196 32.6 360 16.9 251
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
TABLE 2.1.C. LLIN USE AMONG PREGNANT WOMEN LIVING IN A HOUSEHOLD WITH AT LEAST ONE 
                       LLIN FOR EVERY TWO HOUSEHOLD MEMBERS, BY SOCIODEMOGRAPHIC  
                       CHARACTERISTICS
Percentage of pregnant women living in households with at least one LLIN for every two people who slept under an 
LLIN the previous night, September–October 2019




% N % N % N % N
Total 86.7 284 76.7 323 88.4 259 81.2 607
Household wealth         
Lowest 92.6 78 78.7 90 100.0 10 84.3 168
Second 92.2 49 76.0 63 85.0 33 83.1 112
Middle 83.0 49 79.2 61 82.0 53 80.8 110
Fourth 78.6 41 74.0 60 90.7 73 75.8 101
Highest 84.3 67 72.5 49 90.2 90 79.7 116
Maternal age (in years)         
15–24 years 88.8 157 78.5 218 87.4 177 82.6 375
25–34 years 84.7 101 76.4 86 91.3 76 80.8 187
35–49 years 82.7 26 53.5 19 86.0 6 71.0 45
Maternal education (highest level 
attended)         
None 89.5 199 77 255 88.6 150 82.4 454
Primary 81.8 18 70.1 13 91.0 22 76.4 31
Secondary or higher 77.9 55 63.3 25 94.0 59 73.4 80
Islamic 80.3 12 82.9 30 78.0 28 82.2 42
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.1.D. LLIN USE AMONG UNDER-TWOS LIVING IN A HOUSEHOLD WITH AT LEAST ONE LLIN FOR 
                       EVERY TWO HOUSEHOLD MEMBERS, BY SOCIODEMOGRAPHIC CHARACTERISTICS
Percentage of last-born children under 2 years living in households with at least one LLIN for every two people who slept 
under an LLIN the previous night, September–October 2019




% N % N % N % N
Total 97.6 158 89.0 113 92.8 124 94.2 271
Household wealth
Lowest 98.6 99 95.4 62 100.0 2 97.5 161
Second 100.0 11 86.0 24 100.0 26 89.7 35
Middle 92.7 9 100.0 15 93.0 27 98.2 25
Fourth 90.6 4 50.0 12 100.0 32 64.0 17
Highest 96.5 31 0 0 80.5 37 96.5 33
Maternal age (in years)         
15–24 years 96.1 92 88.5 66 99.1 61 93.0 158
25–34 years 99.3 61 85.0 35 88.6 63 94.5 96
35–49 years 100.0 5 100.0 12 0.0 0 100.0 17
Maternal education (highest level attended)        
None 98.6 141 87.4 98 98.2 82 94.2 239
Primary 94.2 7 0.0 0 100.0 4 94.2 7
Secondary or higher 81.3 10 0.0 0 79.6 38 81.3 10
Islamic 0.0 0 100.0 15 0.0 0 100.0 15
 
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indicates 
p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
2.2 Malaria in pregnancy
TABLE 2.2. IPTp DURING LAST PREGNANCY BY SOCIODEMOGRAPHIC CHARACTERISTICS
Percentage of women 15 to 49 years with a child under 2 years who received IPTp (three or more doses SP/Fansidar) 
during pregnancy for their last-born child by sociodemographic characteristics, September–October 2019




% N % N % N % N
Total 23.7 892 14.9 1,078 19.1 1,069 18.6 1,971
Household wealth         
Lowest 8.4 264 11.6 341 11.8 111 10.3 606
Second 29.0 192 10.2 229 11.6 183 18.4 421
Middle 27.6 157 11.7 220 14.5 223 18.1 377
Fourth 34.8 113 23.5 135 17.5 248 28.8 249
Highest 33.3 166 32.0 153 33.8 304 32.6 318
Maternal age (in years)         
15–24 years 18.2 367 14.7 485 15.9 423 16.0 852
25–34 years 23.1 412 14.8 478 20.7 486 18.6 890
35–49 years 40.7 113 16.0 115 23.1 160 27.5 229
Maternal education (highest level attended) 
None 20.1 675 11.3 855 13.9 698 14.9 1,530
Primary 33.8 47 37.1 57 25.0 60 35.6 104
Secondary or higher 28.5 95 53.1 60 43.4 180 37.3 155
Islamic 38.8 75 18.2 106 20.2 131 27.3 182
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indicates 
p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.2.1. IPTp FOR MALARIA DURING LAST PREGNANCY
Percentage of women 15 to 49 years who received IPTp (three or more doses SP/Fansidar) for malaria during pregnancy 
for their last-born child in past two years, September–October 2019






 % % % %  
During your pregnancy with child, did 
you take SP/Fansidar to keep you from 
getting malaria       
No 45.8 59.4 45.2 53.5 1,462 72.309
Yes 48.6 38.1 54.3 42.6 1,498 4.011
Don't know 5.6 2.5 0.6 3.8 79 *
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
How many months pregnant were you 
at your first dose of SP/Fansidar?       
0-3 months 33.4 15.9 20.3 24.5 334 5.772
4–6 months 50.3 68.6 64.3 59.6 916 0.437
7+ months 13.3 12.4 13.5 12.8 205 .
Don't know 3.0 3.1 1.9 3.1 43  
Total 100.0 100.0 100.0 100.0 1,498  
N 435 460 603 895   
How many times did you take SP/ 
Fansidar during your last pregnancy?       
None 0.6 0.0 0.0 0.3 3 23.866
1 22.3 30.6 25.4 26.5 389 1.745
2 20.2 28.1 35.4 24.2 429 .
3 or more 48.7 39.1 35.2 43.8 598  
Don't know 8.2 2.2 4.1 5.2 79  
Total 100.0 100.0 100.0 100.0 1,498  
N 435 460 603 895   
Where did you get SP/Fansidar?
Antenatal care visit       
No 23.0 28.6 15.6 25.8 315 22.864
Yes 77.0 71.4 84.4 74.2 1,183 3.112
Total 100.0 100.0 100.0 100.0 1,498  
N 435 460 603 895   
Another visit to a health facility       
No 92.6 94.5 97.4 93.6 1,431 12.847
Yes 7.4 5.5 2.7 6.5 67 4.466
Total 100.0 100.0 100.0 100.0 1,498  
N 435 460 603 895   
Pharmacy       
No 91.5 81.0 90.6 86.1 1,329 6.838
Yes 8.5 19.0 9.4 13.9 169 1.093
Total 100.0 100.0 100.0 100.0 1,498  
N 435 460 603 895   
Market/store       
No 87.3 93.4 96.9 90.4 1,394 28.443
Yes 12.7 6.6 3.1 9.6 104 4.590
Total 100.0 100.0 100.0 100.0 1,498  
N 435 460 603 895   
Itinerant drug seller       
No 99.1 99.0 98.6 99.1 1,486 0.628
Yes 0.9 1.0 1.4 1.0 12 0.186
Total 100.0 100.0 100.0 100.0 1,498  
N 435 460 603 895   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
30    BS S IN NIGER IA: BASELINE TECHNICA L R EPORT
TABLE 2.2.2. REASONS FOR NO IPTp FOR MALARIA DURING LAST PREGNANCY
Percentage of women 15 to 49 years who did not receive IPTp for their last-born child in past two years by reason, 
September–October 2019






 % % % %
None available at facility       
No 88.4 98.1 89.1 94.5 1,353 13.762
Yes 11.6 1.9 10.9 5.5 109 2.418
Total 100.0 100.0 100.0 100.0 1,462  
N 410 593 459 1,003   
Provider did not offer medicine       
No 88.2 89.4 93.7 89.0 1,343 10.471
Yes 11.8 10.6 6.3 11.0 119 2.946
Total 100.0 100.0 100.0 100.0 1,462  
N 410 593 459 1,003   
Afraid of side effects       
No 92.8 96.6 96.8 95.2 1,395 2.598
Yes 7.2 3.4 3.2 4.8 67 0.237
Total 100.0 100.0 100.0 100.0 1,462  
N 410 593 459 1,003   
Too costly       
No 90.5 95.9 95.3 93.9 1,376 1.312
Yes 9.5 4.1 4.7 6.1 86 0.218
Total 100.0 100.0 100.0 100.0 1,462  
N 410 593 459 1,003   
Respondent opposes       
No 83.1 71.4 70.6 75.7 1,051 4.730
Yes 16.9 28.6 29.4 24.3 411 0.444
Total 100.0 100.0 100.0 100.0 1,462  
N 410 593 459 1,003   
Husband/partner opposes       
No 79.9 88.0 72.1 85.1 1,163 34.713
Yes 20.1 12.0 27.9 15.0 299 3.397
Total 100.0 100.0 100.0 100.0 1,462  
N 410 593 459 1,003   
Religious/community leaders oppose       
No 99.3 98.8 99.7 99.0 1,446 2.745
Yes 0.7 1.2 0.4 1.1 16 1.219
Total 100.0 100.0 100.0 100.0 1,462  
N 410 593 459 1,003   
Other       
No 79.8 69.0 76.2 73.0 1,130 1.975
Yes 20.2 31.0 23.8 27.0 332 0.201
Total 100.0 100.0 100.0 100.0 1,462  
N 410 593 459 1,003   
Don't know       
No 85.3 81.1 86.7 82.6 1,219 4.609
Yes 14.8 18.9 13.3 17.4 243 0.491
Total 100.0 100.0 100.0 100.0 1,462  
N 410 593 459 1,003   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.2.3. WHAT ARE SOME RISKS TO THE BABY IF A WOMAN GETS MALARIA DURING  
                       PREGNANCY?
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report risks 
(unprompted) to the baby if a woman gets malaria during pregnancy by type of risk, September–October 2019






% % % %
Fetal death       
No 62.2 69.3 46.9 66.0 3,629 213.871
Yes 37.8 30.7 53.1 34.0 2,405 8.224
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
Premature birth       
No 74.2 81.8 70.7 78.3 4,547 42.927
Yes 25.8 18.3 29.3 21.7 1,487 1.637
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
Low birth weight       
No 86.5 88.9 79.1 87.8 5,114 76.631
Yes 13.5 11.1 20.9 12.2 920 2.936
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
Miscarriage       
No 65.6 65.4 49.4 65.5 3,595 152.659
Yes 34.4 34.6 50.6 34.5 2,439 6.114
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas. 
2.3 Fever care and treatment
TABLE 2.3.A. DIAGNOSIS FOR PEDIATRIC FEVERS BY SOCIODEMOGRAPHIC CHARACTERISTICS
Percentage of last-born children under 2 years with fever in the past two weeks who received a finger or heel stick for 
testing by sociodemographic characteristics, September–October 2019




% N % N % N % N
Total 22.8 200 16.8 285 24.0 188 19.0 485
Household wealth         
Lowest 14.9 48 10.1 81 (..) 20 11.9 129
Second 22.6 51 17.6 51 17.1 27 19.9 102
Middle 8.0 35 16.6 70 9.7 49 14.5 105
Fourth 60.4 24 23.4 45 25.5 43 36.3 69
Highest 22.5 42 26.5 38 42.7 49 24.4 80
Maternal age (in years)         
15–24 years 24.8 69 18.4 119 23.4 76 20.6 188
25–34 years 19.7 98 15.5 135 24.9 81 17.1 233
35–49 years 27.9 33 16.4 31 23.2 31 21.6 64
Maternal education (highest 
level attended)         
None 19.0 158 15.0 245 15.8 114 16.4 403
Primary (..) 13 (..) 18 (..) 11 27.4 31
Secondary or higher (..) 20 (..) 10 43.4 25 46.3 30
Islamic (..) 9 (..) 12 38.9 38 25.6 21
 (..) Value not shown due to low number of observations. Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be 
interpreted with caution. *** indicates p<0.001, ** indicates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only 
study areas.
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TABLE 2.3.B. ACT TREATMENT FOR PEDIATRIC FEVERS BY SOCIODEMOGRAPHIC CHARACTERISTICS
Percentage of last-born children under 2 years with fever in the past two weeks who received ACT treatment by socio-
demographic characteristics, September–October 2019




% N % N % N % N
Total 28.8 200 17.9 285 36.1 188 22.0 485
Household wealth         
Lowest 21.6 48 12.2 81 (..) 20 15.7 129
Second 31.3 51 21.1 51 29.6 27 25.7 102
Middle 22.7 35 17.1 70 34.9 49 18.5 105
Fourth 38.5 24 19.6 45 28.8 43 26.2 69
Highest 36.0 42 29.6 38 53.9 49 32.9 80
Maternal age (in years)         
15–24 years 27.6 69 (..) 19 23.4 76 23.7 188
25–34 years 25.3 98 18.8 135 45.1 81 21.3 233
35–49 years 41.0 33 3.3 31 47.3 31 20.1 64
Maternal education (highest 
level attended)
        
None 31.0 158 16.7 245 31.2 114 21.7 403
Primary 27.7 13 (..) 18 (..) 11 34.1 31
Secondary or higher (..) 20 (..) 10 46.8 25 22.5 30
Islamic (..) 9 (..) 12 51.8 38 11.2 21
 (..) Value not shown due to low number of observations. Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be 
interpreted with caution. *** indicates p<0.001, ** indicates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only 
study areas.
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TABLE 2.3.1. DIAGNOSIS AND CARE-SEEKING FOR PEDIATRIC FEVERS
Percentage of last-born children under 2 years with fever in the past two weeks who were tested for malaria and 
sought any advice or treatment, September–October 2019






 % % % %  
Has the child had an illness with a fever 
at any time in the last 2 weeks?
      
No 78.0 71.7 83.3 74.4 2,344 36.039
Yes 21.8 27.5 16.4 25.0 673 4.021
Don't know 0.2 0.9 0.3 0.6 22 *
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
At any time during the illness did child 
have blood taken for testing?
      
No 76.7 82.6 76.0 80.4 533 4.210
Yes 22.8 16.8 24.0 19.0 135 1.199
Don't know 0.5 0.6 0.0 0.6 5 .
Total 100.0 100.0 100.0 100.0 673  
N 200 285 188 485   
Did you seek advice or treatment from 
any source for child's fever?
      
No 16.2 41.5 25.6 32.0 187 3.450
Yes 83.8 58.5 74.5 68.0 486 1.089
Total 100.0 100.0 100.0 100.0 673 .
N 200 285 188 485   
How many days after illness started was 
treatment sought?
      
Same/next day 61.7 64.5 70.9 63.2 314 3.849
2 days later 24.7 25.9 21.7 25.3 114 0.670
3+ days later 13.6 9.6 7.4 11.5 58 .
Total 100.0 100.0 100.0 100.0 486  
N 167 174 145 341   
Among children who were taken to any 
care, did child have blood taken for 
testing?
     
No 72.2 70.8 68.4 71.5 314 3.849
Yes 27.2 28.7 31.6 28.0 114 0.670
Don't know 0.5 0.5 0.0 0.5 58 .
Total 100.0 100.0 100.0 100.0 486  
N 167 174 145 341   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.3.2. CARE-SEEKING FOR PEDIATRIC FEVERS
Percentage of last-born children under 2 years with fever in the past two weeks who sought any advice or treatment by 
source of care, September–October 2019






% % % %  
Government hospital       
No 62.7 89.8 79.4 77.3 374 0.325
Yes 37.3 10.2 20.6 22.7 112 0.054
Total 100.0 100.0 100.0 100.0 486 .
N 167 174 145 341   
Governmental PHC       
No 78.9 67.6 79.0 72.8 367 2.547
Yes 21.1 32.4 21.0 27.2 119 0.597
Total 100.0 100.0 100.0 100.0 486 .
N 167 174 145 341   
Dispensary/health post       
No 97.9 91.0 95.9 94.2 456 0.763
Yes 2.1 9.0 4.1 5.8 30 0.124
Total 100.0 100.0 100.0 100.0 486 .
N 167 174 145 341   
Community health outreach post       
No 92.7 99.6 100.0 96.4 473 9.270
Yes 7.3 0.4 0.0 3.6 13 3.423
Total 100.0 100.0 100.0 100.0 486 .
N 167 174 145 341   
Private hospital/clinic       
No 98.2 93.1 98.8 95.5 470 4.927
Yes 1.8 6.9 1.2 4.5 16 1.788
Total 100.0 100.0 100.0 100.0 486 .
N 167 174 145 341   
Pharmacy/chemist       
No 70.9 66.0 45.7 68.3 298 25.316
Yes 29.1 34.0 54.4 31.7 188 7.456
Total 100.0 100.0 100.0 100.0 486 **
N 167 174 145 341   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.3.3. REASONS FOR CHOOSING SOURCE OF CARE FOR PEDIATRIC FEVERS
Percentage of last-born children under 2 years with fever in the past two weeks taken to any source of care by reason 
for choosing treatment location, September–October 2019






% % % %  
Free or inexpensive       
No 91.6 82.2 92.5 86.5 436 33.859
Yes 8.4 17.8 7.5 13.5 47 0.794
Total 100.0 100.0 100.0 100.0 483 .
N 166 172 145 338   
Nearby/transport available       
No 61.9 62.1 71.1 62.0 325 32.807
Yes 38.1 37.9 28.9 38.0 158 0.576
Total 100.0 100.0 100.0 100.0 483 .
N 166 172 145 338   
Medicines often in stock       
No 93.2 86.9 94.3 89.8 447 25.198
Yes 6.9 13.1 5.7 10.2 36 1.421
Total 100.0 100.0 100.0 100.0 483 .
N 166 172 145 338   
Respectful care       
No 94.8 88.5 83.4 91.4 431 49.790
Yes 5.3 11.5 16.6 8.6 52 2.770
Total 100.0 100.0 100.0 100.0 483 .
N 166 172 145 338   
Trust to care for my child       
No 63.3 73.8 59.6 68.9 307 32.930
Yes 36.7 26.2 40.4 31.1 176 1.081
Total 100.0 100.0 100.0 100.0 483 .
N 166 172 145 338   
Effective treatment       
No 80.1 75.2 68.1 77.5 358 38.892
Yes 19.9 24.8 31.9 22.5 125 1.562
Total 100.0 100.0 100.0 100.0 483 .
N 166 172 145 338   
Short wait time       
No 92.0 91.3 86.0 91.6 428 27.473
Yes 8.0 8.7 14.0 8.4 55 0.906
Total 100.0 100.0 100.0 100.0 483 .
N 166 172 145 338   
Privacy       
No 99.7 98.9 98.5 99.2 477 4.712
Yes 0.3 1.1 1.6 0.8 6 0.440
Total 100.0 100.0 100.0 100.0 483 .
N 166 172 145 338   
Family/friends       
No 90.0 88.3 80.9 89.1 414 46.131
Yes 10.0 11.7 19.1 10.9 69 1.687
Total 100.0 100.0 100.0 100.0 483 .
N 166 172 145 338   
Recommended by religious or  
community leader      
No 84.9 100.0 100.0 93.0 453 133.310
Yes 15.1 0.0 0.0 7.0 30 1.507
Total 100.0 100.0 100.0 100.0 483 .
N 166 172 145 338   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.3.4. REASONS FOR NOT SEEKING CARE FOR PEDIATRIC FEVERS
Percentage of last-born children under 2 years with fever in the past two weeks not taken to any source of care by 
reasons for no care-seeking, September–October 2019






% % % %  
Too expensive/could not find 
money       
No 63.7 73.0 66.0 71.2 130 0.574
Yes 36.3 27.0 34.0 28.8 57 0.154
Total 100.0 100.0 100.0 100.0 187 .
N 33 111 43 144   
Facility closed/no one there       
No 94.4 100.0 100.0 98.9 185 0.884
Yes 5.6 0.0 0.0 1.1 2 1.350
Total 100.0 100.0 100.0 100.0 187 .
N 33 111 43 144   
Distance/transportation not avail-
able       
No 100.0 94.8 97.9 95.8 181 0.652
Yes 0.0 5.2 2.1 4.2 6 0.377
Total 100.0 100.0 100.0 100.0 187 .
N 33 111 43 144   
Medicine often not available       
No 93.5 99.0 100.0 98.0 184 1.696
Yes 6.5 1.0 0.0 2.0 3 1.827
Total 100.0 100.0 100.0 100.0 187 .
N 33 111 43 144   
Poor quality service       
No 100.0 99.2 98.0 99.3 185 0.636
Yes 0.0 0.8 2.0 0.7 2 0.682
Total 100.0 100.0 100.0 100.0 187 .
N 33 111 43 144   
Symptoms not severe/provided 
home care      
No 74.2 76.5 83.3 76.1 146 1.473
Yes 25.8 23.5 16.7 23.9 41 0.505
Total 100.0 100.0 100.0 100.0 187 .
N 33 111 43 144   
Husband/partner oppose       
No 93.9 93.7 85.4 93.7 170 3.572
Yes 6.1 6.3 14.6 6.3 17 2.004
Total 100.0 100.0 100.0 100.0 187 .
N 33 111 43 144   
Unable to leave work/home       
No 100.0 99.2 100.0 99.3 186 0.555
Yes 0.0 0.8 0.0 0.7 1 0.885
Total 100.0 100.0 100.0 100.0 187 .
N 33 111 43 144   
Up to God       
No 84.7 66.1 63.3 69.6 126 0.842
Yes 15.3 33.9 36.7 30.4 61 0.183
Total 100.0 100.0 100.0 100.0 187 .
N 33 111 43 144   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.3.5. ANTI-MALARIAL TREATMENT FOR PEDIATRIC FEVERS
Percentage of last-born children under 2 years with fever in the past two weeks given anti-malarials by type, 
September–October 2019






 % % % %  
At any time during the illness, did child 
take any medicines for the illness?       
No 6.4 25.9 18.6 18.6 121 0.000
Yes 93.6 74.1 81.4 81.4 552 0.000
Total 100.0 100.0 100.0 100.0 673 .
N 200 285 188 485   
What medicines did the child take?
Any ACT       
No 71.2 82.1 63.9 78.0 499 16.288
Yes 28.8 17.9 36.1 22.0 174 3.951
Total 100.0 100.0 100.0 100.0 673 *
N 200 285 188 485   
ACT       
No 74.8 84.7 72.7 81.0 532 6.459
Yes 25.2 15.3 27.3 19.0 141 1.649
Total 100.0 100.0 100.0 100.0 673 .
N 200 285 188 485   
SP/Fansidar       
No 83.5 96.4 88.3 91.6 604 2.005
Yes 16.5 3.6 11.7 8.4 69 0.254
Total 100.0 100.0 100.0 100.0 673 .
N 200 285 188 485   
Chloroquine       
No 79.1 91.8 93.1 87.1 589 6.900
Yes 20.9 8.2 6.9 12.9 84 1.300
Total 100.0 100.0 100.0 100.0 673 .
N 200 285 188 485   
Amodiaquine       
No 95.3 97.1 99.2 96.4 649 6.013
Yes 4.7 2.9 0.8 3.6 24 3.752
Total 100.0 100.0 100.0 100.0 673 .
N 200 285 188 485   
Quinine pills       
No 98.4 100.0 96.8 99.4 664 6.147
Yes 1.6 0.0 3.2 0.6 9 6.362
Total 100.0 100.0 100.0 100.0 673 *
N 200 285 188 485   
Quinine injection       
No 93.7 98.2 98.3 96.5 647 2.039
Yes 6.3 1.8 1.7 3.5 26 1.357
Total 100.0 100.0 100.0 100.0 673 .
N 200 285 188 485   
Artesunate rectal       
No 99.3 98.4 93.9 98.7 655 11.158
Yes 0.7 1.6 6.1 1.3 18 5.438
Total 100.0 100.0 100.0 100.0 673 *
N 200 285 188 485   
Artesunate injection       
No 96.4 97.4 95.4 97.0 646 1.219
Yes 3.6 2.6 4.6 3.0 27 0.935
Total 100.0 100.0 100.0 100.0 673 .
N 200 285 188 485   
Other anti-malarial       
No 99.5 99.4 99.5 99.4 669 0.021
Yes 0.6 0.6 0.5 0.6 4 0.017
Total 100.0 100.0 100.0 100.0 673 .
N 200 285 188 485   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.3.6. ANTI-MALARIAL CARE-SEEKING TIMING AND COMPLETION OF ACT COURSE FOR PEDI-
ATRIC FEVERS
Percentage of last-born children under 2 years with fever in the past two weeks who sought treatment and went same/
next day, September–October 2019; Percentage of last-born children under 2 years with fever in the past two weeks 
who received ACT and completed the dose, September–October 2019






 % % % %  
How many days after illness started 
was treatment sought?       
Same/next day 69.6 72.0 74.7 70.8 103 1.964
2 days later 21.1 18.6 13.2 19.9 22 0.548
3+ days later 7.6 9.5 8.7 8.5 13 .
Don't know 1.7 0.0 3.4 0.9 3  
Total 100.0 100.0 100.0 100.0 141  
N 42 46 53 88   
Did child finish the complete ACT 
dose?       
No 37.8 18.2 19.3 27.9 32 2.318
Yes 62.2 81.8 79.0 72.1 108 0.665
Don't know 0.0 0.0 1.7 0.0 1 .
Total 100.0 100.0 100.0 100.0 141  
N 42 46 53   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
BR E A K THROUGH R ESE A RCH  |  JUNE 2020     39 
2.4 Malaria ideations
TABLE 2.4.1. REPORTED CAUSES OF MALARIA IN CHILDREN
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting the causes of 
malaria in children, September–October 2019
 






% % % %  
Mosquito bites
No 8.7 5.9 0.6 7.2 324 200.709
Yes 91.3 94.1 99.4 92.8 5,710 52.808
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Eating dirty food
No 84.9 95.6 94.9 90.6 5,549 42.821
Yes 15.2 4.4 5.1 9.4 485 1.268
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Drinking dirty water
No 80.7 96.1 89.4 89.0 5,397 0.289
Yes 19.3 4.0 10.6 11.1 637 0.006
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Dirty surroundings
No 72.5 93.7 78.6 83.9 4,876 26.187
Yes 27.5 6.4 21.4 16.1 1,158 0.824
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Getting soaked with rain
No 93.3 95.8 97.4 94.7 5,744 30.055
Yes 6.7 4.2 2.6 5.3 290 1.869
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Cold or changing weather
No 92.7 93.9 92.8 93.3 5,610 0.574
Yes 7.3 6.2 7.2 6.7 424 0.021
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Don't know
No 97.0 95.7 99.7 96.3 5,880 103.990
Yes 3.0 4.3 0.3 3.7 154 21.329
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.4.2. REPORTED WAYS TO PREVENT MALARIA IN CHILDREN
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting ways to prevent 
malaria in children, September–October 2019






 % % % %  
Sleep under a mosquito net     
No 8.9 9.7 5.0 9.3 522 43.044
Yes 91.1 90.3 95.0 90.7 5,512 2.902
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Avoid mosquito bites      
No 45.6 49.8 39.3 47.9 2,733 44.042
Yes 54.4 50.2 60.8 52.1 3,301 1.311
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Take preventative medication     
No 84.8 86.7 74.3 85.8 4,921 117.098
Yes 15.3 13.3 25.8 14.2 1,113 4.030
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Spray house with insecticide     
No 77.4 86.7 78.8 82.4 4,854 11.896
Yes 22.6 13.3 21.2 17.6 1,180 0.347
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Cut grass around house     
No 74.2 90.7 81.9 83.1 4,946 1.551
Yes 25.8 9.3 18.1 16.9 1,088 0.045
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Fill puddles/stagnant water     
No 88.9 97.0 94.1 93.3 5,621 1.634
Yes 11.1 3.0 5.9 6.8 413 0.060
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Keep house surroundings clean     
No 77.7 90.7 78.8 84.7 4,929 33.155
Yes 22.3 9.3 21.2 15.3 1,105 1.095
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Burn leaves      
No 93.8 96.8 92.4 95.4 5,684 21.842
Yes 6.2 3.2 7.6 4.6 350 0.666
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Don't know      
No 96.5 96.1 99.7 96.3 5,878 102.223
Yes 3.5 3.9 0.3 3.7 156 20.041
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 2.4.3. MALARIA-RELATED BELIEFS, INTENTIONS, AND SELF-EFFICACY
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting malaria beliefs, 
intentions or self-efficacy, September–October 2019






 % % % %  
When a child has fever it's almost 
always caused by malaria
Agree 86.6 85.3 85.5 85.9 5,180 60.563
Disagree 6.5 10.3 12.3 8.6 572 1.192
Don't know 6.9 4.3 2.3 5.5 281 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Blood test is only way to know if a 
person has malaria
Agree 74.8 60.6 79.4 67.2 4,364 115.751
Disagree 15.5 23.5 11.8 19.8 1,000 2.026
Don't know 9.7 16.0 8.8 13.1 669 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Even if blood test is negative, I still 
worry about malaria
Agree 66.2 53.8 61.8 59.5 3,665 47.656
Disagree 24.3 27.5 29.4 26.0 1,611 0.808
Don't know 9.5 18.8 8.9 14.5 757 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Children under-5 should sleep under a 
net every night of the year
   
Agree 91.1 85.3 97.3 88.0 5,478 206.111
Disagree 5.7 10.3 1.9 8.2 383 6.801
Don't know 3.3 4.4 0.9 3.9 172 **
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Pregnant women should sleep under a 
net every night of the year
   
Agree 90.9 86.8 97.4 88.7 5,495 195.660
Disagree 5.6 9.0 2.0 7.5 380 7.864
Don't know 3.5 4.2 0.6 3.9 158 ***
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
When a pregnant woman gets malaria, 
it can affect the fetus
Agree 88.0 84.7 94.0 86.2 5,328 117.767
Disagree 4.1 5.1 2.9 4.6 263 3.222
Don't know 7.9 10.2 3.1 9.1 442 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Medicine given to pregnant women to 
prevent malaria works well
   
Agree 88.0 83.8 91.3 85.8 5,277 66.662
Disagree 3.9 3.4 3.7 3.7 228 1.770
Don't know 8.1 12.7 5.0 10.6 528 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
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Likelihood to seek treatment for 
febrile child the same/next day
   
Likely 89.3 84.5 96.0 86.7 5,449 192.218
Unlikely 5.5 10.9 3.3 8.4 372 4.114
Don't know 5.2 4.6 0.7 4.9 212 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Likelihood to get all children under-5 
sleeping under net every night
   
Likely 89.7 84.2 96.6 86.7 5,397 208.749
Unlikely 7.3 11.3 2.8 9.4 475 6.295
Don't know 3.0 4.6 0.7 3.8 161 **
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Likelihood to get child to take entire 
course of malaria medicine
   
Likely 86.9 87.5 95.1 87.2 5,422 139.727
Unlikely 9.2 7.1 4.0 8.1 420 3.381
Don't know 3.9 5.4 0.9 4.7 191 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. ** indicates p<0.05 and * indi-
cates p<.0.01 for the chi2 statistic
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Family planning 
Key findings
Contraceptive use: There was overall low modern 
contraceptive use among non-pregnant respondents      
across study areas, with slightly higher use in Zamfara 
(17%) than in Kebbi/Sokoto (11%). Modern contracep-
tive use was lower among respondents in the poorest 
households (6% and 7%) than in the wealthiest house-
holds (24% and 34%), as well as among respondents with 
no schooling (8% and 10%) compared with respondents 
with at least primary school education (18% and 29%) 
in Kebbi/Sokoto and Zamfara, respectively. There was 
also low modern contraceptive use among postpartum 
respondents (birth in the past 12 months) at 10 percent 
(Kebbi/Sokoto) and 14 percent (Zamfara), with similar 
patterns by sociodemographic characteristics across 
study areas. 
Contraceptive methods and access issues: Most respon-
dents had heard of at least one modern contraceptive 
method, with the most recognized methods being inject-
ables, implants, and daily pills. There was significantly 
lower awareness in Kebbi/Sokoto (71% for injectables, 
62% for implants, 67% for daily pills) than in Zamfara 
(85% for injectables, 77% for implants, 81% for daily pills) 
of these three methods. The most common methods 
used were injectables (48%) and implants (25%) among 
non-pregnant respondents currently using contracep-
tion. Most contraceptive users reported obtaining their 
current method the last time at a government hospital or 
government primary health care (PHC), and few respon-
dents (4%) reported difficulties in obtaining the method 
the last time. The most common reasons for not using 
contraception among current non-users were fatalism 
(“It’s up to God”) (25%), current breastfeeding (23%), 
partner opposition (21%), or respondent opposition 
(18%). Among non-users, only 15 percent reported inten-
tions to start contraceptive use in the next six months.
Contraceptive beliefs and attitudes: All respondents 
were asked about their personal beliefs, attitudes, and 
perceptions of contraception. Across study areas, approx-
imately half (52%) of respondents agreed that they do 
not personally approve of using contraception for birth 
spacing, underscoring a critical hurdle to Breakthrough 
ACTION/Nigeria SBC messaging for changing family 
planning practices. Approximately one in five respon-
dents believed that people in their community would 
call them bad names or avoid their company if others 
knew they were using contraception for birth spacing, 
which further highlights the importance of social norms 
related to family planning practices. About half of the 
respondents agreed that religious leaders should speak 
publicly about using modern contraceptives, which is a 
main component of Breakthrough ACTION/Nigeria SBC 
activities. Self-efficacy for negotiating contraceptive use 
with a partner was low. Only half of the respondents 
reported confidence in their ability to convince their 
partner to use modern contraception for birth spacing 
across study areas. Nevertheless, respondents were 
asked about perceived benefits of contraception use for 
birth spacing for both themselves and their children. The 
most commonly reported benefit for themselves was 
rest after giving birth (61% and 71%), while for children 
it was better growth (55% and 63%) in Kebbi/Sokoto and 
Zamfara, respectively. 
Contraceptive myths: A large proportion of respondents 
agreed with various contraceptive myths in Kebbi/Sokoto 
and Zamfara. About one-third of respondents in Kebbi/
Sokoto agreed that contraception could make a woman 
permanently infertile, harm a woman’s womb, and lead 
to health problems, compared with about one-quarter 
of respondents agreeing with those myths in Zamfara. 
About one in five respondents in Kebbi/Sokoto agreed 
that contraceptives cause cancer, can result in deformed 
babies, and can increase promiscuity or reduce sexual 
urges among women and men. In Zamfara, belief in 
these myths was lower at around one in 10 respondents, 
though 16 percent of respondents believed that contra-
ception could cause cancer or deformed babies. 
Spousal communication and decision-making: There 
were overall low rates of spousal communication about 
contraceptive use, although it was much higher in 
Zamfara (22%) than in Kebbi/Sokoto (6%). Unsurprisingly, 
respondents also reported that contraceptive use deci-
sions were mainly made by their partners, with higher 
reports in Kebbi/Sokoto (30%) than in Zamfara (17%). 
When respondents were asked who else influences a 
woman’s decision about contraception use, the most 
commonly mentioned influencers were no one else (61%) 
and partners/spouses (30%) across study areas. 
3
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3.1 Contraception: current use, knowledge, and access issues
TABLE 3.1.A. CONTRACEPTIVE PREVALENCE RATE BY SOCIODEMOGRAPHIC CHARACTERISTICS
Percentage of non-pregnant women aged 15 to 49 years with a child under 2 years who are using any modern contra-
ceptive method by sociodemographic characteristics, September–October 2019




% N % N % N % N
Total 9.1 974 11.9 1,021 15.2 1,007 10.6 1,999
Household wealth         
Lowest 2.4 284 9.2 324 7.6 107 6.3 609
Second 8.3 213 7.8 208 4.8 176 8.0 422
Middle 6.1 170 9.3 208 4.9 205 7.9 379
Fourth 19.8 131 13.1 126 17.8 233 16.5 257
Highest 18.0 176 30.5 155 33.8 286 24.0 332
Maternal age (in years)         
15–24 years 7.0 392 14.1 453 13.6 388 11.0 847
25–34 years 8.8 454 10.3 450 17.3 461 9.6 906
35–49 years 15.4 128 9.9 118 13.0 158 12.7 246
Maternal education (highest 
level attended)        
None 6.2 739 9.5 85 9.5 667 8.1 1546
Primary 12.0 47 23.0 56 29.1 50 18.2 103
Secondary or higher 3.0 102 39.8 58 42.5 170 33.1 161
Islamic 9.7 86 14.7 102 12.2 120 12.3 189
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
TABLE 3.1.B. POSTPARTUM CONTRACEPTIVE PREVALENCE RATE BY SOCIODEMOGRAPHIC  
                       CHARACTERISTICS
Percentage of postpartum non-pregnant women aged 15 to 49 years (with a child under 1 year) who are using any 
modern contraceptive method by sociodemographic characteristics, September–October 2019




% N % N % N % N
Total 9.2 473 9.7 546 13.6 528 9.5 1,021
Household wealth         
Lowest 3.3 136 5.9 162 4.8 47 4.9 299
Second 7.5 95 8.0 126 2.5 81 7.7 222
Middle 5.0 4 6.9 110 4.3 124 6.1 194
Fourth 22.9 65 11.5 70 1.7 106 17.0 135
Highest 15.0 93 27.2 78 34.1 170 20.8 171
Maternal age (in years)         
15–24 years 4.7 186 11.9 251 10.8 216 9.2 438
25–34 years 8.8 231 8.0 230 17.1 231 8.4 462
35–49 years 23.4 56 7.3 65 11.3 81 13.9 121
Maternal education (highest 
level attended)        
None 6.7 361 8.0 465 6.8 367 7.5 827
Primary 21.5 25 28.0 24 30.1 30 24.9 49
Secondary or higher 30.7 47 33.3 28 44.1 94 31.6 75
Islamic 4.6 40 7.9 29 12.1 37 6.0 70
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.1.1. CURRENT USE OF MODERN CONTRACEPTIVE METHODS
Percentage of non-pregnant women aged 15 to 49 years with a child under 2 years who are using any modern con-
traceptive method, September–October 2019; Percentage of non-pregnant women aged 15 to 49 years who are 
postpartum (birth in the past 12 months) who are using any modern contraceptive method, September–October 2019






 % % % %  
Non-pregnant women       
No 90.9 88.1 89.4 84.8 2,607 13.372
Yes 9.1 11.9 10.6 15.2 393 1.703
Total 100.0 100.0 100.0 100.0 3,000 .
N 974 1,021 1,995 1,005   
Postpartum non-pregnant women       
No 90.8 90.3 90.5 86.4 1,359 23.415
Yes 9.2 9.7 9.5 13.6 186 1.252
Total 100.0 100.0 100.0 100.0 1,545 .
N 473 546 1,019 526   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.1.2. CURRENT USE OF CONTRACEPTION BY METHOD TYPE
Percentage of non-pregnant women aged 15 to 49 years with a child under 2 years who are currently using contracep-
tion by method type, September–October 2019






 % % % %  
Are you or your partner currently using 
any method of contraception?
   
No 90.1 87.1 82.9 88.5 2,571 18.060
Yes 9.9 12.9 17.1 11.5 429 2.410
Total 100.0 100.0 100.0 100.0 3,000 .
N 974 1,021 1,005 1,995   
Which method are you using?
IUD      
No 98.5 99.6 92.4 99.2 412 8.383
Yes 1.5 0.4 7.6 0.8 17 9.120
Total 100.0 100.0 100.0 100.0 429 **
N 90 145 194 235   
Injectables      
No 44.6 53.6 52.4 50.1 224 0.194
Yes 55.4 46.4 47.7 49.9 205 0.083
Total 100.0 100.0 100.0 100.0 429 .
N 90 145 194 235   
Implants      
No 75.0 67.1 77.2 70.3 311 2.423
Yes 25.0 32.9 22.8 29.8 118 1.105
Total 100.0 100.0 100.0 100.0 429 .
N 90 145 194 235   
Daily pill      
No 89.0 84.1 81.3 86.1 356 1.508
Yes 11.0 15.9 18.7 13.9 73 1.109
Total 100.0 100.0 100.0 100.0 429 .
N 90 145 194 235   
Male condom      
No 97.6 100.0 97.7 99.1 421 0.918
Yes 2.4 0.0 2.3 0.9 8 1.009
Total 100.0 100.0 100.0 100.0 429 .
N 90 145 194 235   
Withdrawal      
No 96.8 98.4 95.3 97.8 412 1.475
Yes 3.2 1.6 4.7 2.2 17 0.884
Total 100.0 100.0 100.0 100.0 429 .
N 90 145 194 235   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.1.3. HAVE YOU EVER HEARD OF THE FOLLOWING CONTRACEPTION METHODS?
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who have ever heard of 
contraceptive methods by type, September–October 2019






% % % %  
Male condom       
Mentioned spontaneously 8.2 8.9 14.6 8.6 702 52.844
Recognised upon listening 25.5 17.3 21.7 21.1 1,341 1.033
Neither mentioned nor recognised 66.3 73.8 63.7 70.3 3,990 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Female sterilization/ tubal ligation     
Mentioned spontaneously 13.3 4.5 8.0 8.5 497 8.398
Recognised upon listening 16.8 15.8 19.1 16.2 1,091 0.126
Neither mentioned nor recognised 69.9 79.8 72.9 75.2 4,445 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Male sterilization/vasectomy      
Mentioned spontaneously 7.6 3.9 6.2 5.6 371 23.283
Recognised upon listening 10.6 3.7 10.3 6.9 517 0.409
Neither mentioned nor recognised 81.8 92.4 83.4 87.5 5,145 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
IUD       
Mentioned spontaneously 10.6 9.4 18.7 10.0 825 87.544
Recognised upon listening 15.5 15.9 14.7 15.7 970 1.781
Neither mentioned nor recognised 73.9 74.7 66.6 74.3 4,238 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Injectables or injections      
Mentioned spontaneously 35.3 49.3 63.5 42.9 2,983 269.317
Recognised upon listening 33.0 23.3 20.6 27.8 1,515 4.009
Neither mentioned nor recognised 31.7 27.4 15.9 29.4 1,535 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Implants/Implanon/Jadelle      
Mentioned spontaneously 24.8 36.0 58.4 30.8 2,400 443.199
Recognised upon listening 37.3 26.2 18.5 31.3 1,586 7.901
Neither mentioned nor recognised 37.9 37.8 23.2 37.9 2,047 ***
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Daily pill       
Mentioned spontaneously 35.5 38.4 56.0 37.1 2,633 236.584
Recognised upon listening 32.4 27.0 24.6 29.5 1,620 3.830
Neither mentioned nor recognised 32.1 34.6 19.4 33.5 1,780 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Female condom       
Mentioned spontaneously 3.6 4.1 4.9 3.9 289 4.193
Recognised upon listening 11.4 8.9 10.4 10.1 663 0.110
Neither mentioned nor recognised 85.1 87.0 84.7 86.1 5,081 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
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Emergency contraception/morning 
after pill/postinor 2
   
Mentioned spontaneously 3.3 4.9 7.6 4.2 363 44.362
Recognised upon listening 13.9 8.4 7.8 10.9 609 1.038
Neither mentioned nor recognised 82.9 86.7 84.6 84.9 5,061 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Standard days/cycle beads      
Mentioned spontaneously 5.0 3.3 3.3 4.1 261 6.174
Recognised upon listening 16.5 5.8 12.4 10.7 700 0.203
Neither mentioned nor recognised 78.5 90.9 84.3 85.2 5,072 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Lactational amenorrhea (LAM)      
Mentioned spontaneously 11.6 4.9 9.9 8.0 536 7.940
Recognised upon listening 29.1 19.9 22.3 24.2 1,372 0.117
Neither mentioned nor recognised 59.3 75.2 67.9 67.9 4,125 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Rhythm method       
Mentioned spontaneously 5.9 1.6 1.5 3.6 195 29.511
Recognised upon listening 16.6 4.5 10.7 10.1 641 1.055
Neither mentioned nor recognised 77.6 93.9 87.8 86.3 5,197 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Withdrawal       
Mentioned spontaneously 8.8 7.9 10.0 8.3 543 18.484
Recognised upon listening 29.5 17.8 18.9 23.2 1,262 0.285
Neither mentioned nor recognised 61.8 74.4 71.1 68.6 4,228 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Spermicide       
Mentioned spontaneously 3.4 1.2 0.6 2.2 126 31.253
Recognised upon listening 6.4 2.7 4.2 4.4 293 1.384
Neither mentioned nor recognised 90.1 96.2 95.2 93.4 5,614 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Diaphragm       
Mentioned spontaneously 3.8 1.3 0.4 2.5 139 49.552
Recognised upon listening 5.9 2.4 4.5 4.0 273 2.616
Neither mentioned nor recognised 90.4 96.3 95.1 93.5 5,621 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Sayana Press       
Mentioned spontaneously 5.6 1.9 3.0 3.6 247 30.061
Recognised upon listening 8.3 5.4 3.7 6.8 376 0.463
Neither mentioned nor recognised 86.1 92.7 93.2 89.6 5,410 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.1.4. WHERE DID YOU OBTAIN THE [CURRENT METHOD] THE LAST TIME?
Percentage of non-pregnant women aged 15 to 49 years with a child under 2 years using any contraception method by 
location obtained the last time, September–October 2019 






% % % %  
Other private sector 4.7 0.0 1.2 1.9 4 .
Other public sector 0.0 0.4 0.0 0.2 1  
Government hospital 33.8 33.6 47.8 33.7 194  
Governmental PHC 43.6 28.8 20.6 34.6 102  
Dispensary/health post 2.3 12.3 2.0 8.3 24  
Community health outreach post 1.2 0.8 1.3 0.9 4  
Nursing/maternity home 2.9 0.4 1.9 1.4 9  
Private hospital/clinic 3.5 2.3 1.4 2.8 10  
Pharmacy/chemist 7.0 10.4 9.0 9.1 38  
Don't know 0.0 0.0 1.3 0.0 3 27.880
Other 1.0 11.3 13.6 7.2 40 1.329
Total 100.0 100.0 100.0 100.0 429  
N 90 145 194 235   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. ** indicates p<0.05 and * indi-
cates p<.0.01 for the chi2 statistic
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TABLE 3.1.5. DIFFICULTIES FACED OBTAINING [CURRENT METHOD] THE LAST TIME?
Percentage of non-pregnant women aged 15 to 49 years with a child under 2 years using any contraception method by 








 % % % %  
Have you or your partner had any difficul-
ties in obtaining CURRENT METHOD?
No 94.1 86.2 98.7 89.3 399 20.106
Yes 5.9 13.8 1.3 10.7 30 10.516
Total 100.0 100.0 100.0 100.0 429 **
N 90 145 194 235   
Difficulties faced in obtaining CURRENT 
METHOD?
Fear of partner knowing; he opposes 
contraception
No 80.2 74.7 56.9 76.0 23 0.875
Yes 19.8 25.3 43.1 24.1 7 0.181
Total 100.0 100.0 100.0 100.0 30 .
N 7 21 2 28   
Fear of parents/other relatives knowing
No 54.6 90.6 100.0 82.7 25 1.221
Yes 45.4 9.4 0.0 17.3 5 1.188
Total 100.0 100.0 100.0 100.0 30 .
N 7 21 2 28   
High cost of transportation to facility
No 80.2 83.6 100.0 82.9 25 1.209
Yes 19.8 16.4 0.0 17.2 5 1.706
Total 100.0 100.0 100.0 100.0 30 .
N 7 21 2 28   
Long waiting times at facility
No 65.0 86.1 100.0 81.5 24 1.324
Yes 35.0 13.9 0.0 18.5 6 1.377
Total 100.0 100.0 100.0 100.0 30 .
N 7 21 2 28   
Periodic stock-outs at facility
No 100.0 70.5 100.0 77.0 24 1.717
Yes 0.0 29.5 0.0 23.0 6 0.906
Total 100.0 100.0 100.0 100.0 30 .
N 7 21 2 28   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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3.2 Contraception: reasons for use/non-use and intentions
TABLE 3.2.1. REASONS FOR USING A CONTRACEPTIVE METHOD
Percentage of non-pregnant women aged 15 to 49 years with a child under 2 years using any contraception method by 
reasons for method use, September–October 2019




TOTAL N CHI2 
VALUE
% % % % %  
Prefer to wait before having 
more children
    
No 23.7 20.4 23.4 21.7 22.8 100 0.146
Yes 76.3 79.6 76.7 78.3 77.2 329 0.035
Total 100.0 100.0 100.0 100.0 100.0 429 .
N 90 145 194 235 429   
Does not want any more 
children
     
No 85.8 94.6 89.2 91.1 89.8 386 0.374
Yes 14.2 5.4 10.8 8.9 10.2 43 0.213
Total 100.0 100.0 100.0 100.0 100.0 429 .
N 90 145 194 235 429   
My partner wants to use 
contraception
     
No 72.8 60.5 68.7 65.4 67.6 291 0.452
Yes 27.2 39.5 31.4 34.6 32.4 138 0.105
Total 100.0 100.0 100.0 100.0 100.0 429 .
N 90 145 194 235 429   
Health provider says I should 
use contraception
    
No 93.4 94.6 92.9 94.1 93.3 402 0.233
Yes 6.6 5.4 7.2 5.9 6.7 27 0.177
Total 100.0 100.0 100.0 100.0 100.0 429 .
N 90 145 194 235 429   
Protect against STIs       
No 97.8 100.0 98.9 99.1 99.0 424 0.040
Yes 2.3 0.0 1.1 0.9 1.0 5 0.043
Total 100.0 100.0 100.0 100.0 100.0 429 .
N 90 145 194 235 429   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.2.2. REASONS FOR NOT USING A CONTRACEPTIVE METHOD
Percentage of non-pregnant women aged 15 to 49 years with a child under 2 years not using any contraception method 
by reasons for method non-use, September–October 2019






 % % % %  
Knows no method      
No 96.1 98.9 99.3 97.6 2,522 13.186
Yes 3.9 1.2 0.7 2.4 49 3.058
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Doesn't know where to get method    
No 98.8 99.2 99.2 99.0 2,551 0.171
Yes 1.2 0.8 0.8 1.0 20 0.081
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Health concerns/Fear of side effects    
No 97.1 96.8 97.2 96.9 2,501 0.215
Yes 2.9 3.2 2.8 3.1 70 0.052
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Distance to health facility too far     
No 99.1 100.0 99.7 99.6 2,561 0.131
Yes 0.9 0.0 0.4 0.4 10 0.052
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Difficult to get transport to health 
facility
   
No 99.3 99.5 99.7 99.4 2,558 1.054
Yes 0.7 0.5 0.3 0.6 13 0.491
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Costs too much      
No 99.5 99.3 99.6 99.4 2,555 0.350
Yes 0.5 0.7 0.4 0.6 16 0.295
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Inconvenient to use     
No 97.6 96.8 97.7 97.2 2,498 0.748
Yes 2.4 3.2 2.3 2.8 73 0.108
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Preferred method not available     
No 99.8 100.0 99.9 99.9 2,567 0.002
Yes 0.2 0.0 0.1 0.1 4 0.002
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Fear of infertility    
No 86.5 90.0 94.7 88.4 2,323 33.650
Yes 13.5 10.0 5.4 11.6 248 3.795
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
BR E A K THROUGH R ESE A RCH  |  JUNE 2020     53 
Infrequent sex/not having sex     
No 98.2 98.8 97.5 98.5 2,523 3.140
Yes 1.8 1.2 2.5 1.5 48 0.992
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Can't get pregnant      
No 94.6 98.9 93.7 96.9 2,458 14.134
Yes 5.4 1.1 6.3 3.1 113 1.723
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Breastfeeding      
No 83.8 88.6 69.8 86.3 2,069 96.863
Yes 16.2 11.4 30.2 13.7 502 8.956
Total 100.0 100.0 100.0 100.0 2,571 **
N 884 876 811 1,760   
Away from husband/partner     
No 98.9 97.2 97.3 98.0 2,512 1.470
Yes 1.1 2.8 2.7 2.0 59 0.810
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Trying to get pregnant     
No 98.3 96.6 98.7 97.4 2,511 5.610
Yes 1.7 3.4 1.3 2.6 60 1.952
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Wants more children     
No 83.2 85.2 88.3 84.3 2,193 8.840
Yes 16.8 14.8 11.7 15.7 378 0.651
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Respondent opposes     
No 87.7 84.0 79.4 85.7 2,163 16.840
Yes 12.3 16.1 20.6 14.3 408 1.729
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Husband/partner opposes     
No 84.7 82.2 75.5 83.4 2,087 23.633
Yes 15.3 17.8 24.5 16.6 484 2.826
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Others oppose      
No 99.4 99.5 99.5 99.4 2,555 0.152
Yes 0.6 0.5 0.5 0.6 16 0.123
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Interferes with body's natural process
No 96.4 94.4 93.1 95.4 2,452 5.690
Yes 3.6 5.6 6.9 4.6 119 0.657
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Up to God      
No 73.2 65.8 79.9 69.3 1,889 37.974
Yes 26.8 34.2 20.1 30.7 682 3.037
Total 100.0 100.0 100.0 100.0 2,571 .
N 884 876 811 1,760   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.2.3. INTENTION TO USE/CONTINUE TO USE CONTRACEPTION IN THE NEXT SIX MONTHS
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years intending to start or con-
tinue to use contraception in next six months by method, September–October 2019






 % % % %  
In the next 6 months, do you plan to start 
using a method of contraception?
   
No 79.0 85.7 78.3 82.5 2,073 34.195
Yes 13.8 7.8 17.7 10.6 333 2.739
Don't know 7.3 6.6 3.9 6.9 165 .
Total 100.0 100.0 100.0 100.0 2,571  
N 884 876 811 1,760   
In the next 6 months, do you plan to con-
tinue using a method of contraception?
   
No 14.1 6.4 27.7 9.5 76 18.871
Yes 85.2 91.9 71.8 89.2 350 5.518
Don't know 0.8 1.7 0.5 1.3 3 **
Total 100.0 100.0 100.0 100.0 429  
N 90 145 194 235   
Method you intend to use?
IUD       
No 98.4 99.8 97.4 99.1 670 2.230
Yes 1.6 0.3 2.6 0.9 13 2.393
Total 100.0 100.0 100.0 100.0 683 .
N 185 209 289 394   
Injectables      
No 44.1 48.4 52.2 46.3 346 2.113
Yes 55.9 51.6 47.8 53.7 337 0.705
Total 100.0 100.0 100.0 100.0 683 .
N 185 209 289 394   
Implants       
No 75.2 70.4 71.4 72.7 484 0.131
Yes 24.8 29.6 28.6 27.3 199 0.039
Total 100.0 100.0 100.0 100.0 683 .
N 185 209 289 394   
Daily pill       
No 90.8 82.6 81.3 86.6 576 2.997
Yes 9.3 17.4 18.7 13.4 107 1.653
Total 100.0 100.0 100.0 100.0 683 .
N 185 209 289 394   
Male condom      
No 99.0 100.0 99.5 99.5 678 0.015
Yes 1.0 0.0 0.6 0.5 5 0.021
Total 100.0 100.0 100.0 100.0 683 .
N 185 209 289 394   
Lactational amenorrhea method     
No 100.0 99.5 99.0 99.7 679 1.308
Yes 0.0 0.5 1.1 0.3 4 2.269
Total 100.0 100.0 100.0 100.0 683 .
N 185 209 289 394   
Withdrawal      
No 99.8 99.4 97.6 99.6 673 3.565
Yes 0.2 0.6 2.4 0.4 10 5.609
Total 100.0 100.0 100.0 100.0 683 *
N 185 209 289 394   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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3.3 Contraception: beliefs, perceptions, and self-efficacy
TABLE 3.3.1. PERCEIVED CONTRACEPTION BENEFITS FOR FUTURE CHILDREN
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years reporting contraceptive benefits 
for children by benefit, September–October 2019






% % % %  
No benefits      
No 89.8 81.5 89.7 85.4 5,236 25.914
Yes 10.2 18.5 10.3 14.6 798 1.433
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Better growth     
No 43.0 47.7 37.0 45.5 2,550 43.701
Yes 57.1 52.3 63.0 54.5 3,484 1.673
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Better nutritional status     
No 81.6 80.4 62.2 81.0 4,505 243.768
Yes 18.4 19.6 37.8 19.0 1,529 10.710
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Better overall health     
No 75.6 83.6 58.1 80.0 4,355 314.285
Yes 24.4 16.4 42.0 20.1 1,679 13.681
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Better survival chance     
No 93.2 90.3 79.3 91.6 5,259 167.649
Yes 6.8 9.8 20.7 8.4 775 9.225
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
More attention by mother     
No 79.8 78.5 68.0 79.1 4,526 91.448
Yes 20.2 21.5 32.1 21.0 1,508 3.912
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Better education     
No 96.3 96.7 91.0 96.5 5,634 72.819
Yes 3.7 3.3 9.1 3.5 400 6.505
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
More opportunities     
No 97.6 98.0 90.0 97.8 5,758 139.643
Yes 2.4 2.0 10.0 2.2 276 9.951
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.3.2. PERCEIVED CONTRACEPTION BENEFITS FOR WOMEN
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report any contracep-
tive benefits for themselves by type of benefit, September–October 2019






 % % % %  
No benefits      
No 89.7 84.5 89.6 86.9 5,269 10.803
Yes 10.3 15.5 10.4 13.1 765 0.576
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Woman gets rest after birth     
No 39.3 39.0 29.5 39.1 2,227 61.025
Yes 60.7 61.0 70.5 60.9 3,807 2.201
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Better health and nutrition     
No 71.0 77.1 56.7 74.3 4,052 194.827
Yes 29.0 22.9 43.3 25.8 1,982 8.955
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Beauty and youthfulness     
No 86.1 84.1 67.5 85.0 4,729 236.897
Yes 13.9 15.9 32.6 15.0 1,305 10.885
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Fewer pregnancy complications     
No 91.4 85.9 80.9 88.4 5,193 61.231
Yes 8.6 14.2 19.1 11.6 841 2.207
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Reduce unwanted pregnancies     
No 90.8 89.3 80.7 90.0 5,240 96.667
Yes 9.2 10.7 19.3 10.0 794 2.888
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Fewer children to educate     
No 98.5 98.3 94.6 98.4 5,818 57.258
Yes 1.5 1.7 5.4 1.6 216 7.019
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Family has more money     
No 98.9 99.0 96.9 99.0 5,909 28.352
Yes 1.1 1.0 3.1 1.1 125 4.047
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.3.3. CONTRACEPTION BELIEFS, ATTITUDES, AND PERCEIVED SOCIAL NORMS
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting contraception 
beliefs, attitudes, or perceived social norms, September–October 2019






 % % % %  
Do you personally approve of using contraception for SPACING BIRTHS? 
No 50.3 58.7 50.1 54.8 3,126 59.974
Yes 43.3 35.1 46.8 38.9 2,576 1.745
Don't know 6.4 6.2 3.1 6.3 331 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Do you think people would call you bad names or avoid your company if they knew you were using contraception to space births?
No 65.1 43.5 68.8 53.5 3,556 198.886
Yes 14.9 34.2 21.5 25.2 1,441 4.209
Don't know 20.0 22.4 9.7 21.3 1,036 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Couples who use modern contraception have a better quality of life 
Agree 62.8 55.9 59.7 59.1 3,638 107.833
Disagree 24.2 27.3 33.0 25.9 1,646 2.518
Don't know 13.0 16.8 7.3 15.0 749 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Side effects are normal and usually go away in a few months
Agree 50.1 42.7 52.3 46.2 2,990 58.092
Disagree 25.0 30.6 29.9 28.0 1,583 1.484
Don't know 24.9 26.7 17.8 25.9 1,460 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Religious leaders should speak publicly about modern contraception
Agree 51.5 49.5 50.0 50.5 3,079 106.955
Disagree 32.6 37.5 43.2 35.3 2,187 2.344
Don't know 15.9 13.0 6.8 14.3 767 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Most couples in my community use modern contraception for birth spacing
Agree 42.8 34.2 51.7 38.2 2,752 138.535
Disagree 37.6 38.1 34.1 37.9 2,033 2.398
Don't know 19.6 27.7 14.2 23.9 1,248 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
It is important that husbands and wives discuss contraception 
Agree 69.4 62.5 72.4 65.7 4,165 82.298
Disagree 19.4 29.7 23.8 24.9 1,388 1.943
Don't know 11.2 7.8 3.9 9.3 480 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
A woman's body is not ready for childbirth until she is 18     
Agree 27.4 22.6 26.7 24.8 1,546 125.008
Disagree 59.9 69.9 70.3 65.3 4,026 2.506
Don't know 12.8 7.5 3.1 10.0 461 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Women over 35 have a higher risk of complications and 
should consider limiting births
  
Agree 36.6 32.4 42.8 34.3 2,265 173.162
Disagree 48.3 53.8 52.2 51.3 3,092 3.470
Don't know 15.2 13.8 5.0 14.4 676 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.3.4. CONTRACEPTION MYTHS AND PERCEIVED HEALTH RISKS
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting contraception 
myths and perceived health risks, September–October 2019





TOTAL N CHI2 
VALUE
 % % %  
Use of some contraceptives can make a woman 
permanently infertile      
Agree 31.4 25.1 27.6 1,728 101.959
Disagree 40.9 54.1 48.7 2,684 2.063
Don't know 27.7 20.8 23.6 1,621 .
Total 100.0 100.0 100.0 6,033  
N 4,022 2,011 6,033   
Contraceptives can harm a woman's womb      
Agree 32.8 23.8 27.5 1,738 135.019
Disagree 39.2 54.4 48.2 2,645 2.738
Don't know 28.0 21.9 24.3 1,650 .
Total 100.0 100.0 100.0 6,033  
N 4,022 2,011 6,033   
Contraceptives can cause cancer      
Agree 21.3 16.0 18.2 1,173 157.593
Disagree 36.5 52.9 46.2 2,513 3.183
Don't know 42.2 31.1 35.6 2,347 *
Total 100.0 100.0 100.0 6,033  
N 4,022 2,011 6,033   
Contraceptives can give you deformed babies      
Agree 20.6 15.5 17.6 1,128 103.150
Disagree 44.8 58.1 52.7 2,978 2.324
Don't know 34.6 26.4 29.7 1,927 .
Total 100.0 100.0 100.0 6,033  
N 4,022 2,011 6,033   
Women who use contraception end up with 
health problems      
Agree 35.0 30.5 32.3 1,974 123.174
Disagree 36.8 50.5 45.0 2,490 2.640
Don't know 28.2 19.0 22.7 1,569 .
Total 100.0 100.0 100.0 6,033  
N 4,022 2,011 6,033   
Contraceptives can reduce a man's sexual urge      
Agree 17.8 11.1 13.8 954 162.542
Disagree 38.2 54.5 47.9 2,613 3.377
Don't know 44.0 34.4 38.3 2,466 *
Total 100.0 100.0 100.0 6,033  
N 4,022 2,011 6,033   
Contraceptives can reduce a woman's sexual 
urge      
Agree 17.6 12.8 14.8 991 147.498
Disagree 38.4 54.3 47.8 2,612 3.151
Don't know 44.1 32.9 37.4 2,430 *
Total 100.0 100.0 100.0 6,033  
N 4,022 2,011 6,033   
Women who use contraceptives may become 
promiscuous      
Agree 19.6 11.1 14.6 1,064 166.608
Disagree 40.8 56.6 50.1 2,753 3.281
Don't know 39.6 32.4 35.3 2,216 *
Total 100.0 100.0 100.0 6,033  
N 4,022 2,011 6,033   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.3.5. SPOUSAL COMMUNICATION ABOUT CONTRACEPTION
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting on spousal com-
munication about contraception, September–October 2019






 % % % %  
Ever talked to your husband/partner 
about the number of children to have?
   
No 94.5 92.1 91.0 93.2 5,565 36.612
Yes 4.8 6.6 8.8 5.7 423 3.104
Don't know 0.7 1.4 0.2 1.1 45 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Ever talked with husband/partner 
about using modern contraception?
   
No 85.2 83.4 73.9 84.2 4,898 96.933
Yes 14.2 15.3 25.3 14.8 1,079 4.811
Don't know 0.7 1.3 0.8 1.0 56 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Discussion with partner included
Which method to use      
No 54.9 44.8 40.1 49.3 498 7.614
Yes 45.1 55.2 59.9 50.7 581 0.817
Total 100.0 100.0 100.0 100.0 1,079 .
N 245 321 513 566   
Using a method to space births     
No 29.2 31.2 27.1 30.3 308 1.133
Yes 70.8 68.8 72.9 69.7 771 0.170
Total 100.0 100.0 100.0 100.0 1,079 .
N 245 321 513 566   
Using a method to not have more 
births
   
No 94.3 94.6 78.5 94.5 954 39.866
Yes 5.7 5.4 21.5 5.5 125 5.225
Total 100.0 100.0 100.0 100.0 1,079 *
N 245 321 513 566   
Side effects of methods     
No 89.4 88.9 77.9 89.1 926 18.151
Yes 10.6 11.1 22.1 10.9 153 1.389
Total 100.0 100.0 100.0 100.0 1,079 .
N 245 321 513 566   
Who decides if you use a contraceptive 
method?
    
Mainly your decision 22.9 17.2 26.8 19.9 1,458 137.967
Mainly your partner's decision 32.9 26.9 17.2 29.7 1,494 2.548
Both decide together 44.2 55.9 56.0 50.5 3,081 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.3.6. WHO ELSE INFLUENCES DECISIONS ABOUT CONTRACEPTIVE USE?
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting on who else influ-
ences a woman’s decision about contraceptive use, September–October 2019





TOTAL N CHI2 
VALUE
% % %  
No one else    
No 38.7 39.0 38.9 2,294 0.044
Yes 61.3 61.0 61.1 3,740 0.002
Total 100.0 100.0 100.0 6,034 .
N 4,022 2,012 6,034   
Partner     
No 69.9 69.9 69.9 4,236 0.001
Yes 30.1 30.1 30.1 1,798 0.000
Total 100.0 100.0 100.0 6,034 .
N 4,022 2,012 6,034   
Mother-in-law    
No 94.0 98.4 96.6 5,780 83.068
Yes 6.0 1.6 3.4 254 14.751
Total 100.0 100.0 100.0 6,034 ***
N 4,022 2,012 6,034   
Mother     
No 95.4 95.9 95.7 5,786 0.784
Yes 4.6 4.1 4.3 248 0.064
Total 100.0 100.0 100.0 6,034 .
N 4,022 2,012 6,034   
Other own family    
No 99.5 98.7 99.0 5,986 9.401
Yes 0.5 1.3 1.0 48 2.905
Total 100.0 100.0 100.0 6,034 .
N 4,022 2,012 6,034   
Other partner's family    
No 99.8 99.3 99.5 6,020 7.725
Yes 0.2 0.7 0.5 14 3.674
Total 100.0 100.0 100.0 6,034 .
N 4,022 2,012 6,034   
Friends     
No 98.4 97.4 97.8 5,914 6.675
Yes 1.7 2.7 2.2 120 1.071
Total 100.0 100.0 100.0 6,034 .
N 4,022 2,012 6,034   
Health provider    
No 96.7 96.1 96.4 5,829 1.281
Yes 3.3 3.9 3.6 205 0.116
Total 100.0 100.0 100.0 6,034 .
N 4,022 2,012 6,034   
Community/religious leader   
No 99.6 99.9 99.8 6,019 4.513
Yes 0.4 0.1 0.2 15 1.995
Total 100.0 100.0 100.0 6,034 .
N 4,022 2,012 6,034   
Other     
No 99.8 99.1 99.4 6,007 12.058
Yes 0.2 0.9 0.6 27 5.329
Total 100.0 100.0 100.0 6,034 *
N 4,022 2,012 6,034   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 3.3.7. SELF-EFFICACY TO CONVINCE PARTNER ABOUT CONTRACEPTION USE
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting on self-efficacy to 
convince partner about contraceptive use, September–October 2019






 % % % %  
Confident in ability to convince 
partner to use modern  
contraception to SP
      
Confident 53.8 41.2 52.2 47.0 3,022 99.746
Uncertain 37.9 52.1 45.6 45.5 2,641 2.695
Don't know 8.3 6.8 2.2 7.5 370 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Confidence in ability to use  
modern contraception even if 
partner opposes
      
Confident 35.1 29.6 40.9 32.1 2,134 104.217
Uncertain 55.8 65.4 56.7 60.9 3,549 2.831
Don't know 9.2 5.1 2.4 7.0 350 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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Current pregnancy 
Key findings
Among respondents who were currently pregnant, 87 
percent reported that they wanted to get pregnant at 
the time they did for this pregnancy, and 84 percent 
planned to have another child in the future. Among those 
currently in late pregnancy (7–9 months pregnant), only 
half (53%) reported attending any ANC; 66 percent of 
respondents went for their first visit during the second 
trimester. In Kebbi/Sokoto, the most common sources for 
the first ANC visit were government PHC (49%) or govern-
ment hospital (37%), whereas in Zamfara respondents in 
late pregnancy who attended ANC were 1.5 times more 
likely to go to a government hospital than a government 
PHC. Among respondents currently in late pregnancy 
(7–9 months) who did not attend antenatal care, the 
most common reasons for non-attendance included: lack 
of perceived need (47%), spousal opposition (37%), and 
fatalism (“It’s up to God”) (20%). 
Most respondents currently in late pregnancy (7-9 
months) and who attended ANC reported that the 
following checks were done: blood pressure measured 
(90%), urine sample taken (72%), blood sample taken 
(76%), HIV testing (50%), weight measured (79%), 
pregnancy danger signs discussed (67%), and baby’s due 
date discussed (50%). About half of these respondents 
were given iron tablets or folic acid supplements, and 
only 39 percent and 17 percent, respectively, reported 
receiving a tetanus injection or being given deworming 
medication. Only 16 percent of respondents currently in 
late pregnancy and who attended ANC reported receiving 
a mosquito net during ANC. In addition, few of these 
respondents discussed a birth plan with a health worker, 
with significantly lower birth planning practiced in Kebbi/
Sokoto (25%) than in Zamfara (45%). This suggests that 
developing a birth plan is not a standard practice in these 
areas, and that birth planning could be a potential topic 
for more focused SBC programming. 
All currently pregnant respondents were asked about 
their dietary intake in the previous 24 hours. Seven out 
of 10 respondents (71%) reported eating at least three 
main meals during the previous day or night. Nearly all 
pregnant respondents (92%) reported eating breads, 
rice, tuwo (stodgy, tuber- or grain-based meal),  or other 
grains. Other commonly reported foods eaten in the 
previous 24-hour period included: beans, peas, or lentils 
(59%); oil, fats, and butters (59%); dark green leafy veg-
etables (58%); meat, poultry, or fish (48%); milk, cheese, 
yogurt, or other dairy (43%); and sugary foods (36%). Few 
pregnant respondents across study areas reportedly ate 
eggs (21%) or mangoes or papaya (14%).
4
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TABLE 4.1.1. PREGNANCY INTENTIONS DURING CURRENT PREGNANCY
Percentage of currently pregnant women aged 15 to 49 years who report pregnancy intentions for this current preg-
nancy, September–October 2019






% % % %  
How many months pregnant are 
you?       
0-3 months 22.9 22.4 26.5 22.6 685 44.990
4-6 months 40.1 35.7 37.4 37.7 1,114 3.140
7+ months 32.2 31.2 33.3 31.7 1,031 *
Don't know 4.8 10.8 2.8 8.0 198  
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
When you got pregnant, did you 
want to get pregnant at that time?       
No 14.7 8.5 13.3 11.4 375 2.327
Yes 85.3 91.5 86.7 88.6 2,653 0.331
Total 100.0 100.0 100.0 100.0 3,028 .
N 984 1,040 1,004 2,024   
Want to have a baby later or no 
more children? (among mothers)       
No more/None 37.0 19.1 19.3 29.5 84 4.422
Later 63.0 80.9 80.7 70.5 235 1.325
Total 100.0 100.0 100.0 100.0 319 .
N 117 85 117 202   
Want to have a baby later or no 
more children? (among never 
mothers)       
No more/None 16.8 17.0 19.6 16.9 12 0.051
Later 83.2 83.0 80.4 83.1 44 0.039
Total 100.0 100.0 100.0 100.0 56 .
N 22 10 24 32   
How much longer did you want to 
wait (in years)?       
Don't know 20.2 11.6 1.8 16.3 30 23.365
0-2 35.9 19.4 41.2 28.5 90 3.620
3 30.6 39.1 30.9 34.4 92 *
4-8 13.4 29.9 26.2 20.8 67  
Total 100.0 100.0 100.0 100.0 279  
N 92 76 111 168   
Do you plan to have another child 
in the future?       
No 10.3 6.7 17.7 8.4 343 109.335
Yes 83.3 90.0 81.9 86.9 2,578 7.791
Don't know 6.4 3.4 0.5 4.8 107 **
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 4.1.2. ANC VISITS AND TIMING DURING CURRENT PREGNANCY
Percentage of women aged 15 to 49 currently in late pregnancy (7–9 months) reporting ANC visits and timing for cur-
rent pregnancy, September–October 2019






% % % %  
At anytime during this pregnancy, 
have you seen anyone for ANC?
  
No 47.8 48.7 47.0 48.3 451 0.903
Yes 52.2 51.3 53.0 51.7 580 0.018
Total 100.0 100.0 100.0 100.0 1,031 .
N 334 340 357 674   
When did you first receive ANC for this 
pregnancy?
    
0–3 months 18.6 21.5 15.8 20.1 104 75.416
4–6 months 64.7 63.6 67.6 64.2 380 1.519
7+ months 13.8 14.6 16.6 14.2 90 .
Don't know 2.9 0.4 0.0 1.6 6  
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Where did you receive ANC for this first 
visit during the pregnancy?
   
Don't know 1.3 0.0 0.0 0.6 2 .
Other 0.0 1.0 0.0 0.5 2 .
Other private sector 0.0 0.0 0.0 0.0 0 .
Government hospital 38.9 35.8 55.0 37.3 267  
Governmental PHC 49.3 48.7 37.0 49.0 249  
Dispensary/health post 2.9 9.8 1.6 6.5 26  
Community health outreach post 3.0 0.8 3.9 1.8 15  
Nursing/maternity home 0.9 0.0 0.8 0.4 3  
Private hospital/clinic 3.2 3.3 0.0 3.3 11  
Pharmacy/chemist 0.5 0.7 1.7 0.6 5  
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Whom did you see when you first re-
ceived ANC during this pregnancy? 
   
Don't know/don't remember 0.0 0.0 0.0 0.0 0 .
Other 0.7 0.5 0.0 0.6 2 .
Other health personnel 0.5 0.0 0.0 0.2 1 .
Doctor 11.4 20.1 8.4 16.0 77  
Nurse/midwife 60.2 51.6 66.8 55.7 352  
Community health worker 25.6 27.3 24.9 26.5 144  
Chemist 1.0 0.0 0.0 0.5 2  
Traditional healer/birth attendant 0.0 0.5 0.0 0.3 1  
Family 0.7 0.0 0.0 0.3 1  
Friends/neighbors 0.0 0.0 0.0 0.0 0  
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 4.1.3. ANC CONTENT DURING CURRENT PREGNANCY
Percentage of women aged 15 to 49 currently in late pregnancy (7–9 months) reporting ANC content for current preg-
nancy, September–October 2019






% % % %  
How many checkups have you had for this preg-
nancy?       
None 2.0 0.0 0.0 0.9 2 267.055
1 18.2 19.7 17.1 19.0 98 3.363
2 16.4 14.9 26.6 15.6 114 **
3 15.3 16.5 21.8 15.9 111  
4+ 45.1 46.7 34.5 45.9 245  
Don't know 3.2 2.3 0.0 2.7 10  
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Was your blood pressure measured?       
No 21.1 13.7 5.3 17.2 71 220.168
Yes 78.9 85.9 94.7 82.6 508 8.029
Don't know 0.0 0.4 0.0 0.2 1 **
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Did you give a urine sample?       
No 40.7 38.6 21.6 39.6 173 210.334
Yes 59.3 61.4 78.4 60.4 407 5.113
Total 100.0 100.0 100.0 100.0 580 *
N 181 190 209 371   
Did you give a blood sample?       
No 30.7 28.2 20.5 29.4 142 .
Yes 69.3 71.8 79.5 70.6 438 .
Don't know 0.0 0.0 0.0 0.0 0 .
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Were you tested for HIV?       
No 43.6 37.7 29.3 40.5 202 501.476
Yes 34.7 30.5 61.0 32.5 260 6.291
Don't know 21.8 31.8 9.7 27.0 118 **
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Was your weight measured?       
No 42.3 18.2 14.7 29.7 125 218.840
Yes 56.4 81.3 85.4 69.4 451 4.299
Don't know 1.3 0.4 0.0 0.9 4 *
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Did you discuss with a health provider when the 
baby is due?       
No 59.6 58.8 43.7 59.2 293 176.048
Yes 40.4 39.0 56.3 39.7 282 3.154
Don't know 0.0 2.3 0.0 1.2 5 .
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Told by health worker about danger signs in 
pregnancy?       
No 44.0 36.1 29.4 39.8 206 .
Yes 56.1 63.9 70.7 60.2 374 .
Don't know 0.0 0.0 0.0 0.0 0 .
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Ever been given a mosquito net as part of ANC?       
No 95.4 82.4 81.9 88.6 497 45.192
Yes 4.6 17.6 18.1 11.4 83 2.336
Total 100.0 100.0 100.0 100.0 580 .
N 181 190 209 371   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 4.1.4. BIRTH PLANNING DURING CURRENT PREGNANCY
Percentage of women aged 15 to 49 currently in late pregnancy (7–9 months) reporting on childbirth planning with 
health worker during current pregnancy, September–October 2019






% % % %  
Discussed with a health worker a plan 
for your delivery?       
No 77.9 71.6 54.6 74.6 383 231.967
Yes 21.7 28.4 45.4 25.2 196 4.155
Don't know 0.5 0.0 0.0 0.2 1 *
Total 100.0 100.0 100.0 100.0 580  
N 181 190 209 371   
Where you plan to deliver the baby?       
No 26.1 14.8 3.6 19.5 22 351.219
Yes 73.9 85.2 96.4 80.5 174 13.204
Total 100.0 100.0 100.0 100.0 196 ***
N 38 56 102 94   
If you wanted to have a relative/friend/
neighbor with you during labor       
No 26.4 42.7 33.2 36.0 67 46.143
Yes 71.0 57.3 66.8 62.9 128 0.444
Don't know 2.6 0.0 0.0 1.1 1 .
Total 100.0 100.0 100.0 100.0 196  
N 38 56 102 94   
Transportation to where the baby 
would be born?       
No 53.7 42.3 33.4 47.0 79 160.490
Yes 41.7 57.7 66.6 51.1 115 1.690
Don't know 4.6 0.0 0.0 1.9 2 .
Total 100.0 100.0 100.0 100.0 196  
N 38 56 102 94   
What funds or finances you would use 
for delivery?       
No 49.4 31.7 24.9 39.0 60 177.141
Yes 45.9 68.3 75.1 59.1 134 2.284
Don't know 4.6 0.0 0.0 1.9 2 .
Total 100.0 100.0 100.0 100.0 196  
N 38 56 102 94   
Finding a skilled birth attendant to 
deliver your child       
No 32.6 22.8 20.6 26.8 47 99.559
Yes 62.8 77.3 79.4 71.3 147 1.613
Don't know 4.6 0.0 0.0 1.9 2 .
Total 100.0 100.0 100.0 100.0 196  
N 38 56 102 94   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 4.1.5. REASONS FOR NOT ATTENDING ANC DURING CURRENT PREGNANCY
Percentage of women aged 15 to 49 currently in late pregnancy (7–9 months) reporting reasons for not attending any 
antenatal care during current pregnancy, September–October 2019






% % % %  
Costs too much/Difficulty getting 
money       
No 85.0 85.2 90.9 85.1 397 43.674
Yes 15.0 14.8 9.1 14.9 54 0.836
Total 100.0 100.0 100.0 100.0 451 .
N 153 150 148 303   
Don't know where to go       
No 96.7 97.4 96.7 97.1 436 0.738
Yes 3.3 2.6 3.3 2.9 15 0.027
Total 100.0 100.0 100.0 100.0 451 .
N 153 150 148 303   
Health facility not open       
No 97.3 95.9 98.1 96.5 437 12.601
Yes 2.7 4.1 1.9 3.5 14 0.303
Total 100.0 100.0 100.0 100.0 451 .
N 153 150 148 303   
Distance to health facility too far       
No 95.6 98.8 97.3 97.3 437 0.003
Yes 4.4 1.2 2.7 2.7 14 0.000
Total 100.0 100.0 100.0 100.0 451 .
N 153 150 148 303   
Poor quality of service       
No 98.5 99.6 99.6 99.1 446 6.378
Yes 1.5 0.4 0.4 0.9 5 0.609
Total 100.0 100.0 100.0 100.0 451 .
N 153 150 148 303   
No female provider at facility       
No 100.0 96.0 75.0 97.9 423 498.139
Yes 0.0 4.0 25.0 2.1 28 5.916
Total 100.0 100.0 100.0 100.0 451 *
N 153 150 148 303   
Husband/partner oppose       
No 66.8 72.7 58.7 70.0 303 70.411
Yes 33.2 27.3 41.3 30.0 148 0.537
Total 100.0 100.0 100.0 100.0 451 .
N 153 150 148 303   
Religious leader opposes       
No 95.0 99.4 98.7 97.3 440 13.595
Yes 5.1 0.6 1.3 2.7 11 0.459
Total 100.0 100.0 100.0 100.0 451 .
N 153 150 148 303   
Not necessary to go       
No 65.1 52.0 49.5 58.2 274 39.169
Yes 34.9 48.0 50.5 41.8 177 0.337
Total 100.0 100.0 100.0 100.0 451 .
N 153 150 148 303   
Not customary       
No 93.5 68.5 91.6 80.3 392 148.691
Yes 6.5 31.5 8.4 19.7 59 1.632
Total 100.0 100.0 100.0 100.0 451 .
N 153 150 148 303   
Up to God       
No 82.3 68.8 82.4 75.1 356 42.339
Yes 17.8 31.2 17.6 24.9 95 0.940
Total 100.0 100.0 100.0 100.0 451 .
N 153 150 148 303   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 4.1.6. MEDICINES OR VACCINATIONS RECEIVED DURING CURRENT PREGNANCY
Percentage of women 15 to 49 years currently in late pregnancy (7–9 months) reporting medicines or vaccinations 
received during ANC for current pregnancy, September–October 2019






% % % %  
Were you given an injection in the arm 
to prevent tetanus?       
No 63.9 63.3 58.9 63.6 597 47.500
Yes 34.4 36.7 41.2 35.6 427 1.057
Don't know 1.8 0.0 0.0 0.8 7 .
Total 100.0 100.0 100.0 100.0 1,031  
N 334 340 357 674   
Before this pregnancy, how many 
times did you get a tetanus injection?       
None 44.3 62.2 63.4 53.7 552 287.726
1 5.9 5.3 3.1 5.6 54 2.710
2 5.8 5.9 11.2 5.9 84 .
3 or more 4.2 7.4 9.0 5.9 80  
Don't know 39.7 19.3 13.3 29.0 258  
Total 100.0 100.0 100.0 100.0 1,028  
N 333 339 356 672   
During this pregnancy, have you taken 
any iron tablet or iron syrup?       
No 54.2 56.4 50.3 55.4 513 35.616
Yes 45.6 42.8 49.7 44.1 513 0.651
Don't know 0.2 0.8 0.0 0.5 5 .
Total 100.0 100.0 100.0 100.0 1,031  
N 334 340 357 674   
During this pregnancy, have you taken 
any folic acid supplements?       
No 56.5 56.0 50.7 56.2 521 81.318
Yes 40.0 43.0 49.1 41.6 490 1.441
Don't know 3.5 1.0 0.2 2.2 20 .
Total 100.0 100.0 100.0 100.0 1,031  
N 334 340 357 674   
During this pregnancy, have you taken 
any drugs for intestinal worms?       
No 65.3 75.6 81.3 70.7 742 90.720
Yes 25.8 18.3 14.1 21.8 215 2.258
Don't know 8.9 6.1 4.6 7.4 74 .
Total 100.0 100.0 100.0 100.0 1,031  
N 334 340 357 674   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
. 
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TABLE 4.1.7. NUTRITIONAL INTAKE DURING CURRENT PREGNANCY
Percentage of women aged 15 to 49 who are currently pregnant reporting foods eaten during the previous 24 hours, 
September–October 2019






% % % %  
How many meals did you have at any 
time yesterday?
      
None 0.1 0.2 0.1 0.1 4 113.635
1 1.7 7.3 1.8 4.7 106 5.742
2 17.2 25.2 9.5 21.5 523 ***
3 or more 81.0 66.5 88.3 73.3 2,380  
Don't know 0.1 0.8 0.4 0.5 15  
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Did you  eat any of the following at 
any time yesterday (during the day or 
night)?
      
Milk, cheese, yoghurt, other dairy       
No 65.6 53.9 55.5 59.4 1,792 5.515
Yes 34.4 45.9 44.2 40.5 1,230 0.280
Don't know 0.0 0.2 0.3 0.1 6 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Bread, rice, tuwo or other grains       
No 8.3 3.5 7.6 5.8 173 5.756
Yes 91.67 96.4 92.2 94.2 2,851 0.240
Don't know 0.0 0.1 0.2 0.0 4 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
White potato, cassava, yam, eba, or 
other foods from roots or tubers
      
No 58.1 72.4 56.9 65.8 1,890 23.621
Yes 41.5 27.3 42.6 33.9 1,127 1.562
Don't know 0.3 0.3 0.5 0.3 11 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Pumpkin, squash, or other that is yel-
low or orange inside
      
No 82.8 86.4 79.3 84.8 2,532 15.024
Yes 16.5 13.3 19.7 14.8 477 0.719
Don't know 0.6 0.3 1.0 0.5 19 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Any dark and leafy vegetables       
No 37.5 51.4 40.1 44.9 1,330 7.046
Yes 62.2 48.3 59.6 54.7 1,686 0.501
Don't know 0.4 0.3 0.4 0.3 12 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Ripe mangoes, pawpaw       
No 87.7 91.9 82.6 90.0 2,665 31.884
Yes 12.2 7.8 16.7 9.8 352 1.806
Don't know 0.1 0.3 0.7 0.2 11 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
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Other kinds of fruits/vegetables (other 
local vitamin A rich fruits)
      
No 57.6 79.9 67.2 69.5 2,062 1.950
Yes 42.0 19.8 32.4 30.1 952 0.104
Don't know 0.4 0.3 0.5 0.4 14 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Eggs       
No 80.7 86.1 75.4 83.6 2,429 29.028
Yes 19.2 13.6 24.4 16.2 592 1.890
Don't know 0.1 0.3 0.2 0.2 7 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Any kinds of meat, poultry, fish, or 
shellfish (or organ meats)
      
No 53.9 56.5 49.1 55.3 1,586 11.563
Yes 45.9 43.2 50.5 44.5 1,432 0.716
Don't know 0.1 0.3 0.4 0.2 10 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Any foods made from beans, peas, 
lentils or nuts
      
No 44.8 58.3 32.5 52.0 1,363 117.060
Yes 53.7 41.4 67.0 47.2 1,642 5.578
Don't know 1.4 0.3 0.5 0.8 23 **
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Any oil, fats, butter or foods made with 
these
      
No 41.4 53.5 35.7 47.8 1,317 47.337
Yes 56.8 46.2 63.7 51.1 1,681 1.590
Don't know 1.9 0.3 0.6 1.0 30 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Sugary foods such as  dates, sweets, 
biscuits
      
No 70.1 67.9 58.7 68.9 1,945 34.988
Yes 28.2 31.7 40.6 30.0 1,051 1.536
Don't know 1.8 0.4 0.7 1.1 32 .
Total 100.0 100.0 100.0 100.0 3,028  
N 984 1,040 1,004 2,024   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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ANC attendance: Among respondents with a completed 
pregnancy in the past two years, only 32 percent in 
Kebbi/Sokoto and 38 percent in Zamfara made at least 
one ANC visit with a skilled health provider. This percent-
age was significantly higher among respondents in the 
wealthiest households (58% and 75%) than in the poorest 
households (18% and 12%) in Kebbi/Sokoto and Zamfara, 
respectively. Similarly, respondents who attended pri-
mary or secondary/higher education in both areas were 
more likely to attend ANC at least one time than their less 
educated counterparts. As a result, only 20 percent of 
respondents in Kebbi/Sokoto and 26 percent in Zamfara 
made the recommended four or more ANC visits during 
their last pregnancy, with similar patterns by sociodemo-
graphic characteristics. 
ANC awareness and non-use reasons: Among respon-
dents who chose not to make any ANC visits during the 
last pregnancy, the most common reasons were lack of 
perceived need (42%), spousal opposition (25%), fatalism 
(“It’s up to God”) (20%), and the perception that ANC 
is not the norm (13%). Few respondents were aware of 
the suggested number and timing of ANC visits during 
pregnancy. There was higher awareness about attending 
ANC four or more times in Zamfara (49%) than in Kebbi/
Sokoto (34%). Only one quarter of respondents reported 
that a woman should go for her first ANC visit as soon as 
she thinks she is pregnant or in the first trimester. 
ANC decision-making, self-efficacy, and intentions: All 
respondents were asked about who influences a woman’s 
decision to go to four or more ANC visits. The most com-
mon responses were spouse (67%) and no one else (26%). 
Nearly all respondents (92%) agreed that it is important 
to discuss their pregnancies with their husbands yet only 
73 percent of respondents had the confidence to start a 
conversation with their husband about attending ANC. 
Only about two-thirds of respondents (66%) intended 
to make at least four ANC visits during their next preg-
nancies with fewer (48%) intending to go to ANC eight or 
more times. 
ANC myths: All respondents were asked about the ben-
efits of ANC to a woman. The most common responses 
were to monitor the mother’s health (66%) and the 
baby’s growth (65%). Nevertheless, there were some 
common myths about ANC, with a greater proportion of 
respondents agreeing with these myths in Kebbi/Sokoto 
than in Zamfara. Overall, 48 percent and 35 percent of 
respondents in Kebbi/Sokoto and Zamfara, respectively, 
agreed that pregnant women need ANC only when sick, 
while 40 percent and 30 percent of respondents in these 
areas agreed that it is better to use a traditional provider 
than a health facility for ANC. One-quarter of respon-
dents (25%) believed that only first-time mothers need 
ANC. These responses point to areas for SBC activities to 
improve ANC attendance by dispelling myths and raising 
awareness of ANC benefits among women in these areas.
ANC content: Beyond malaria prevention during 
pregnancy, few respondents received other essential 
pregnancy-related care during their last pregnancy. For 
example, roughly half of respondents (47%) in Zamfara 
and one-third (35%) in Kebbi/Sokoto received a tetanus 
injection during their most recent pregnancy, even 
though the majority (66% in Kebbi/Sokoto and 61% in 
Zamfara) had not received any tetanus injection prior to 
the most recent pregnancy. Only about half of respon-
dents reported having taken iron tablets/iron syrup (42% 
in Kebbi/Sokoto and 53% in Zamfara). Similarly, only 41 
percent of respondents in Kebbi/Sokoto and 54 percent 
of respondents in Zamfara took any folic acid supple-
ments during their most recent pregnancy. 
Birth planning: Developing a birth plan with the assis-
tance of a health worker does not appear to be standard 
practice in study areas, and baseline results point to the 
need for more intensified SBC messaging to improve this 
practice going forward. Only one in three respondents 
reported discussing birth plans with a health worker, 
with the majority of these respondents reporting that 
discussions focused on delivery location (92%), delivery 
financing (74%), finding a skilled birth attendant (72%), 
choosing personnel to have present during the delivery 
(67%), and transportation (60%).
5
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TABLE 5.1.A. ANC 1+ DURING LAST PREGNANCY BY SOCIODEMOGRAPHIC CHARACTERISTICS
Percentage of women 15 to 49 years with a child under 2 years who attended ANC one or more times where at least 
one visit was with a skilled provider for their last-born child by sociodemographic characteristics, September–October 
2019




% N % N % N % N
Total 41.9 892 24.4 1,078 38.2 1,069 32.0 1,971
Household wealth         
Lowest 26.2 264 11.7 341 11.7 111 17.5 606
Second 38.9 192 19.2 229 18.0 183 27.8 421
Middle 44.4 157 31.7 220 24.6 223 36.8 377
Fourth 57.7 113 32.9 135 41.1 248 44.6 249
Highest 61.8 166 54.4 153 75.3 304 58.4 318
Maternal age (in years)         
15–24 years 36.2 367 24.8 485 32.8 423 29.3 852
25–34 years 43.7 412 23.7 478 41.6 486 32.8 890
35–49 years 52.0 113 25.5 115 43.7 160 37.8 229
Maternal education (highest 
level attended)         
None 33.5 675 22.4 855 28.9 698 27.0 1,530
Primary 64.7 47 48.9 57 74.1 60 55.8 104
Secondary or higher 83.5 95 62.2 60 85.3 180 75.9 155
Islamic 54.7 75 15.6 106 23 131 32.9 182
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.B. ANC 4+ DURING LAST PREGNANCY BY SOCIODEMOGRAPHIC CHARACTERISTICS
Percentage of women 15 to 49 years with a child under 2 years who attended ANC four or more times where at least 
one visit was with a skilled provider for their last-born child by sociodemographic characteristics, September–October 
2019




 % N % N % N % N
Total 23.5 892 16.9 1,078 26.1 1,069 19.7 1,971
Household wealth         
Lowest 12.1 264 6.2 341 5.9 111 8.5 606
Second 23.5 192 10.5 229 12.7 183 16.2 421
Middle 19.7 157 23.3 220 13.9 223 21.9 377
Fourth 37.8 113 25.7 135 25.7 248 31.3 249
Highest 39.1 166 43.7 153 56.8 304 41.4 318
Maternal age (in years)         
15–24 years 19.5 367 18.2 485 19.2 423 18.7 852
25–34 years 24.0 412 15.9 478 29.3 486 19.6 890
35–49 years 33.1 113 15.5 115 35.9 160 23.7 229
Maternal education (highest 
level attended)         
None 17.6 675 11.1 855 17.6 698 15.9 1,530
Primary 43.6 47 23.8 57 53.6 60 42.0 104
Secondary or higher 53.2 95 41.7 60 67.7 180 53.2 155
Islamic 30.5 75 17.2 106 15.8 131 19.0 182
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
TABLE 5.1.1. PREGNANCY INTENTIONS DURING LAST PREGNANCY
Percentage of women 15 to 49 years with a child under 2 years reporting pregnancy intentions for their last-born child 
in the past two years, September–October 2019






 % % % %  
When you got pregnant, did you want 
to pregnant at that time?       
No 8.8 7.8 14.1 8.2 316 23.870
Yes 91.2 92.2 85.9 91.8 2,723 2.660
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Did you want to have a baby later on or 
did you not want any more children?       
No more/None 24.4 22.7 23.7 23.5 80 0.001
Later 75.6 77.3 76.3 76.5 236 0.000
Total 100.0 100.0 100.0 100.0 316 .
N 86 87 143 173   
How much longer did you want to 
wait?       
0–6 months 97.3 87.2 95.6 91.7 219 8.289
7–12 months 0.7 1.4 3.6 1.1 6 3.889
Don't know 2.0 11.4 0.9 7.2 11 *
Total 100.0 100.0 100.0 100.0 236  
N 64 66 106 130   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.2. SOURCE AND TIMING OF ANC DURING LAST PREGNANCY
Percentage of women 15 to 49 years with a child under 2 years reporting source and timing of ANC for their last-born 
child in the past two years, September–October 2019






 % % % %  
During your pregnancy, did you see 
anyone for antenatal care?       
No 47.0 61.8 47.4 55.4 1,523 29.969
Yes 52.7 37.5 52.6 44.1 1,502 1.894
Don't know 0.3 0.7 0.0 0.6 14 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
When did you first receive antenatal 
care for last pregnancy?       
0–3 months 30.7 25.5 20.5 28.1 356 32.632
4–6 months 53.7 60.6 63.2 57.0 912 3.300
7+ months 9.0 11.0 14.9 10.0 188 *
Don't know 6.6 3.0 1.4 4.9 46  
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Where did you receive ANC for this first 
visit during your pregnancy       
Her home 4.2 2.5 0.8 3.4 37  
Other home 0.6 0.0 0.1 0.3 5  
Government hospital 31.8 30.8 46.6 31.4 616  
Governmental PHC 55.2 48.2 41.0 51.8 668  
Dispensary/health post 2.0 12.6 3.2 7.1 85  
Community health outreach post 2.7 0.9 4.1 1.8 31  
Nursing/maternity home 0.2 0.6 0.0 0.4 3  
Private hospital/clinic 1.4 3.2 0.8 2.3 29  
Pharmacy 0.5 0.4 2.6 0.4 15  
Don't know/don't remember 1.0 0.0 0.0 0.5 3 84.832
Other 0.3 0.0 0.5 0.2 3 2.001
Other public source 0.2 0.0 0.0 0.1 1 .
Other private  source 0.0 0.9 0.4 0.4 6  
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.3. WHOM DID YOU SEE FOR THE FIRST ANC VISIT DURING LAST PREGNANCY? 
Percentage of women 15 to 49 years with a child under 2 years reporting whom they saw for their first ANC visit for 
their last-born child in the past two years, September–October 2019






 % % % %  
Doctor
No 83.9 80.7 89.4 82.4 1,255 15.179
Yes 16.2 19.3 10.6 17.7 247 1.733
Total 100.0 100.0 100.0 100.0 1,502  .
N 452 457 593 909   
Nurse/midwife
No 35.2 48.5 32.1 41.6 565 13.480
Yes 64.8 51.5 67.9 58.4 937 1.217
Total 100.0 100.0 100.0 100.0 1,502 .
N 452 457 593 909  
Community health worker
No 80.8 62.8 69.0 72.0 1,085 1.496
Yes 19.2 37.3 31.0 28.0 417 0.119
Total 100.0 100.0 100.0 100.0 1,502 .
N 452 457 593 909  
Chemist
No 99.3 100.0 98.6 99.6 1,492 3.320
Yes 0.8 0.0 1.4 0.4 10 1.645
Total 100.0 100.0 100.0 100.0 1,502 .
N 452 457 593 909  
Traditional healer/birth attendant
No 99.7 100.0 99.8 99.9 1,499 0.051
Yes 0.3 0.0 0.2 0.2 3 0.055
Total 100.0 100.0 100.0 100.0 1,502 .
N 452 457 593 909   
Family
No 98.8 99.9 99.7 99.3 1,494 1.166
Yes 1.2 0.1 0.3 0.7 8 1.035
Total 100.0 100.0 100.0 100.0 1,502 .
N 452 457 593 909
Friends/neighbors
No 99.8 100.0 100.0 99.9 1,501 0.933
Yes 0.2 0.0 0.0 0.1 1 1.788
Total 100.0 100.0 100.0 100.0 1,502 .
N 452 457 593 909
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.4. ANC CONTENT DURING LAST PREGNANCY 
Percentage of women 15 to 49 years with a child under 2 years reporting on content of ANC visits for their last-born 








 % % % %  
How many check-ups did you have for your last pregnancy?       
Don't know 11.5 5.1 1.7 8.4 96 42.962
0 0.3 0.0 0.8 0.1 6 3.173
1–3 34.4 29.5 36.0 32.0 481 *
4–6 43.3 43.8 46.7 43.5 692  
7–60 10.7 21.6 14.8 16.0 227  
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Was your blood pressure measured?       
No 21.1 11.4 9.7 16.4 181 15.139
Yes 78.1 88.6 90.1 83.2 1,317 1.178
Don't know 0.8 0.0 0.2 0.4 4 .
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Did you give a urine sample?       
No 33.3 32.8 20.4 33.1 380 30.888
Yes 66.2 67.2 79.6 66.7 1,119 2.810
Don't know 0.5 0.0 0.1 0.3 3 .
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Did you give a blood sample?       
No 27.9 22.3 17.8 25.2 310 11.604
Yes 71.8 77.6 82.0 74.6 1,186 1.085
Don't know 0.3 0.1 0.3 0.2 6 .
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Were you tested for HIV?       
No 36.8 37.6 24.4 37.2 465 67.647
Yes 42.6 38.7 62.7 40.7 761 3.856
Don't know 20.6 23.7 12.9 22.1 276 *
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Was your weight measured?       
No 40.6 16.1 9.8 28.7 298 94.643
Yes 58.8 82.9 90.1 70.5 1,191 7.987
Don't know 0.6 1.0 0.1 0.8 13 **
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Did a health provider ask if you had vaginal bleeding?       
No 50.9 52.4 44.4 51.7 708 7.840
Yes 48.2 45.9 54.6 47.1 772 0.624
Don't know 0.9 1.6 0.9 1.2 22 .
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Were you told to pay attention to baby movements?       
No 34.2 26.0 27.2 30.2 416 6.529
Yes 64.9 72.7 72.5 68.7 1,073 0.562
Don't know 0.9 1.3 0.3 1.1 13 .
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Did you discuss baby due date?       
No 54.1 57.4 46.1 55.7 753 24.670
Yes 44.7 39.7 53.5 42.3 726 1.903
Don't know 1.2 2.9 0.4 2.0 23 .
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Told about danger signs in pregnancy?       
No 43.7 35.4 36.9 39.7 566 1.893
Yes 54.9 63.7 62.3 59.2 919 0.146
Don't know 1.4 0.9 0.8 1.2 17 .
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
As part of your ANC during your pregnancy were you ever 
given a mosquito net?       
No 74.0 82.9 63.8 78.3 1,079 34.177
Yes 25.6 17.1 36.0 21.5 420 6.990
Don't know 0.4 0.0 0.2 0.2 3 **
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.5. BIRTH PLANNING DURING LAST PREGNANCY
Percentage of women 15 to 49 years with a child under 2 years who discussed a birth plan with a health worker for 
their last-born child in past two years by content, September–October 2019
 






 % % % %  
Discuss with a health worker a plan for 
your delivery during your last pregnancy?       
No 74.4 69.7 64.9 72.1 1,019 8.167
Yes 25.2 30.3 34.7 27.7 478 0.651
Don't know 0.4 0.0 0.4 0.2 5 .
Total 100.0 100.0 100.0 100.0 1,502  
N 452 457 593 909   
Where you plan to deliver the baby?       
No 18.6 10.5 4.5 14.3 45 14.040
Yes 81.0 89.3 95.3 85.4 430 5.085
Don't know 0.4 0.2 0.1 0.3 3 *
Total 100.0 100.0 100.0 100.0 478  
N 116 147 215 263   
Wanted to have relative/friend/neighbor 
with you during labor?       
No 29.5 42.8 30.9 36.5 164 1.862
Yes 70.1 57.0 68.2 63.2 309 0.254
Don't know 0.4 0.2 0.9 0.3 5 .
Total 100.0 100.0 100.0 100.0 478  
N 116 147 215 263   
Transport to where the baby would be 
born?       
No 47.0 50.7 34.5 49.0 189 9.735
Yes 52.6 49.3 64.2 50.8 283 1.743
Don't know 0.4 0.0 1.3 0.2 6 .
Total 100.0 100.0 100.0 100.0 478  
N 116 147 215 263   
What funds you would use for delivery?       
No 49.4 34.3 18.3 41.4 146 28.711
Yes 49.2 65.5 80.4 57.8 324 5.518
Don't know 1.5 0.2 1.4 0.8 8 **
Total 100.0 100.0 100.0 100.0 478  
N 116 147 215 263   
Finding a skilled birth attendant for 
delivery?       
No 35.8 27.3 24.5 31.3 134 3.278
Yes 63.8 72.1 73.8 68.2 336 0.558
Don't know 0.4 0.7 1.7 0.5 8 .
Total 100.0 100.0 100.0 100.0 478  
N 116 147 215 263   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.6. REASONS FOR NOT ATTENDING ANC DURING LAST PREGNANCY
Percentage of women 15 to 49 years who did not attend ANC for their last-born child in past two years by reason, 
September–October 2019






 % % % %  
Costs too much/Difficulty getting 
money
      
No 91.4 93.9 93.6 93.0 1,416 0.219
Yes 8.6 6.2 6.4 7.0 107 0.040
Total 100.0 100.0 100.0 100.0 1,523 .
N 435 612 476 1,047   
Don't know where to go       
No 97.3 97.0 93.9 97.1 1,467 8.440
Yes 2.7 3.1 6.1 2.9 56 1.064
Total 100.0 100.0 100.0 100.0 1,523 .
N 435 612 476 1,047   
Health facility not open       
No 96.5 98.5 96.0 97.8 1,487 3.874
Yes 3.5 1.5 4.0 2.2 36 0.369
Total 100.0 100.0 100.0 100.0 1,523 .
N 435 612 476 1,047   
Distance to health facility too far       
No 95.6 96.8 88.7 96.4 1,434 29.570
Yes 4.4 3.2 11.3 3.7 89 4.038
Total 100.0 100.0 100.0 100.0 1,523 *
N 435 612 476 1,047   
Poor quality of service       
No 98.6 99.2 98.2 99.0 1,501 1.639
Yes 1.4 0.8 1.8 1.0 22 0.575
Total 100.0 100.0 100.0 100.0 1,523 .
N 435 612 476 1,047   
No female provider at facility       
No 98.9 95.1 94.1 96.5 1,446 4.642
Yes 1.1 4.9 5.9 3.5 77 0.212
Total 100.0 100.0 100.0 100.0 1,523 .
N 435 612 476 1,047   
Husband/partner oppose       
No 76.2 82.5 70.5 80.2 1,151 18.770
Yes 23.8 17.5 29.6 19.8 372 1.797
Total 100.0 100.0 100.0 100.0 1,523 .
N 435 612 476 1,047   
Not wanting to go alone       
No 98.1 98.3 98.7 98.2 1,501 0.625
Yes 1.9 1.7 1.3 1.8 22 0.185
Total 100.0 100.0 100.0 100.0 1,523 .
N 435 612 476 1,047   
Not necessary to go       
No 47.1 52.7 64.3 50.7 847 28.662
Yes 52.9 47.3 35.7 49.3 676 2.495
Total 100.0 100.0 100.0 100.0 1,523 .
N 435 612 476 1,047   
Not customary       
No 93.0 79.1 89.7 84.2 1,332 10.193
Yes 7.0 20.9 10.3 15.8 191 0.784
Total 100.0 100.0 100.0 100.0 1,523 .
N 435 612 476 1,047   
Up to God       
No 90.2 70.2 81.3 77.6 1,228 3.247
Yes 9.8 29.8 18.7 22.5 295 0.505
Total 100.0 100.0 100.0 100.0 1,523 .
N 435 612 476 1,047   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.7. MEDICINES OR VACCINATIONS RECEIVED DURING LAST PREGNANCY
Percentage of women 15 to 49 years who received certain medicines or vaccinations during pregnancy for their last-
born child in past two years, September–October 2019






 % % % %  
Given an injection in the arm to prevent the 
baby from getting tetanus
      
No 60.6 66.7 52.4 64.0 1,775 54.182
Yes 38.3 32.1 47.3 34.8 1,233 4.344
Don't know 1.2 1.2 0.3 1.2 31 *
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
During your last pregnancy, how many 
times were you given a tetanus injection?
      
None 42.3 59.4 43.8 52.0 1,457 87.691
1 13.2 11.2 11.6 12.0 385 2.081
2 14.7 14.5 21.0 14.6 527 .
3 or more 9.6 6.4 15.8 7.8 327  
Don't know 20.2 8.6 7.8 13.6 343  
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Before your last pregnancy, how many 
times did you get a tetanus injection?
      
 0.0 0.1 0.0 0.0 1 93.569
None 59.3 70.9 60.6 65.9 1,905 2.617
1 5.4 5.2 5.8 5.3 175 .
2 4.0 6.3 10.4 5.3 222  
3 or more 3.0 2.9 9.6 3.0 169  
Don't know 28.3 14.7 13.7 20.5 567  
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
During your last pregnancy with child, did 
you take any iron tables or iron syrup?
      
No 48.0 61.4 47.2 55.6 1,542 62.296
Yes 49.4 36.9 52.7 42.3 1,449 5.025
Don't know 2.7 1.8 0.1 2.2 48 *
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
During your last pregnancy with child, did 
you take any folic acid supplements?
      
No 49.5 59.2 46.3 55.0 1,522 89.884
Yes 45.3 38.3 53.5 41.3 1,438 6.945
Don't know 5.2 2.5 0.2 3.6 79 **
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
During your last pregnancy, did you take 
any drugs for intestinal worms?
      
No 59.2 74.9 77.4 68.1 2,110 35.497
Yes 28.9 18.2 17.3 22.8 685 2.163
Don't know 11.9 7.0 5.3 9.1 244 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.8. KNOWLEDGE OF ANC TIMING AND VISITS
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report the number and 
timing of ANC visits during pregnancy, September–October 2019






 % % % %  
Number of times women should get 
a checkup during pregnancy
      
None 4.4 1.8 5.5 3.0 228 260.703
1–3 5.4 5.4 8.8 5.4 385 3.713
4 or more 29.3 37.5 48.7 33.7 2,469 *
Don't know 60.8 55.3 36.9 57.9 2,951  
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Opinion on timing of 1st ANC visit for 
pregnant woman
      
As soon as she thinks she is pregnant 22.2 15.6 11.5 18.7 963 260.078
In the 1st trimester 7.5 10.0 14.7 8.9 689 2.355
At the beginning of the 2nd trimester 12.5 17.7 27.4 15.3 1,236 *
At the beginning of the 3rd trimester 12.4 7.9 5.9 10.0 565  
Any time during pregnancy 19.6 12.4 17.0 15.7 944  
Other 1.9 1.1 1.9 1.5 95  
Don't know 24.0 35.3 21.8 30.0 1,541  
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.9. PERCEIVED MATERNAL BENEFITS OF ANC
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report ANC benefits for 
themselves by type of benefit, September–October 2019






 % % % %  
No benefits to mother       
No 93.9 93.2 95.8 93.6 5,710 15.240
Yes 6.1 6.8 4.2 6.4 324 0.385
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Monitor baby's growth by provider       
No 41.3 41.1 31.4 41.2 2,211 61.550
Yes 58.7 58.9 68.6 58.8 3,823 2.063
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Monitor mother's health by provider       
No 43.2 41.6 28.1 42.3 2,270 130.938
Yes 56.8 58.4 71.9 57.7 3,764 4.644
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Receive mosquito net       
No 78.4 90.4 73.7 84.9 4,923 106.175
Yes 21.6 9.6 26.3 15.1 1,111 3.916
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Receive medicine to prevent malaria 
during pregnancy
      
No 75.4 84.6 71.5 80.3 4,653 60.786
Yes 24.6 15.5 28.5 19.7 1,381 2.238
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Reduce risk of pregnancy complica-
tions
      
No 85.7 87.2 82.0 86.5 5,118 22.212
Yes 14.3 12.8 18.1 13.5 916 0.914
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Reduce risk of delivery complications       
No 89.8 91.6 83.5 90.8 5,315 66.454
Yes 10.2 8.4 16.6 9.2 719 3.386
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.10. WHAT ARE SOME DANGER SIGNS DURING PREGNANCY?
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who report any danger signs 
during pregnancy by type, September–October 2019






 % % % %  
No knowledge of pregnancy danger 
signs
      
No 87.5 89.9 91.9 88.8 5,425 16.868
Yes 12.5 10.1 8.1 11.2 609 0.788
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Severe weakness       
No 63.2 67.5 49.9 65.5 3,659 144.598
Yes 36.8 32.5 50.1 34.5 2,375 5.559
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Convulsions or fits       
No 78.7 84.4 71.4 81.8 4,788 85.798
Yes 21.3 15.6 28.7 18.2 1,246 2.999
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Severe headache       
No 68.2 73.8 58.8 71.2 4,069 97.236
Yes 31.9 26.2 41.2 28.8 1,965 4.326
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Blurred vision       
No 82.4 87.2 84.7 85.0 5,143 0.106
Yes 17.6 12.8 15.3 15.0 891 0.004
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Fever       
No 62.6 56.1 56.1 59.1 3,484 5.388
Yes 37.4 43.9 43.9 40.9 2,550 0.217
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Severe stomach pain       
No 64.4 67.4 67.9 66.0 4,007 2.416
Yes 35.6 32.7 32.1 34.0 2,027 0.134
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Fast or difficult breathing       
No 85.7 85.9 87.7 85.8 5,260 4.709
Yes 14.3 14.1 12.3 14.2 774 0.245
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Swollen feet       
No 83.2 79.5 74.4 81.2 4,747 38.639
Yes 16.8 20.5 25.6 18.8 1,287 1.846
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Swollen hands       
No 86.7 88.2 86.6 87.6 5,310 1.216
Yes 13.3 11.8 13.4 12.5 724 0.054
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.11. SELF-EFFICACY FOR ANC AND FACILITY BIRTH
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report confidence to 
start a conversation or get to a facility for ANC/delivery, September–October 2019






 % % % %  
Confidence to start a conversation 
with husband about attending ANC
      
Confident 73.7 67.1 74.9 70.2 4,414 44.298
Uncertain 23.3 29.9 24.2 26.8 1,484 1.228
Don't know 3.0 3.0 0.9 3.0 135 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Confidence that you could get to a 
health facility for ANC
      
Confident 67.4 63.0 71.3 65.0 4,161 41.605
Uncertain 28.6 33.6 27.1 31.3 1,707 0.984
Don't know 4.0 3.4 1.7 3.7 165 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Confidence to start a conversation 
with husband about facility delivery
      
Confident 56.8 47.5 49.7 51.8 3,213 63.754
Uncertain 38.2 49.5 49.3 44.3 2,646 1.578
Don't know 5.0 3.1 1.0 3.9 174 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Confidence that you could get to a 
health facility for delivery
      
Confident 48.6 43.3 43.5 45.8 2,855 76.230
Uncertain 46.7 53.1 55.6 50.1 3,000 1.957
Don't know 4.7 3.6 0.9 4.1 178 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.12. INTENTIONS FOR ANC AND FACILITY BIRTH DURING NEXT PREGNANCY
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report intent to attend 
ANC and have a facility birth during next pregnancy, September–October 2019






 % % % %  
Make at least 1 ANC visit during next 
pregnancy
      
Likely 65.4 58.7 65.7 61.8 3,907 95.242
Unlikely 28.5 34.6 32.6 31.8 1,827 2.492
Don't know 6.1 6.8 1.7 6.5 299 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Make at least 4 ANC visits during next 
pregnancy
      
Likely 65.2 58.6 68.8 61.7 3,983 127.378
Unlikely 27.8 34.0 29.6 31.1 1,714 3.422
Don't know 7.0 7.4 1.7 7.2 336 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Make at least 8 ANC visits during next 
pregnancy
      
Likely 52.7 46.2 46.4 49.2 2,938 103.863
Unlikely 37.3 44.6 49.8 41.2 2,612 2.614
Don't know 10.0 9.2 3.8 9.6 483 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Take SP/Fansidar to prevent malaria 
during next pregnancy
      
Likely 76.3 66.9 81.4 71.3 4,581 185.937
Unlikely 15.6 22.6 16.6 19.3 1,020 4.749
Don't know 8.1 10.5 2.0 9.4 432 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Have facility delivery during next 
pregnancy
      
Likely 56.3 45.2 51.7 50.3 3,209 98.262
Unlikely 37.2 48.6 46.7 43.3 2,537 2.500
Don't know 6.6 6.1 1.6 6.3 287 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.13. WHO ELSE INFLUENCES DECISIONS ABOUT ANC AND FACILITY DELIVERY?
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report influences on 
their decision to go for ANC or facility delivery, September–October 2019






% % % %  
To attend 4+ ANC visits       
No one else 27.3 27.3 25.5 27.3 1,582 117.315
Partner 67.0 63.6 67.4 65.2 3,988 1.818
Mother-in-law 2.8 3.6 0.9 3.3 153 .
Mother 1.6 1.0 1.2 1.3 89  
Other own family 0.2 0.3 0.3 0.2 18  
Other partner's family 0.1 0.1 0.3 0.1 10  
Friends 0.2 0.1 0.4 0.1 14  
Health provider 0.7 3.7 1.5 2.3 117  
Community/religious leader 0.0 0.2 0.0 0.1 4  
Other 0.1 0.1 2.5 0.1 58  
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
For facility delivery       
No one else 30.4 31.1 36.8 30.7 1,969 173.590
Partner 60.3 57.2 56.5 58.6 3,508 2.752
Mother-in-law 4.1 4.3 0.8 4.2 173 *
Mother 2.4 1.4 1.3 1.9 110  
Other own family 0.1 0.3 0.6 0.2 18  
Other partner's family 0.1 0.1 0.2 0.1 9  
Friends 0.2 0.2 0.1 0.2 13  
Health provider 2.5 5.4 2.0 4.0 188  
Community/religious leader 0.0 0.1 0.0 0.1 3  
Other 0.0 0.1 1.8 0.1 42  
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.1.14. PREGNANCY-RELATED BELIEFS, ATTITUDES AND VALUES
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who agree with certain 
beliefs, attitudes, or values about ANC or facility delivery, September–October 2019






 % % % %  
It is important for a woman to discuss 
her pregnancy with her husband
      
Agree 89.7 87.8 94.8 88.7 5,480 88.462
Disagree 6.9 8.3 4.3 7.7 404 2.293
Don't know 3.4 3.9 0.9 3.7 149 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Pregnant women need ANC only when 
sick
      
Agree 45.2 50.8 34.8 48.2 2,535 129.623
Disagree 49.4 40.0 59.2 44.3 3,088 2.423
Don't know 5.4 9.3 6.1 7.5 410 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Only first-time pregnant women need 
ANC
      
Agree 33.5 26.2 21.2 29.6 1,638 55.400
Disagree 58.6 62.4 67.0 60.6 3,766 0.976
Don't know 7.9 11.5 11.7 9.8 629 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Better to use traditional provider than 
health facility for ANC
      
Agree 41.3 38.2 29.9 39.7 2,116 83.144
Disagree 51.0 54.6 64.6 52.9 3,515 2.009
Don't know 7.7 7.2 5.5 7.4 402 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
The health facility is the best place to 
deliver a baby
      
Agree 58.6 47.7 56.3 52.7 3,401 46.154
Disagree 36.6 47.7 42.0 42.6 2,404 1.090
Don't know 4.8 4.5 1.7 4.7 228 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Pregnant women attending 4+ ANC 
visits have safer pregnancies
      
Agree 67.8 58.3 63.2 62.7 3,924 24.781
Disagree 20.9 27.7 27.7 24.5 1,431 0.413
Don't know 11.3 14.1 9.1 12.8 678 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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5.2 Delivery care 
Key findings
Across study areas, more than 80% of women 15 to 49 
years with a completed pregnancy in the past two years 
delivered at home, either at their own home (74%) or at 
another home (9%). Births were most commonly assisted 
by family members (36%) or traditional birth attendants 
(29%). Only 14% and 16% of women delivered in a health 
facility in Kebbi/Sokoto and Zamfara, respectively. Facility 
deliveries were more common among women living in 
the wealthiest households (36% and 43%) than in the 
poorest households (5% and 4%) in Kebbi/Sokoto and 
Zamfara. Women who attended primary education (31% 
and 19%) had higher facility delivery rates than those 
with no school attendance (10% and 9%) in Kebbi/Sokoto 
and Zamfara, respectively. Among women who did not 
have a facility delivery, the most common reasons for not 
doing so were lack of perceived need (75% and 61%) and 
spousal opposition (15% and 36%) in Kebbi/Sokoto and 
Zamfara. 
All respondents were asked about decision-making for 
facility deliveries and other related beliefs or attitudes. 
The most commonly reported influencers of a woman’s 
decision to have a facility delivery were spouses (57%) 
and no one else (34%). Despite reasons for non-facility 
delivery, including lack of perceived need, 55% of all 
respondents nevertheless agreed that the health facility 
is the best place to deliver a baby. Moreover, only 44% 
felt confident that they could get to a health facility for 
delivery. Only 51% were confident that they could start 
a conversation with their husband about facility delivery, 
and a similar proportion (51%) intended to deliver their 
next child at a health facility. There was no real difference 
in responses to these questions across Kebbi/Sokoto and 
Zamfara. 
TABLE 5.2. FACILITY DELIVERY DURING LAST PREGNANCY BY SOCIODEMOGRAPHIC  
                    CHARACTERISTICS
Percentage of women 15 to 49 years with a child under 2 years with a facility delivery for their last-born child by socio-
demographic characteristics, September–October 2019




% N % N % N % N
Total 14.8 892 13.8 1,078 16.3 1,069 14.2 1,971
Household wealth         
Lowest 5.7 264 5.3 341 3.5 111 5.4 606
Second 11.0 192 11.8 229 5.5 183 11.5 421
Middle 13.1 157 14.8 220 9.1 223 14.1 377
Fourth 28.1 113 15.6 135 10.8 248 21.4 249
Highest 29.5 166 42.1 153 42.5 304 35.6 318
Maternal age (in years)         
15–24 years 15.8 367 16.6 485 13.1 423 16.3 852
25–34 years 13.8 412 11.7 478 17.7 486 12.7 890
35–49 years 15.5 113 10.8 115 21.7 160 13.0 229
Maternal education (highest 
level attended)
        
None 8.8 675 10.3 855 9.0 698 9.7 1,530
Primary 36.9 47 26.9 57 18.9 60 31.2 104
Secondary or higher 40.5 95 68.1 60 54.4 180 50.4 155
Islamic 24.8 75 15.5 106 15.4 131 19.6 182
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.2.1. WHO ASSISTED IN THE DELIVERY OF YOUR CHILD DURING THE LAST PREGNANCY?
Percentage of women 15 to 49 years with a child under 2 years reporting who assisted in the delivery of their last-born 
child in past two years by reason, September–October 2019






 % % % %  
Doctor       
No 96.1 95.9 97.0 96.0 2,912 2.355
Yes 3.9 4.1 3.0 4.0 127 0.467
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Nurse/midwife       
No 77.9 89.8 83.1 84.7 2,507 1.384
Yes 22.2 10.2 17.0 15.3 532 0.145
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Community health worker       
No 94.9 94.8 92.5 94.8 2,851 6.675
Yes 5.1 5.2 7.5 5.2 188 1.582
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Chemist       
No 100.0 100.0 100.0 100.0 3,038 0.280
Yes 0.0 0.0 0.0 0.0 1 1.555
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Traditional birth attendant       
No 84.5 63.5 70.1 72.5 2,203 2.062
Yes 15.5 36.5 29.9 27.5 836 0.133
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Religious leader       
No 99.7 99.9 99.9 99.8 3,034 0.786
Yes 0.3 0.1 0.1 0.2 5 0.848
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Family       
No 58.0 67.5 64.6 63.4 1,918 0.415
Yes 42.0 32.5 35.5 36.6 1,121 0.033
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Friends/neighbors       
No 82.1 92.0 84.6 87.7 2,627 5.874
Yes 17.9 8.0 15.4 12.3 412 0.627
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Itinerant drug seller       
No 99.9 100.0 99.9 100.0 3,037 0.452
Yes 0.1 0.0 0.1 0.0 2 0.571
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.2.2. DELIVERY LOCATION AND RESPECTFUL CARE DURING LAST PREGNANCY
Percentage of women 15 to 49 years with a child under 2 years reporting where they gave birth during the delivery of 
their last-born child in past two years and respectful care among facility births, September–October 2019






 % % % %  
Where did you give birth to child?       
Her home 77.1 75.6 72.2 76.3 2,208 74.368
Other home 7.1 6.3 10.2 6.6 236 1.812
Government hospital 7.4 7.6 11.4 7.5 326 .
Governmental PHC 7.0 4.8 3.1 5.8 144  
Dispensary/health post 0.1 0.5 0.0 0.3 8  
Community health outreach post 0.1 0.0 0.8 0.0 10  
Nursing/maternity home 0.0 0.0 0.6 0.0 11  
Private hospital/clinic 0.2 0.9 0.5 0.6 21  
Pharmacy 0.0 0.0 0.0 0.0 1  
Other 0.8 4.1 0.9 2.7 62  
Don't know 0.2 0.2 0.4 0.2 12  
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
When giving birth (in a facility),  
did you feel ignored or neglected by 
health staff?
      
No 83.8 85.2 85.3 84.6 405 5.692
Yes 15.1 12.4 14.8 13.6 76 1.490
Don't know 1.1 2.4 0.0 1.8 7 .
Total 100.0 100.0 100.0 100.0 488  
N 138 156 194 294   
When giving birth (in a facility),  
did you have privacy?
      
No 25.5 3.2 13.1 13.5 70 28.982
Yes, separate room 44.5 47.2 25.7 45.9 182 2.535
Yes, curtains 28.8 48.5 59.8 39.5 228 .
Other 0.0 0.0 1.3 0.0 3  
Don't know 1.2 1.1 0.0 1.2 5  
Total 100.0 100.0 100.0 100.0 488  
N 138 156 194 294   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** 
indicates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas. Note: The respectful care questions 
were only asked for respondents that had a facility delivery, or more specifically, who gave birth during their last pregnancy at a government hospital, 
government PHC, dispensary/health post, or community health outreach post.
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TABLE 5.2.3. REASONS FOR NO FACILITY DELIVERY DURING LAST PREGNANCY
Percentage of women 15 to 49 years with a child under 2 years who did not deliver their last-born child in the past two 








 % % % %  
Costs too much       
No 92.7 95.5 95.5 94.3 2,386 1.700
Yes 7.3 4.5 4.5 5.7 132 0.228
Total 100.0 100.0 100.0 100.0 2,518 .
N 750 908 860 1,658   
Facility not open       
No 97.8 98.7 95.3 98.3 2,455 16.722
Yes 2.2 1.3 4.7 1.7 63 1.934
Total 100.0 100.0 100.0 100.0 2,518 .
N 750 908 860 1,658   
Health facility too far away/ 
no transportation       
No 97.1 97.5 92.2 97.3 2,408 28.694
Yes 3.0 2.6 7.8 2.7 110 4.151
Total 100.0 100.0 100.0 100.0 2,518 *
N 750 908 860 1,658   
No female provider at facility       
No 99.4 98.7 95.6 99.0 2,461 24.011
Yes 0.6 1.3 4.4 1.0 57 4.418
Total 100.0 100.0 100.0 100.0 2,518 *
N 750 908 860 1,658   
Poor quality of service       
No 99.3 99.4 99.6 99.4 2,501 0.483
Yes 0.7 0.6 0.4 0.6 17 0.418
Total 100.0 100.0 100.0 100.0 2,518 .
N 750 908 860 1,658   
Husband/family does not allow       
No 84.1 85.9 64.3 85.1 1,942 131.939
Yes 15.9 14.1 35.7 14.9 576 11.712
Total 100.0 100.0 100.0 100.0 2,518 ***
N 750 908 860 1,658   
Not necessary to go       
No 24.3 25.7 38.6 25.1 761 49.618
Yes 75.7 74.3 61.4 74.9 1,757 3.736
Total 100.0 100.0 100.0 100.0 2,518 .
N 750 908 860 1,658   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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5.3 Newborn care 
Key findings
Newborn care practices: Among respondents with a 
completed pregnancy in the past two years, only 32 
percent and 22 percent reported placing the newborn 
on a bare chest directly after birth in Kebbi/Sokoto and 
Zamfara, respectively. Less than one in five newborns had 
chlorhexidine applied to their stump across study areas. 
In the two days following birth, less than one in five new-
borns were provided with all other essential measures, 
including examining the cord, measuring temperature, 
and checking on the child for feeding practices, breathing 
problems, weakness, convulsions, swollen/red umbilical 
cord, skin boils, and pus in the eyes. 
All respondents were asked about ways to protect 
a newborn after delivery. While nearly two-thirds of 
respondents across study areas (65%) reported imme-
diate breastfeeding, awareness of other measures was 
far lower: getting the child immunized (23%), skin-to-skin 
contact (19%), and using chlorhexidine for the child’s 
stump (7%), with generally higher awareness in Zamfara 
than in Kebbi/Sokoto for each of these measures. Taken 
together, these results point to low awareness and 
provision of newborn care in study areas, which could be 
an area for SBC activities to help raise rates of essential 
newborn care. 
Postpartum care and counseling: Among respondents 
with a completed pregnancy in the past two years, only 
13 percent and 20 percent were given misoprostol after 
their most recent birth in Kebbi/Sokoto and Zamfara, 
respectively. Less than one-third received a postpar-
tum check following birth. Of those who did, nearly all 
received a check within the first 12 hours post-birth, 
either by a nurse/midwife (33%), community health 
worker (27%), or doctor (22%). Few respondents (10% 
and 12%) in Kebbi/Sokoto and Zamfara were counseled 
on postpartum family planning in the first few days after 
delivery. In addition, few respondents were counseled on 
newborn danger signs (16% and 15%) and breastfeeding 
practices (17% and 16%) within the first 2 days after birth 
in Kebbi/Sokoto and Zamfara.
All respondents were asked about ways to help a mother 
recover from childbirth. While most respondents      
reported rest (62%) and good nutrition (58%), far fewer 
reported the need to take misoprostol immediately after 
birth (14%), thereby indicating low awareness of this 
practice. There was much lower awareness of misopros-
tol in Kebbi/Sokoto (9%) than in Zamfara (18%). Taken 
together, these results point to low awareness and provi-
sion of postpartum care and counseling in study areas to 
help women recover from childbirth.
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TABLE 5.3.1. NEWBORN CARE IMMEDIATELY AFTER DELIVERY 
Percentage of women 15 to 49 years with a child under 2 years reporting the following procedures done immediately 
after delivery for her last-born child in the past two years, September–October 2019






 % % % %  
Was child wiped dry within a few min-
utes after birth?
      
No 41.1 48.5 45.4 45.3 1,330 2.204
Yes 53.9 47.5 51.2 50.2 1,564 0.087
Don't know 5.0 4.1 3.4 4.5 145 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Was child bathed immediately after 
birth?
      
No 30.9 28.5 31.9 29.5 1,000 5.035
Yes 65.9 68.2 65.9 67.2 1,941 0.204
Don't know 3.2 3.4 2.2 3.3 98 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
How long after birth was child bathed 
for the first time (in hours)?
      
1 58.5 50.6 48.8 53.9 1,015 113.686
2 10.1 14.8 13.5 12.8 260 3.139
3–5 4.8 10.8 21.5 8.3 243 *
6–11 2.1 7.2 6.2 5.0 107  
12–23 2.8 7.2 5.1 5.3 106  
24+ 9.1 5.9 3.9 7.3 113  
Don't know 12.6 3.6 1.2 7.4 97  
Total 100.0 100.0 100.0 100.0 1,941  
N 539 725 677 1,264   
Child placed directly on bare skin of 
chest
      
No 66.4 64.7 76.5 65.4 2,056 45.522
Yes 31.5 32.9 21.5 32.3 905 2.397
Don't know 2.1 2.4 2.0 2.3 78 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
New blade to cut child's cord       
No 13.2 7.0 7.7 9.7 290 4.057
Yes 85.6 90.6 90.6 88.4 2,687 0.204
Don't know 1.2 2.5 1.7 1.9 62 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Chlorhexidine applied to child's stump       
No 75.2 79.0 77.7 77.4 2,268 5.964
Yes 17.5 15.9 18.1 16.6 583 0.327
Don't know 7.3 5.2 4.3 6.1 188 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Given misoprostol (miso miso)       
No 78.7 83.2 75.0 81.3 2,348 26.393
Yes 13.7 12.6 20.3 13.1 509 1.562
Don't know 7.6 4.1 4.7 5.6 182 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.3.2. NEWBORN CARE IN THE FIRST TWO DAYS AFTER DELIVERY 
Percentage of women 15 to 49 years with a child under 2 years reporting the following procedures done within two 








 % % % %  
Examine the cord       
No 80.6 71.2 75.2 75.2 2,242 10.093
Yes 16.1 25.2 23.0 21.3 712 0.615
Don't know 3.3 3.6 1.7 3.5 85 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Measure child temperature       
No 85.4 80.5 80.0 82.6 2,424 9.591
Yes 10.7 16.6 17.7 14.1 528 0.747
Don't know 3.9 2.9 2.3 3.3 87 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Check child feeding problems       
No 83.5 79.6 82.4 81.3 2,422 7.653
Yes 12.1 17.3 15.5 15.0 520 0.596
Don't know 4.4 3.1 2.0 3.7 97 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Check child for jaundice       
No 83.9 80.7 80.2 82.1 2,414 30.729
Yes 10.2 15.0 17.7 12.9 496 2.688
Don't know 6.0 4.3 2.1 5.0 129 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Check child breathing problems       
No 82.2 80.7 81.0 81.3 2,407 6.158
Yes 13.2 15.8 16.5 14.7 523 0.477
Don't know 4.6 3.6 2.6 4.0 109 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Check child for  convulsions       
No 84.2 82.6 83.2 83.3 2,483 10.034
Yes 9.7 12.6 13.5 11.4 411 0.778
Don't know 6.1 4.8 3.3 5.4 145 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Check child for  weakness/lethargy       
No 83.5 81.7 83.5 82.5 2,465 17.773
Yes 10.4 12.3 13.5 11.5 414 1.417
Don't know 6.1 6.0 3.1 6.0 160 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Check child for swollen/red umbilicus 
with pus       
No 83.9 81.5 81.6 82.5 2,438 10.786
Yes 11.1 13.2 15.1 12.3 456 0.849
Don't know 5.1 5.3 3.3 5.2 145 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Check child for skin boils       
No 83.3 82.4 82.8 82.8 2,467 4.835
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Yes 12.0 13.0 13.9 12.5 442 0.391
Don't know 4.8 4.6 3.3 4.7 130 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Check child for pus in eyes       
No 83.8 80.8 82.4 82.1 2,446 3.607
Yes 11.6 14.4 14.2 13.2 461 0.276
Don't know 4.6 4.8 3.4 4.7 132 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Counsel on newborn danger signs       
No 85.3 76.7 83.5 80.4 2,447 9.732
Yes 10.6 19.9 14.5 15.9 490 0.502
Don't know 4.1 3.4 2.0 3.7 102 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Counsel on breastfeeding       
No 84.5 76.0 82.2 79.6 2,411 5.565
Yes 12.0 21.4 15.9 17.4 546 0.291
Don't know 3.6 2.6 1.9 3.0 82 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Counsel on nutrition for new mothers       
No 84.5 76.2 83.2 79.8 2,436 8.750
Yes 11.5 21.3 15.0 17.1 518 0.432
Don't know 4.1 2.5 1.8 3.2 85 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.3.3. POSTPARTUM CARE FOR MOTHERS AFTER DELIVERY
Percentage of women 15 to 49 years with a child under 2 years reporting the following procedures done within two 
days after delivery for her last-born child in the past two years, September–October 2019






 % % % %  
Did anyone check on your health after 
you gave birth to child?
      
No 80.6 76.7 66.0 78.4 2,201 57.431
Yes 18.2 22.2 33.1 20.5 804 3.973
Don't know 1.2 1.1 0.9 1.1 34 *
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
How long after delivery did the first 
check take place?
      
0–11 hours 82.5 65.7 63.8 72.2 541 5.538
12–23 hours 2.1 0.7 1.0 1.2 9 1.193
24+ hours 15.4 33.7 35.2 26.5 239 .
Total 100.0 100.0 100.0 100.0 789  
N 168 244 377 412   
Who checked on your health at that 
time?
      
Other health personnel 0.0 0.0 0.4 0.0 1 95.866
Doctor 19.4 22.1 22.6 21.1 186 3.837
Nurse/midwife 52.5 23.0 31.8 34.4 277 ***
Community health worker 20.1 18.9 30.0 19.4 198  
Chemist 0.8 0.1 8.0 0.4 29  
Traditional healer/birth attendant 4.5 8.8 4.9 7.2 48  
Religious leader 0.0 0.4 0.0 0.2 1  
Family 2.8 22.8 1.1 15.1 50  
Friends/neighbors 0.0 3.5 0.5 2.1 10  
Other 0.0 0.0 0.6 0.0 2  
Don't know 0.0 0.4 0.2 0.2 2  
Total 100.0 100.0 100.0 100.0 804  
N 171 250 383 421   
After childbirth, did anyone talk to you 
about using modern contraception?
      
No 90.8 87.9 87.4 89.2 2,659 14.162
Yes 7.9 11.2 12.4 9.8 351 1.486
Don't know 1.4 0.9 0.2 1.1 29 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
After giving birth,  did anyone counsel 
you on nutrition for new mothers?
      
No 84.5 76.2 83.2 79.8 2,436 8.750
Yes 11.5 21.3 15.0 17.1 518 0.432
Don't know 4.1 2.5 1.8 3.2 85 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.3.4. WHAT ARE SOME WAYS TO PROTECT A NEWBORN IMMEDIATELY AFTER BIRTH?
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report ways to protect 
a newborn immediately after birth by method, September–October 2019






% % % %  
Skin to skin contact    
No 81.7 79.0 81.1 80.2 4,888 0.627
Yes 18.3 21.1 18.9 19.8 1,146 0.020
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Immediate breastfeeding    
No 31.0 46.3 31.8 39.2 2,299 35.481
Yes 69.1 53.7 68.2 60.8 3,735 1.132
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Give fluids excluding breastmilk    
No 83.2 79.8 90.0 81.4 5,086 92.970
Yes 16.8 20.3 10.0 18.6 948 2.464
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Get child immunized    
No 83.4 81.2 73.2 82.3 4,667 67.682
Yes 16.6 18.8 26.9 17.8 1,367 2.175
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Chlorhexidine for baby's stump    
No 95.6 94.5 91.3 95.0 5,661 30.284
Yes 4.4 5.5 8.7 5.0 373 0.966
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Traditional medicine for stump    
No 85.2 78.5 83.0 81.6 5,027 2.096
Yes 14.8 21.5 17.0 18.4 1,007 0.050
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 5.3.5. WHAT ARE SOME WAYS TO HELP A MOTHER RECOVER WELL AFTER BIRTH?
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report ways to help a 
mother recover well from childbirth by method, September–October 2019






 % % % %  
Take misoprostol immediately after 
birth     
No 94.0 89.3 81.6 91.5 5,297 114.640
Yes 6.0 10.7 18.4 8.5 737 4.576
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Ensure good nutrition is taken     
No 41.4 52.8 37.6 47.5 2,661 58.892
Yes 58.6 47.3 62.4 52.5 3,373 1.869
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Lose weight gained during pregnancy     
No 94.5 93.9 86.9 94.2 5,567 84.542
Yes 5.5 6.1 13.1 5.8 467 3.285
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Resume regular activity immediately     
No 85.0 86.2 75.3 85.6 5,016 95.435
Yes 15.0 13.8 24.7 14.4 1,018 2.792
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Rest     
No 47.9 26.9 38.4 36.6 2,342 1.868
Yes 52.1 73.1 61.7 63.4 3,692 0.060
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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Child nutrition and breastfeeding
6.1 Child nutrition and 
breastfeeding practices
Key findings
Nearly all respondents (96%) reported ever breastfeeding 
their last-born child under 2 years old. Among the few 
respondents who never breastfed, the most common 
reasons were respondent and partner opposition. 
Despite high rates of ever breastfeeding, initiation of 
breastfeeding within one hour of birth was low overall 
but higher in Zamfara (46%) than in Kebbi/Sokoto (36%). 
Immediate breastfeeding was higher among respondents 
in the wealthiest (40% and 57%) than in the poorest 
(35% and 47%) households and among respondents with 
secondary/higher schooling (47% and 58%) than among 
respondents with no education (33% and 43%) in Kebbi/
Sokoto and Zamfara, respectively. 
Exclusive breastfeeding was also low across study areas, 
with higher rates in Zamfara (46%) than in Kebbi/Sokoto 
(26%) and with similar patterns by sociodemographic 
characteristics. This low coverage is in large part due to 
high rates of giving non-breastmilk liquids to a child in 
the first three days after birth, with much higher prac-
tice rates in Kebbi/Sokoto (73%) than in Zamfara (50%). 
In addition, 73 percent of respondents agreed that the 
mother’s breastmilk after birth is bad, which may be 
linked with giving non-breastmilk liquids to a newborn. 
Taken together, this points to a potential area for SBC 
activities to help promote exclusive breastfeeding.
All respondents were asked who else influences decisions 
about breastfeeding, with the most common responses 
being spouse (60%) and no one else (34%). Respondents 
were also asked about the benefits of breastfeeding for 
women. The most commonly reported benefits were 
promoting infant bonding (31%) and convenience (20%). 
One in five respondents reported no benefits whatso-
ever. Nearly two-thirds (64%) of respondents reported 
that breastfeeding should last 12 to 23 months, and a 
similar proportion agreed that exclusive breastfeeding 
was important. Most respondents (86%) also agreed that 
breastmilk contains essential nutrients for the child’s first 
six months of life. 
Yet despite this reported high awareness of breastfeeding 
and its benefits, only about half (55%) of respondents felt 
confident to exclusively breastfeed their child for the first 
six months, with higher confidence in Zamfara (64%) than 
in Kebbi/Sokoto (42%). In Kebbi/Sokoto and Zamfara, 
respectively, 30 percent and 49 percent of respondents 
believed that most women in their communities gave 
breastmilk alone to infants, suggesting weak social norms 
favoring exclusive breastfeeding in this area. There was 
also relatively low intent to exclusively breastfeed their 
next child for the first six months, with higher intent in 
Zamfara (59%) than in Kebbi/Sokoto (46%).
6
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TABLE 6.1.A. IMMEDIATE BREASTFEEDING AFTER BIRTH BY SOCIODEMOGRAPHIC  
                       CHARACTERISTICS
Percentage of last-born children in past two years who were breastfed within one hour of birth by sociodemographic 
characteristics, September–October 2019




% N % N % N % N
Total 41.6 892 31.6 1,078 46.1 1,069 35.9 1,971
Household wealth         
Lowest 32.0 264 36.9 341 46.9 111 35.0 606
Second 40.1 192 30.1 229 36.7 183 34.5 421
Middle 40.4 157 24.9 220 32.3 223 31.1 377
Fourth 63.7 113 28.2 135 55.0 248 44.9 249
Highest 46.1 166 32.7 153 56.5 304 39.6 318
Maternal age (in years)        
15–24 years 46.8 367 27.9 485 38.9 423 35.4 852
25–34 years 37.2 412 35.5 478 51.9 486 36.2 890
35–49 years 42.3 113 31.3 115 48.8 160 36.4 229
Maternal education (highest 
level attended)
     
None 40.2 675 28.4 855 42.5 698 33.2 1530
Primary 55.2 47 28.0 57 56.0 60 39.8 104
Secondary or higher 47.8 95 46.4 60 58.4 180 47.3 155
Islamic 40.2 75 52.1 106 50.5 131 46.9 182
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
TABLE 6.1.B. EXCLUSIVE BREASTFEEDING IN FIRST SIX MONTHS OF LIFE BY SOCIODEMOGRAPHIC 
                       CHARACTERISTICS
Percentage of last-born children aged 0–5 months who were exclusively breastfed (defined in BSS as current 
breastfeeding without solid or semi-solid foods and not given non-breastmilk liquids within first 3 days of life) by socio-
demographic characteristics, September–October 2019




  % N % N % N % N
Total 20.3 212 29.3 276 45.9 233 25.6 488
Household wealth         
Lowest 14.6 58 27.4 96 9.2 21 23.2 154
Second 20.9 44 35.3 61 43.6 38 29.1 105
Middle 27.9 34 30.9 45 41.1 51 29.7 79
Fourth 17.6 28 22.6 35 53.0 45 20.2 63
Highest 23.3 48 28.0 39 60.9 78 25.6 87
Maternal age (in years)
15–24 years 19.6 89 27.6 115 37.6 89 24.4 204
25–34 years 17.5 100 30.9 132 52.3 109 25.3 232
35–49 years 33.4 23 28.8 29 50.9 35 30.8 52
Maternal education (highest 
level attended)
None 17.1 156 26.4 236 44.4 159 22.9 392
Primary (..) 11 (..) 14 (..) 9 25.1 25
Secondary or higher 43.4 24 (..) 14 62.8 42 44.4 38
Islamic 21.2 21 (..) 12 24.2 23 36.4 33
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 6.1.1. BREASTFEEDING PRACTICES IMMEDIATELY AFTER BIRTH
Percentage of last-born children in past two years who ever breastfed, initiated breastfeeding within one hour of birth 
or received non-breastmilk liquids in first three days, September–October 2019
 






 % % % %  
Did you ever breastfeed your  
last-born child?       
No 1.9 2.4 4.9 2.2 126 14.336
Yes 98.1 97.6 95.1 97.8 2,913 2.471
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Did the child start breastfeeding 
within 1 hour of birth?     
No 57.6 67.4 53.6 63.2 1,812 34.620
Yes 41.6 31.6 46.1 35.9 1,201 2.158
Don't know 0.8 1.0 0.3 0.9 26 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
In the first 3 days, was the child  
given something to drink apart 
from breastmilk?    
No 21.6 29.1 49.9 25.9 979 168.895
Yes 76.9 70.3 49.7 73.2 1,903 12.643
Don't know 1.5 0.5 0.5 1.0 31 ***
Total 100.0 100.0 100.0 100.0 2,913  
N 864 1,045 1,004 1,909   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 6.1.2. REASONS FOR CHOOSING NOT TO EVER BREASTFEED YOUR CHILD
Percentage of women 15 to 49 years with a child under 2 years who did not ever breastfeed their last-born child by 
reasons for choosing not to breastfeed, September–October 2019






% % % %  
Respondent opposed    
No 95.4 65.6 46.0 76.8 82 8.447
Yes 4.6 34.4 54.1 23.3 44 3.435
Total 100.0 100.0 100.0 100.0 126 .
N 28 33 65 61   
Partner opposed    
No 63.2 74.9 70.4 70.5 89 0.000
Yes 36.8 25.1 29.6 29.5 37 0.000
Total 100.0 100.0 100.0 100.0 126 .
N 28 33 65 61   
Inadequate milk    
No 92.4 90.7 96.5 91.3 116 1.337
Yes 7.6 9.3 3.5 8.7 10 1.082
Total 100.0 100.0 100.0 100.0 126 .
N 28 33 65 61   
Not necessary    
No 77.2 86.0 92.4 82.7 114 2.363
Yes 22.8 14.0 7.6 17.3 12 1.079
Total 100.0 100.0 100.0 100.0 126 .
N 28 33 65 61   
Up to God     
No 77.5 80.3 90.5 79.3 110 2.649
Yes 22.5 19.7 9.5 20.7 16 0.684
Total 100.0 100.0 100.0 100.0 126 .
N 28 33 65 61   
Introduced other fluids    
No 89.9 97.8 95.3 94.9 119 0.009
Yes 10.1 2.2 4.7 5.1 7 0.009
Total 100.0 100.0 100.0 100.0 126 .
N 28 33 65 61   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 6.1.3. REASONS FOR GIVING NON-BREASTMILK LIQUIDS TO A NEWBORN IN FIRST THREE 
                       DAYS AFTER BIRTH
Percentage of women 15 to 49 years with a child under 2 years who gave non-breastmilk liquids in first three days to 
last-born child by reasons for not exclusively breastfeeding, September–October 2019






% % % %  
Respondent opposed    
No 62.7 63.7 56.8 63.2 1,177 8.042
Yes 37.3 36.3 43.2 36.8 726 0.484
Total 100.0 100.0 100.0 100.0 1,903 .
N 657 738 508 1,395   
Partner opposed     
No 70.3 74.0 60.8 72.3 1,303 28.517
Yes 29.7 26.0 39.2 27.7 600 2.324
Total 100.0 100.0 100.0 100.0 1,903 .
N 657 738 508 1,395   
Religious/community leader  
opposed
   
No 97.9 92.9 97.3 95.2 1,817 5.561
Yes 2.1 7.1 2.8 4.8 86 0.830
Total 100.0 100.0 100.0 100.0 1,903 .
N 657 738 508 1,395   
Inadequate milk for newborn    
No 85.5 86.5 82.3 86.1 1,608 5.129
Yes 14.5 13.5 17.7 13.9 295 0.354
Total 100.0 100.0 100.0 100.0 1,903 .
N 657 738 508 1,395   
Painful breastfeeding    
No 99.1 99.0 99.0 99.0 1,884 0.000
Yes 0.9 1.1 1.0 1.0 19 0.000
Total 100.0 100.0 100.0 100.0 1,903 .
N 657 738 508 1,395   
Not necessary     
No 75.1 82.9 78.2 79.4 1,509 0.372
Yes 24.9 17.1 21.8 20.6 394 0.038
Total 100.0 100.0 100.0 100.0 1,903 .
N 657 738 508 1,395   
Healthworker attitude    
No 100.0 99.9 99.6 100.0 1,899 2.919
Yes 0.0 0.1 0.4 0.0 4 5.676
Total 100.0 100.0 100.0 100.0 1,903 *
N 657 738 508 1,395   
Up to God     
No 87.6 88.6 87.2 88.1 1,668 0.381
Yes 12.4 11.4 12.8 11.9 235 0.040
Total 100.0 100.0 100.0 100.0 1,903 .
N 657 738 508 1,395   
Introduced food <6 months    
No 98.0 96.3 91.7 97.1 1,825 26.028
Yes 2.0 3.7 8.3 2.9 78 3.578
Total 100.0 100.0 100.0 100.0 1,903 .
N 657 738 508 1,395   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 6.1.4. BREASTFEEDING PRACTICES AMONG INFANTS AGED 0–5 MONTHS
Percentage of last-born children in past two years aged 0–5 months who were ever breastfed, are still breastfeeding, 








 % % % %  
Did you ever breastfeed your  
last-born child?       
No 1.3 0.8 4.3 1.0 21 53.748
Yes 98.7 99.2 95.7 99.0 700 4.223
Total 100.0 100.0 100.0 100.0 721 *
N 212 276 233 488   
In the first 3 days, was the child  
given something to drink apart 
from breastmilk?    
No 25.7 37.4 52.2 32.6 264 232.426
Yes 73.9 62.0 47.7 66.9 431 4.751
Don't know 0.4 0.6 0.2 0.5 5 *
Total 100.0 100.0 100.0 100.0 700  
N 206 273 221 479   
Are you still breastfeeding the 
child?      
No 3.9 5.2 2.6 4.7 56 19.285
Yes 96.1 94.8 97.4 95.3 644 1.332
Total 100.0 100.0 100.0 100.0 700 .
N 206 273 221 479   
Are you giving the child soft or 
semi-solid food?      
No 85.4 81.7 82.3 83.2 581 0.788
Yes 14.7 18.3 17.7 16.8 140 0.035
Total 100.0 100.0 100.0 100.0 721 .
N 212 276 233 488   
Was the child exclusively breastfed 
(0–5 months)?     
No 79.3 70.2 54.1 74.0 512 271.828
Yes 20.3 29.3 45.9 25.6 206 7.402
Don't know 0.4 0.5 0.0 0.5 3 **
Total 100.0 100.0 100.0 100.0 721  
N 212 276 233 488   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas. Note that exclusive breastfeeding in BSS 
is defined as infants 0-5 months who are currently breastfeeding and who received no solid or semi-solid foods in the past 24 hours and no non-breast-
milk liquids in first three days after birth.
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TABLE 6.1.5. BREASTFEEDING AND NUTRITION AMONG CHILDREN AGED 6–23 MONTHS
Percentage of last-born children in past two years aged 6–23 months who are still breastfeeding, or given solid or semi-








 % % % %  
Are you still breastfeeding the child?      
No 12.6 10.2 12.6 11.3 357 2.347
Yes 87.5 89.8 87.4 88.8 1,817 0.239
Total 100.0 100.0 100.0 100.0 2,174 .
N 649 757 768 1,406   
Are you giving the child soft or 
semi-solid food?      
No 16.4 12.5 13.0 14.2 332 1.631
Yes 83.7 87.5 87.0 85.8 1,945 0.220
Total 100.0 100.0 100.0 100.0 2,277 .
N 671 787 819 1,458   
How many times did the child eat 
solid/semi-solid food yesterday?    
No times 0.5 1.2 0.4 0.9 12 20.039
1 time 4.5 8.8 8.3 7.0 133 0.338
2 times 23.8 29.0 28.9 26.8 500 .
3+ times 66.6 53.2 57.8 58.9 1,164  
Don't know 4.7 7.9 4.6 6.5 136  
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Did child eat any of these yesterday?
Milk, cheese, yoghurt, other dairy    
No 51.8 46.8 42.9 48.9 893 21.744
Yes 48.2 52.8 57.0 50.9 1,046 0.698
Don't know 0.0 0.4 0.1 0.2 6 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Bread, rice, tuwo, other grains    
No 15.5 11.9 16.0 13.4 257 9.745
Yes 84.5 88.1 83.8 86.5 1,684 0.647
Don't know 0.0 0.1 0.2 0.1 4 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Potato, other roots or tubers    
No 78.9 83.2 72.3 81.4 1,485 62.234
Yes 20.7 16.2 27.2 18.1 447 2.269
Don't know 0.4 0.6 0.5 0.5 13 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Pumpkin squash or similar food    
No 89.0 91.9 86.5 90.7 1,716 22.580
Yes 11.0 7.6 13.1 9.0 221 0.881
Don't know 0.0 0.5 0.4 0.3 8 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Dark or leafy vegetables    
No 56.9 73.1 74.3 66.2 1,344 43.575
Yes 43.1 26.0 25.3 33.2 591 1.933
Don't know 0.0 1.0 0.4 0.6 10 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
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Mango, pawpaw or vitamin A fruits    
No 90.6 93.8 88.2 92.4 1,738 26.325
Yes 9.3 5.5 11.1 7.1 192 1.132
Don't know 0.1 0.7 0.7 0.5 15 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Any other fruits or vegetables    
No 72.0 81.8 73.3 77.6 1,452 13.764
Yes 27.9 17.6 26.0 22.0 479 0.506
Don't know 0.1 0.7 0.7 0.4 14 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Eggs      
No 79.5 79.8 71.4 79.7 1,466 60.324
Yes 20.2 19.0 28.3 19.5 465 2.296
Don't know 0.3 1.3 0.4 0.9 14 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Meat, poultry, fish     
No 61.5 70.7 56.8 66.8 1,181 64.787
Yes 38.2 28.4 42.9 32.5 752 2.189
Don't know 0.3 1.0 0.3 0.7 12 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Bean food, peas, lentils or nuts    
No 52.6 69.4 42.3 62.3 1,016 220.035
Yes 47.2 29.9 57.4 37.2 918 7.469
Don't know 0.2 0.7 0.4 0.5 11 **
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Any oil, fats, butter, or foods made 
with these     
No 48.9 65.6 49.5 58.5 1,029 51.290
Yes 50.9 33.6 50.3 40.9 905 1.230
Don't know 0.2 0.8 0.2 0.6 11 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Dates, sweets, biscuits    
No 57.2 52.8 42.9 54.7 931 76.651
Yes 42.6 46.2 56.5 44.6 995 1.960
Don't know 0.2 1.0 0.6 0.7 19 .
Total 100.0 100.0 100.0 100.0 1,945  
N 551 681 713 1,232   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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6.2 Breastfeeding ideations
TABLE 6.2.1. PERCEIVED BENEFITS OF EXCLUSIVE BREASTFEEDING FOR THE MOTHER
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report breastfeeding 
benefits for the mother by perceived benefit, September–October 2019






% % % %  
None     
No 69.3 77.9 79.2 73.9 4,560 22.578
Yes 30.7 22.1 20.8 26.1 1,474 0.760
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Free/No cost     
No 88.8 88.2 83.9 88.5 5,224 24.655
Yes 11.2 11.8 16.1 11.5 810 0.908
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Convenient     
No 89.5 84.7 74.7 86.9 5,000 134.187
Yes 10.5 15.3 25.3 13.1 1,034 4.386
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Promotes bonding with infant    
No 89.4 71.7 61.5 79.9 4,431 230.443
Yes 10.6 28.3 38.5 20.1 1,603 8.242
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Promotes weight loss    
No 95.2 94.6 82.3 94.9 5,479 209.408
Yes 4.8 5.4 17.7 5.1 555 10.031
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Reduces blood post-delivery    
No 96.6 94.4 83.4 95.5 5,535 204.831
Yes 3.4 5.6 16.6 4.6 499 8.728
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Relieves pain after birth    
No 96.1 93.6 87.3 94.8 5,573 91.711
Yes 3.9 6.4 12.7 5.2 461 3.511
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Promotes maternal health    
No 94.8 91.6 86.8 93.1 5,515 61.027
Yes 5.2 8.4 13.2 6.9 519 2.282
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Improves emotional well-being   
No 93.9 93.5 87.7 93.7 5,526 57.895
Yes 6.1 6.5 12.3 6.3 508 2.807
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 6.2.2. PERCEIVED BENEFITS OF EXCLUSIVE BREASTFEEDING FOR THE BABY
Percentage of women aged 15-49 years with a child under 2 years who report breastfeeding benefits for the baby by 
perceived benefit, September–October 2019






 % % % %  
Good nutrition
No 92.5 90.0 92.2 91.2 2,860 1.031
Yes 7.6 10.0 7.8 8.8 267 0.124
Total 100.0 100.0 100.0 100.0 3,127 .
N 1,240 1,062 825 2,302   
Prevents illness
No 98.4 93.8 93.4 96.1 2,966 12.047
Yes 1.6 6.2 6.6 3.9 161 0.960
Total 100.0 100.0 100.0 100.0 3,127 .
N 1,240 1,062 825 2,302   
Promotes long-term health
No 99.3 98.2 94.8 98.8 3,036 39.490
Yes 0.7 1.9 5.2 1.3 91 6.465
Total 100.0 100.0 100.0 100.0 3,127 *
N 1,240 1,062 825 2,302   
Promotes bonding with mother
No 99.3 98.2 98.7 98.8 3,089 0.073
Yes 0.7 1.9 1.4 1.2 38 0.017
Total 100.0 100.0 100.0 100.0 3,127 .
N 1,240 1,062 825 2,302   
Leads to weight gain
No 99.8 98.5 97.8 99.1 3,084 9.555
Yes 0.3 1.5 2.3 0.9 43 1.735
Total 100.0 100.0 100.0 100.0 3,127 .
N 1,240 1,062 825 2,302   
Leads to higher IQ
No 99.6 99.3 95.2 99.5 3,072 56.275
Yes 0.4 0.7 4.8 0.5 55 11.855
Total 100.0 100.0 100.0 100.0 3,127 ***
N 1,240 1,062 825 2,302   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 6.2.3. WHO ELSE INFLUENCES DECISIONS ABOUT BREASTFEEDING?
Percentage of women aged 15 to 49 years who are currently pregnant or with a child under 2 years who report influ-
encers on a woman’s decisions about breastfeeding, September–October 2019






% % % %  
No one else    
No 71.6 62.2 65.0 66.5 3,951 1.439
Yes 28.4 37.8 35.0 33.5 2,083 0.040
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Partner   
No 32.8 46.4 39.5 40.1 2,455 0.233
Yes 67.2 53.6 60.5 59.9 3,579 0.006
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Mother in-law  
No 91.1 86.4 95.7 88.6 5,536 110.887
Yes 8.9 13.6 4.3 11.5 498 10.482
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Mother
No 92.7 91.4 93.9 92.0 5,575 7.719
Yes 7.3 8.6 6.1 8.0 459 0.549
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Own other family members
No 99.5 98.7 99.3 99.1 5,984 0.812
Yes 0.5 1.3 0.7 0.9 50 0.262
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Partner’s other family members
No 99.8 99.3 99.3 99.5 6,005 0.969
Yes 0.3 0.7 0.7 0.5 29 0.304
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Friends
No 99.4 99.1 97.1 99.2 5,935 32.939
Yes 0.6 0.9 2.9 0.8 99 6.445
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Health provider
No 97.8 96.6 93.6 97.2 5,792 40.263
Yes 2.2 3.4 6.4 2.8 242 2.266
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Religious/community leader
No 99.2 99.8 99.7 99.5 6,010 1.441
Yes 0.8 0.2 0.3 0.5 24 0.459
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 6.2.4. BREASTFEEDING KNOWLEDGE, BELIEFS, INTENTIONS, AND SELF-EFFICACY
Percentage of women aged 15 to 49 years who are currently pregnant or with a child under 2 years with breastfeeding 








 % % % %  
In your opinion, how long should a woman breastfeed her child?    
6 months or less 2.7 1.1 2.3 1.9 133 129.116
6–11 months 3.1 7.2 8.1 5.3 327 1.027
12–23 months 64.2 68.3 62.5 66.4 3,957 .
24 months or more  
(correct response) 27.9 21.7 19.8 24.6 1,353  
Other 1.2 1.0 6.1 1.1 178  
Don't know 0.9 0.7 1.2 0.8 85  
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Breastmilk contains essential nutrients for first 6 months of life    
Agree 77.1 85.0 88.7 81.3 5,005 95.845
Disagree 15.8 9.9 9.5 12.6 691 2.510
Don't know 7.1 5.2 1.8 6.1 337 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Breastmilk immediately after birth is bad      
Agree 29.9 28.2 18.8 29.0 1,489 190.173
Disagree 61.3 65.5 78.7 63.6 4,145 5.282
Don't know 8.8 6.3 2.5 7.5 399 **
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Likelihood you would exclusively breastfeed next child for first 6 months    
Likely 45.4 45.8 59.3 45.6 2,987 147.534
Unlikely 47.8 49.9 39.1 49.0 2,759 2.871
Don't know 6.8 4.3 1.7 5.4 287 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Most women in my community only give infants breastmilk     
Agree 31.5 28.8 48.8 30.0 2,270 211.334
Disagree 58.2 60.0 43.6 59.2 3,127 3.611
Don't know 10.3 11.3 7.6 10.8 636 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Important for mothers to only give child breastmilk for first 6 months    
Agree 48.6 53.0 70.6 51.0 3,462 246.712
Disagree 41.8 39.9 25.6 40.8 2,150 4.297
Don't know 9.6 7.1 3.8 8.3 421 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Confidence to exclusively breastfeed your child for first 6 months    
Confident 40.4 43.5 64.2 42.1 2,921 334.042
Uncertain 50.7 53.4 34.7 52.2 2,829 6.956
Don't know 8.9 3.0 1.2 5.7 283 **
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Confidence to start conversation with husband about breastfeeding child    
Confident 59.3 61.5 75.1 60.5 3,928 184.155
Uncertain 34.8 35.4 24.0 35.1 1,903 4.678
Don't know 5.9 3.1 0.9 4.4 202 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 6.2.5. WHAT ARE SOME WAYS TO RECOGNIZE POOR NUTRITION IN A CHILD?
Percentage of women aged 15 to 49 years who are pregnant or with a child under 2 years who report ways of recogniz-
ing poor nutrition in a child by symptom, September–October 2019






% % % %  
Lack of energy     
No 56.7 62.7 52.3 59.9 3,392 34.015
Yes 43.3 37.3 47.7 40.1 2,642 1.448
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Trouble paying attention    
No 74.2 81.7 74.4 78.2 4,677 11.927
Yes 25.8 18.3 25.6 21.8 1,357 0.362
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Trouble learning     
No 83.3 89.8 82.4 86.8 5,142 21.107
Yes 16.7 10.2 17.6 13.2 892 0.790
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Irritability     
No 77.2 91.1 85.7 84.7 5,106 1.205
Yes 22.8 8.9 14.3 15.3 928 0.040
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Becomes ill easily     
No 68.0 77.5 73.8 73.1 4,476 0.399
Yes 32.0 22.5 26.2 26.9 1,558 0.011
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Weakness     
No 71.0 75.9 63.9 73.6 4,298 63.379
Yes 29.0 24.1 36.1 26.4 1,736 2.418
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Dry/scaly skin     
No 88.6 80.2 76.8 84.1 4,926 48.345
Yes 11.4 19.8 23.2 15.9 1,108 2.021
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Longer time to healing for wounds    
No 94.6 94.7 92.4 94.6 5,706 11.847
Yes 5.4 5.3 7.6 5.4 328 0.824
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Stunted growth     
No 78.5 66.4 64.1 72.0 4,272 41.217
Yes 21.5 33.7 35.9 28.0 1,762 1.660
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Thin arms and legs     
No 81.6 71.8 67.2 76.3 4,501 58.853
Yes 18.4 28.2 32.8 23.7 1,533 1.829
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Visible ribs     
No 87.0 72.7 67.4 79.3 4,616 102.197
Yes 13.1 27.3 32.6 20.7 1,418 3.534
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.




From the baseline results, it is clear that promoting 
norms and awareness of the value of routine vaccinations 
should be a priority area for SBC efforts. There was low 
vaccination coverage in study areas, with generally higher 
vaccination rates in Zamfara than in Kebbi/Sokoto. Based 
on BSS baseline results, only 4 percent and 8 percent 
of children 12–23 months in Kebbi/Sokoto and Zamfara 
received all basic vaccinations (BCG, measles, DPT3, 
polio3) before the survey interview. Children 12 to 23 
months in the poorest households (2% and 2%) and with 
least educated mothers (4% and 5%) had lower rates of 
full vaccination than those in the wealthiest households 
(9% and 18%) and with mothers who attended second-
ary/higher school (17% and 19%) in Kebbi/Sokoto and 
Zamfara, respectively. The most important reasons for 
not vaccinating a child across study areas were spousal 
opposition (33%), distance to health facilities (14%), 
and fear of needles (11%). The person most commonly 
reported to influence a woman’s decision to vaccinate 
her child was her spouse (73%), making their opposition 
an important barrier to vaccine uptake. 
All respondents were asked about their views of health 
services for child vaccinations. Most respondents (76%)      
agreed that vaccination services in their communities 
were free of charge, and 75 percent agreed that people 
in their communities trust health providers with vaccina-
tion services. Yet in Kebbi/Sokoto, only about half (52%) 
of respondents believed that health facilities frequently 
had vaccines available, as compared with 61 percent in 
Zamfara. Only 47 percent of respondents in Kebbi/Sokoto 
and 66 percent in Zamfara believed that most women in 
their communities take children to facilities for routine 
vaccinations. Approximately one-quarter (26%) believed 
that vaccines contain dangerous chemicals that could 
harm a child.
Nevertheless, most respondents (72%) agreed that 
childhood vaccinations were effective in preventing 
illnesses, and 70 percent agreed that the illnesses 
vaccines prevent are severe. Seventy-two percent also 
agreed that they knew when and where to get a child 
vaccinated. Yet results from more specific vaccine 
questions elicit a less rosy picture: Only 17 percent and 
30 percent of respondents in Kebbi/Sokoto and Zamfara, 
respectively, reported that a child should be given his/
her first vaccination at birth. Two-thirds of respondents 
could not recall the number of times a child should be 
vaccinated before his or her first birthday. This suggests 
some disconnect between respondents’ positive reports 
of their own vaccine knowledge and the more realistic 
picture derived from specific questions. Indeed, BSS 
baseline results suggest that vaccine-specific knowledge 
is relatively low, that there are common perceptions of 
frequent vaccine stock-outs at health facilities, and that 
vaccine myths persist in this area. 
7
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TABLE 7.1. FULLY VACCINATED CHILDREN 12–23 MONTHS BY SOCIODEMOGRAPHIC  
                   CHARACTERISTICS
Percentage of last-born children aged 12–23 months who received all basic vaccinations (BCG, measles1, polio3, DPT3) 
at any time before the survey by sociodemographic characteristics, September–October 2019




% N % N % N % N
Total 3.6 482 4.5 548 7.7 578 4.1 1,030
Household wealth         
Lowest 1.5 149 1.9 172 2.0 65 1.7 321
Second 2.7 104 1.2 106 1.7 105 1.9 210
Middle 3.0 90 6.2 121 3.1 120 4.8 211
Fourth 11.5 58 6.8 67 9.0 144 9.1 126
Highest 4.2 81 13.3 82 18.1 144 8.7 162
Maternal age (in years)        
15–24 years 2.4 201 5.4 240 5.0 227 4.1 440
25–34 years 4.4 213 4.0 253 7.2 269 4.2 466
35–49 years 4.5 68 2.4 55 16.5 82 3.6 124
Maternal education  
(highest level attended)
     
None 3.7 365 3.6 401 5.3 365 3.6 766
Primary (..) 21 4.5 32 33.7 32 2.6 53
Secondary or higher 9.3 58 3.1 35 19.3 88 17.0 93
Islamic (..) 38 1.1 80 0.0 93 0.7 118
(..) Value not shown due to low number of observations. Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be 
interpreted with caution. *** indicates p<0.001, ** indicates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only 
study areas.
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TABLE 7.1.1. VACCINATION PRACTICES FOR CHILDREN 12–23 MONTHS 
Percentage of last-born children aged 12–23 months whoever received vaccinations, and among those, total times 
taken for vaccination and vaccine card receipt, September–October 2019






 % % % %  
Has the child ever received any 
immunizations?
    
No 48.6 59.2 60.1 54.4 896 82.007
Yes 48.9 38.3 39.7 43.1 680 2.126
Don't know 2.5 2.6 0.2 2.6 32 .
Total 100.0 100.0 100.0 100.0 1,608  
N 482 548 578 1,030   
Total times child taken for routine 
immunization since birth
    
No times 5.9 4.5 3.0 5.2 27 300.385
1–3 times 40.2 47.2 46.1 43.6 300 3.269
4–6 times 35.4 30.8 39.3 33.2 256 *
7+ times 9.4 5.8 11.0 7.7 55  
Don't know 9.1 11.6 0.6 10.3 42  
Total 100.0 100.0 100.0 100.0 680  
N 240 221 219 461   
Do you have a card where child 
vaccinations are written down?
   
Yes, only has a card 56.0 39.3 58.8 47.9 348 70.600
Yes, has only another document 2.8 0.0 2.1 1.5 8 1.119
Yes, has card and other document 1.3 4.7 1.7 3.0 13 .
No, has no card and no other 
document
39.8 56.0 37.4 47.7 311  
Total 100.0 100.0 100.0 100.0 680  
N 240 221 219 461   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.1.2. VACCINATED CHILDREN 12–23 MONTHS BY TYPE OF VACCINE
Percentage of last-born children aged 12-23 months who received specific vaccines at any time before the survey, 
September–October 2019






 % % % %  
BCG coverage       
No 57.4 73.0 69.7 65.9 1,051 74.678
Yes 32.8 21.9 27.8 26.8 448 1.796
Don't know 9.9 5.1 2.6 7.3 109 .
Total 100.0 100.0 100.0 100.0 1,608  
N 482 548 578 1,030   
DPT1 coverage       
No 65.3 75.6 71.1 70.9 1,125 61.258
Yes 19.4 18.1 23.4 18.7 343 1.115
Don't know 15.3 6.3 5.5 10.4 140 .
Total 100.0 100.0 100.0 100.0 1,608  
N 482 548 578 1,030   
DPT2 coverage       
No 73.9 79.3 78.6 76.8 1,233 56.504
Yes 10.8 14.4 15.9 12.8 235 1.216
Don't know 15.3 6.3 5.5 10.4 140 .
Total 100.0 100.0 100.0 100.0 1,608  
N 482 548 578 1,030   
DPT3 coverage       
No 79.1 84.1 83.8 81.8 1,325 59.564
Yes 5.7 9.6 10.7 7.8 143 1.300
Don't know 15.3 6.3 5.5 10.4 140 .
Total 100.0 100.0 100.0 100.0 1,608  
N 482 548 578 1,030   
Polio1 coverage       
No 50.5 61.1 63.6 56.3 930 177.505
Yes 37.7 31.1 34.3 34.1 560 4.168
Don't know 11.9 7.8 2.0 9.6 116 *
Total 100.0 100.0 100.0 100.0 1,606  
N 482 546 578 1,028   
Polio2 coverage       
No 52.2 64.4 65.3 58.9 974 174.445
Yes 35.9 27.8 32.7 31.5 518 4.167
Don't know 11.9 7.8 2.0 9.6 116 *
Total 100.0 100.0 100.0 100.0 1,608  
N 482 548 578 1,030   
Polio3 coverage       
No 59.2 71.3 69.8 65.9 1,079 174.762
Yes 28.9 20.9 28.1 24.5 413 4.123
Don't know 11.9 7.8 2.0 9.6 116 *
Total 100.0 100.0 100.0 100.0 1,608  
N 482 548 578 1,030   
Measles1 coverage       
No 67.6 78.6 76.4 73.7 1,189 80.083
Yes 15.9 16.5 19.2 16.2 288 1.792
Don't know 16.5 4.9 4.4 10.1 131 .
Total 100.0 100.0 100.0 100.0 1,608  
N 482 548 578 1,030   
All basic vaccinations (BCG, Mea-
sles1, DPT3, Polio3)
    
No 96.4 95.6 92.4 95.9 1,521 31.269
Yes 3.7 4.5 7.7 4.1 87 2.128
Total 100.0 100.0 100.0 100.0 1,608 .
N 482 548 578 1,030   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.1.3. REASONS FOR NOT VACCINATING A CHILD
Percentage of pregnant women and women with a child under 2 years who reported specific reasons why a mother in 
her community may not get her child vaccinated, September–October 2019






% % % %  
Too expensive     
No 92.8 91.7 96.1 92.1 1,734 13.424
Yes 7.2 8.3 3.9 7.9 113 1.571
Total 100.0 100.0 100.0 100.0 1,847 .
N 496 688 663 1,184   
Facility closed      
No 89.0 96.9 88.8 93.8 1,697 13.029
Yes 11.0 3.1 11.2 6.2 150 1.051
Total 100.0 100.0 100.0 100.0 1,847 .
N 496 688 663 1,184   
Distance/transport not available    
No 90.5 90.4 83.0 90.5 1,631 20.203
Yes 9.5 9.6 17.0 9.6 216 1.864
Total 100.0 100.0 100.0 100.0 1,847 .
N 496 688 663 1,184   
No female provider     
No 98.5 96.9 95.2 97.5 1,773 6.394
Yes 1.5 3.1 4.8 2.5 74 0.519
Total 100.0 100.0 100.0 100.0 1,847 .
N 496 688 663 1,184   
Disrespectful provider     
No 98.6 97.9 99.3 98.2 1,817 5.058
Yes 1.4 2.1 0.7 1.8 30 2.684
Total 100.0 100.0 100.0 100.0 1,847 .
N 496 688 663 1,184   
Poor quality service     
No 95.9 96.9 96.4 96.5 1,776 0.035
Yes 4.1 3.1 3.7 3.5 71 0.006
Total 100.0 100.0 100.0 100.0 1,847 .
N 496 688 663 1,184   
Vaccines not effective     
No 96.1 96.8 99.6 96.5 1,798 25.885
Yes 3.9 3.2 0.4 3.5 49 15.040
Total 100.0 100.0 100.0 100.0 1,847 ***
N 496 688 663 1,184   
Vaccines not safe/fear side effects    
No 80.5 83.7 95.8 82.4 1,602 92.640
Yes 19.5 16.3 4.2 17.6 245 10.598
Total 100.0 100.0 100.0 100.0 1,847 **
N 496 688 663 1,184   
Fear needles      
No 93.1 91.0 86.4 91.8 1,652 12.784
Yes 6.9 9.0 13.6 8.2 195 1.349
Total 100.0 100.0 100.0 100.0 1,847 .
N 496 688 663 1,184   
Husband/partner oppose     
No 70.8 65.4 66.8 67.5 1,210 0.105
Yes 29.2 34.6 33.2 32.5 637 0.010
Total 100.0 100.0 100.0 100.0 1,847 .
N 496 688 663 1,184   
Religious/community leaders oppose    
No 98.8 98.9 99.4 98.8 1,823 1.767
Yes 1.2 1.1 0.6 1.2 24 0.661
Total 100.0 100.0 100.0 100.0 1,847 .
N 496 688 663 1,184   
Don't know where to go     
No 95.1 96.5 97.9 95.9 1,788 6.110
Yes 4.9 3.5 2.1 4.1 59 1.363
Total 100.0 100.0 100.0 100.0 1,847 .
N 496 688 663 1,184   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.1.4. WHO ELSE INFLUENCES DECISIONS ABOUT GETTING A CHILD VACCINATED?
Percentage of pregnant women and women with a child under 2 years reporting who influences decisions to vaccinate 
a child, September–October 2019






% % % %  
No one else    
No 76.0 79.4 78.1 77.9 2,364 0.025
Yes 24.0 20.6 21.9 22.1 675 0.002
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Husband/partner    
No 27.0 26.5 27.2 26.7 819 0.086
Yes 73.0 73.5 72.8 73.3 2,220 0.005
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Mother-in-law    
No 92.5 83.7 95.5 87.5 2,771 65.394
Yes 7.5 16.3 4.5 12.5 268 11.386
Total 100.0 100.0 100.0 100.0 3,039 ***
N 892 1,078 1,069 1,970   
Mother     
No 94.2 94.7 93.8 94.5 2,853 0.587
Yes 5.8 5.3 6.2 5.5 186 0.090
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Own other family members    
No 99.7 99.3 99.1 99.5 3,019 1.859
Yes 0.3 0.7 1.0 0.5 20 1.164
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Partner’s other family members    
No 99.9 99.3 99.2 99.6 3,026 1.831
Yes 0.1 0.7 0.9 0.4 13 0.897
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Friends     
No 99.3 98.9 96.1 99.1 2,975 25.194
Yes 0.7 1.1 3.9 0.9 64 7.136
Total 100.0 100.0 100.0 100.0 3,039 **
N 892 1,078 1,069 1,970   
Health provider    
No 97.3 95.8 93.9 96.4 2,910 9.636
Yes 2.7 4.2 6.1 3.6 129 1.287
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Community/religious leader    
No 99.3 98.9 98.5 99.0 3,008 1.546
Yes 0.7 1.2 1.5 1.0 31 0.626
Total 100.0 100.0 100.0 100.0 3,039 .
N 892 1,078 1,069 1,970   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.1.5. VACCINE KNOWLEDGE, PERCEPTIONS, SELF-EFFICACY, AND INTENTIONS
Percentage of pregnant women and women with a child under 2 years reporting specific knowledge, perceptions, 
self-efficacy, and intentions for child vaccinations, September–October 2019






 % % % %  
Before 12 months, how many times should a child be vaccinated?    
No times 5.4 3.6 6.0 4.4 158 76.635
1–5 times 15.0 16.8 18.3 16.0 566 2.066
6–10 times 2.0 7.7 14.0 5.2 281 .
11+ times 1.7 0.1 0.7 0.8 22  
Don't know 75.9 71.9 61.0 73.6 2,012  
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
What age should child go for first routine vaccination?     
At birth 24.6 11.8 29.6 17.3 681 87.751
Before naming ceremony 12.4 12.0 9.7 12.2 394 1.717
After naming ceremony but before coming out 9.7 15.3 10.7 12.9 395 .
At coming out/6 weeks 6.2 2.5 1.9 4.1 102  
3 months 4.7 3.7 1.5 4.1 96  
After 1 year 0.8 0.9 0.6 0.8 22  
Other 0.9 1.2 1.4 1.1 43  
Don't know 40.8 52.8 44.6 47.6 1,306  
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
In your opinion, how effective are childhood vaccines?     
Effective 73.6 67.5 72.6 70.2 2,204 15.116
Not effective 4.8 7.4 8.8 6.3 204 0.640
Don't know 21.6 25.1 18.7 23.6 631 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Many of the illnesses vaccines prevent are severe     
Agree 70.3 68.9 71.1 69.5 2,145 8.207
Disagree 16.8 12.7 16.3 14.5 458 0.344
Don't know 12.9 18.5 12.6 16.1 436 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
I know where and when to get a child vaccinated     
Agree 64.2 63.6 75.6 63.9 2,138 50.324
Disagree 25.4 21.7 14.6 23.3 579 1.660
Don't know 10.4 14.7 9.8 12.9 322 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Easy for mothers in my community to take child for routine immunizations    
Agree 53.1 45.2 66.3 48.6 1,773 120.177
Disagree 40.3 44.6 24.0 42.8 1,008 3.359
Don't know 6.6 10.2 9.7 8.6 258 *
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Easy for mothers in my community to track child routine immunizations    
Agree 46.6 38.3 62.1 41.9 1,583 172.165
Disagree 46.4 50.9 25.8 49.0 1,149 4.879
Don't know 7.0 10.8 12.1 9.1 307 **
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Vaccines have chemicals that can be dangerous to a child’s health    
Agree 34.4 26.0 23.1 29.6 835 16.814
Disagree 42.3 44.0 48.6 43.2 1,437 0.592
Don't know 23.3 30.1 28.3 27.2 767 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Likelihood to make sure next child receives all vaccines     
Likely 78.4 68.5 78.4 72.8 2,277 14.627
Unlikely 14.1 23.4 16.3 19.4 560 0.572
Don't know 7.6 8.1 5.3 7.9 202 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.1.6. VACCINATIONS AND HEALTH SERVICES PERCEPTIONS
Percentage of pregnant women and women with a child under 2 years who reported specific perceptions about health 
services for child vaccinations, September–October 2019






 % % % %  
Immunization services in my  
community are free
    
Agree 75.5 68.4 78.7 71.5 2,288 33.447
Disagree 13.7 15.9 8.4 15.0 376 1.089
Don't know 10.8 15.7 12.9 13.6 375 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Most people in my community trust 
immunization services
    
Agree 75.5 60.8 80.1 67.1 2,203 69.938
Disagree 15.4 25.1 11.2 20.9 536 2.274
Don't know 9.1 14.2 8.7 12.0 300 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Health facilities in my community  
frequently have vaccines available
   
Agree 57.8 47.8 60.6 52.1 1,736 21.536
Disagree 30.3 33.0 26.8 31.9 880 0.684
Don't know 11.8 19.2 12.7 16.0 423 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Most parents take children to a health 
facility for routine immunizations
   
Agree 48.2 45.9 65.9 46.9 1,724 155.535
Disagree 43.6 44.7 22.8 44.2 1,010 5.040
Don't know 8.2 9.5 11.3 8.9 305 **
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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7.2 Acute respiratory infections
Key findings
Care-seeking and treatment: Among last-born children 
in the past two years, 7 percent were reported to have 
had a cough, rapid breaths, and a chest-related problem 
in the past two weeks, or acute respiratory infections 
(ARI). Among these children, 81 percent and 77 percent 
were taken for any care in Kebbi/Sokoto and Zamfara, 
respectively. However, only 49 percent and 33 percent 
of children with these respiratory symptoms who were 
taken for any care were brought to a formal medical 
source in Kebbi/Sokoto and Zamfara, indicating that 
many children may not have received adequate health 
care. Few children with these symptoms were given 
antibiotics across study areas, although Zamfara (41%) 
had higher antibiotic treatment rates than Kebbi/Sokoto 
(26%).
Reasons for source of care or not seeking any care: 
The most important reasons for choosing the source of 
care were nearby location (40%), trust in provider (36%), 
recommendation by family member or friend (30%), 
and effective treatment (27%) across study areas. These 
results point to the importance to respondents of con-
venient, trusted, and high-quality health services in their 
communities as a complement to SBC activities. The most 
important reasons for not seeking care included expense 
or cost (33%) and perceptions that symptoms were not 
severe or that home care was provided (25%).
Pneumonia ideations: Pediatric pneumonia knowledge 
is low across study areas. Only 28 percent and 37 percent 
of respondents currently pregnant or with a child under 
2 years reported rapid or difficult breathing as a sign or 
symptom of pediatric pneumonia; 45 percent and 31 
percent of respondents were unable to report any way 
to help prevent a child from getting pneumonia; and 62 
percent and 56 percent were unable to report any effec-
tive medicine to treat pneumonia in Kebbi/Sokoto and 
Zamfara, respectively. Across study areas, most respon-
dents (72%) agreed that pneumonia is a serious illness 
that can result in hospitalization and even death. Most 
respondents (80%) said that they were likely to have 
their child complete a full course of antibiotics, and most 
(86%) also said that they intended to seek treatment the 
same or next day for pneumonia symptoms. 
TABLE 7.2. ARI CARE-SEEKING FROM FORMAL MEDICAL SOURCES, BY SOCIODEMOGRAPHIC  
                   CHARACTERISTICS
Percentage of last-born children under 2 years with ARI in the past two weeks who were taken to a formal medical 
source by sociodemographic characteristics, September–October 2019




% N % N % N % N
Total 38.0 42 53.9 84 32.6 77 48.8 126
Household wealth         
Lowest (..) 11 49.8 30 (..) 5 48.1 41
Second (..) 7 (..) 10 (..) 13 (..) 17
Middle (..) 8 61.3 24 (..) 14 56.1 32
Fourth (..) 10 (..) 10 34.7 25 (..) 20
Highest (..) 6 (..) 10 (..) 20 (..) 16
Maternal age (in years)        
15–24 years (..) 9 49.4 30 29.4 33 42.1 39
25–34 years 42.4 31 55.8 45 27.1 33 50.5 76
35–49 years (..) 2 (..) 9 (..) 11 (..) 11
Maternal education  
(highest level attended)
None 48.7 27 51.9 64 25.2 45 51.0 91
Primary (..) 3 (..) 5 (..) 10 (..) 8
Secondary or higher (..) 8 (..) 1 (..) 8 (..) 9
Islamic (..) 4 (..) 14 (..) 14 (..) 18
(..) Value is not shown due to few observations. Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted 
with caution. *** indicates p<0.001, ** indicates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.2.1. ARI BY SYMPTOM
Percentage of last-born children under 2 years with ARI symptoms in the past two weeks, September–October 2019






 % % % %  
Has child had cough, rapid breaths, 
chest issue in past 2 weeks?
   
No 94.1 90.8 92.9 92.2 2,802 6.033
Yes 5.1 8.1 6.9 6.8 203 0.959
Don't know 0.8 1.1 0.3 0.9 28 .
Total 100.0 100.0 100.0 100.0 3,033  
N 887 1,077 1,069 1,964   
Has child had an illness with a cough 
at any time in the last 2 weeks?
   
No 84.0 75.7 77.1 79.3 2,373 8.434
Yes 15.3 23.3 22.6 19.9 639 0.949
Don't know 0.8 1.0 0.3 0.9 27 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Did child have short, rapid breaths or 
difficulty breathing?
    
No 46.4 38.9 47.8 41.4 283 7.894
Yes 49.2 61.1 52.2 57.2 351 1.289
Don't know 4.4 0.0 0.0 1.5 5 .
Total 100.0 100.0 100.0 100.0 639  
N 138 245 256 383   
Was this a problem in the chest or a 
blocked/runny nose?
    
Chest only 12.3 14.1 14.9 13.6 45 2.072
Nose only 32.3 42.0 42.0 39.2 146 0.294
Both chest and nose 55.4 42.8 43.1 46.4 158 .
Other 0.0 0.5 0.0 0.4 1  
Don't know 0.0 0.5 0.0 0.4 1  
Total 100.0 100.0 100.0 100.0 351  
N 69 151 131 220   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.2.2. ARI CARE-SEEKING BY SOURCE









 % % % %  
Did you seek advice or treatment for the illness?
No 12.2 22.8 22.9 19.4 41 10.684
Yes 87.8 77.2 77.1 80.6 162 0.200
Total 100.0 100.0 100.0 100.0 203 .
N 42 84 77 126   
Source of care for respiratory symptoms
No care sought 12.2 22.8 22.9 19.4 41 163.354
Informal private source 49.8 23.3 44.5 31.9 76 1.545
Formal medical source 38.0 53.9 32.6 48.8 86 .
Total 100.0 100.0 100.0 100.0 203  
N 42 84 77 126   
Where did you seek advice or treatment?
Government hospital
No 82.8 93.4 81.9 89.7 139 68.305
Yes 17.2 6.6 18.1 10.4 23 1.236
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Governmental PHC
No 89.6 63.6 79.6 72.7 122 39.094
Yes 10.4 36.4 20.4 27.3 40 0.420
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Dispensary/health post
No 97.6 90.1 98.4 92.7 152 120.759
Yes 2.5 9.9 1.7 7.3 10 2.240
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Community health outreach post
No 90.7 91.0 100.0 90.9 156 335.472
Yes 9.3 9.0 0.0 9.1 6 3.137
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Nursing/maternity home
No 97.6 100.0 97.1 99.2 160 29.524
Yes 2.4 0.0 2.9 0.8 2 0.831
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Private hospital/clinic
No 96.1 97.8 97.0 97.2 156 0.226
Yes 3.9 2.2 3.0 2.8 6 0.004
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Pharmacy/chemist
No 44.6 73.9 50.0 63.6 94 109.370
Yes 55.4 26.1 50.0 36.4 68 1.536
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** 
indicates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas. Note that the respondent was not 
prompted about the type of facility attended. The interviewer is trained to code any secondary level government (or general) hospital mentioned as 
“government hospital.”
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TABLE 7.2.3. REASONS FOR CHOOSING SOURCE OF CARE FOR ARI
Percentage of last-born children under 2 years with ARI in the past two weeks who were taken to care by reason for 
treatment location, September–October 2019






% % % %  
Free or inexpensive     
No 94.6 69.4 89.2 78.2 143 133.929
Yes 5.4 30.6 10.8 21.8 19 1.300
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Nearby/transport available    
No 55.5 47.6 66.7 50.4 102 161.706
Yes 44.6 52.4 33.3 49.7 60 2.164
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Medicines often in stock    
No 94.1 97.4 97.1 96.3 155 3.488
Yes 5.9 2.6 2.9 3.8 7 0.074
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Respectful care     
No 97.6 97.1 89.0 97.3 153 141.101
Yes 2.4 2.9 11.0 2.7 9 3.483
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Trust to care for child     
No 62.6 75.7 58.8 71.1 102 95.120
Yes 37.4 24.3 41.3 28.9 60 1.216
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Effective treatment     
No 76.8 83.1 68.0 80.9 119 121.602
Yes 23.2 16.9 32.0 19.1 43 1.467
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Short wait time     
No 68.6 90.5 87.7 82.8 135 28.788
Yes 31.4 9.5 12.3 17.2 27 0.284
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Privacy      
No 97.6 96.9 100.0 97.1 158 103.063
Yes 2.4 3.1 0.0 2.9 4 3.501
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Family/friends recommend    
No 84.2 94.0 55.6 90.5 121 836.974
Yes 15.8 6.1 44.4 9.5 41 10.966
Total 100.0 100.0 100.0 100.0 162 ***
N 37 64 61 101   
Religious/community leaders    
No 98.7 100.0 100.0 99.5 161 16.387
Yes 1.3 0.0 0.0 0.5 1 1.423
Total 100.0 100.0 100.0 100.0 162 .
N 37 64 61 101   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.2.4. REASONS FOR NOT SEEKING CARE FOR ARI
Percentage of last-born children under 2 years with ARI in the past two weeks not taken to care by reason for no 
care-seeking, September–October 2019




TOTAL N CHI2 
VALUE
% % % % %  
Too expensive/could not 
find money
    
No 56.9 50.5 76.1 51.8 67.5 27 361.503
Yes 43.1 49.5 23.9 48.2 32.5 14 2.620
Total 100.0 100.0 100.0 100.0 100.0 41 .
N 5 20 16 25 41   
Facility closed/no one there     
No 100.0 97.4 87.7 97.9 91.4 39 178.178
Yes 0.0 2.6 12.3 2.1 8.7 2 2.065
Total 100.0 100.0 100.0 100.0 100.0 41 .
N 5 20 16 25 41   
Distance/transportation not 
available
    
No 86.1 100.0 100.0 97.2 99.0 40 107.571
Yes 13.9 0.0 0.0 2.8 1.0 1 1.630
Total 100.0 100.0 100.0 100.0 100.0 41 .
N 5 20 16 25 41   
Medicine often not available     
No 80.3 100.0 100.0 96.0 98.6 40 153.740
Yes 19.8 0.0 0.0 4.0 1.4 1 1.677
Total 100.0 100.0 100.0 100.0 100.0 41 .
N 5 20 16 25 41   
Treatment not effective      
No 100.0 93.8 94.5 95.1 94.7 39 0.847
Yes 0.0 6.2 5.5 4.9 5.3 2 0.006
Total 100.0 100.0 100.0 100.0 100.0 41 .
N 5 20 16 25 41   
Symptoms not severe/pro-
vided home care
   
No 76.7 89.2 67.9 86.7 74.6 31 250.013
Yes 23.3 10.8 32.1 13.3 25.4 10 1.139
Total 100.0 100.0 100.0 100.0 100.0 41 .
N 5 20 16 25 41   
Husband/partner oppose      
No 100.0 87.3 90.3 89.9 90.1 37 0.207
Yes 0.0 12.7 9.7 10.1 9.9 4 0.001
Total 100.0 100.0 100.0 100.0 100.0 41 .
N 5 20 16 25 41   
Up to God       
No 94.0 69.2 91.5 74.2 85.4 31 322.832
Yes 6.1 30.8 8.5 25.8 14.6 10 1.166
Total 100.0 100.0 100.0 100.0 100.0 41 .
N 5 20 16 25 41   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.2.5. ARI TREATMENT BY MEDICATION TYPE
Percentage of last-born children under 2 years with ARI in the past two weeks who were given antibiotics to treat the 
condition, September–October 2019






 % % % %  
At any time during the illness,  
did the child take any medicines?
No 5.2 16.6 14.7 12.9 27 3.757
Yes 94.8 83.4 85.3 87.1 176 0.062
Total 100.0 100.0 100.0 100.0 203 .
N 42 84 77 126   
What medicines did the child take?
Any antibiotic drug
No 54.5 83.8 58.9 74.3 136 150.251
Yes 45.5 16.3 41.1 25.7 67 1.884
Total 100.0 100.0 100.0 100.0 203 .
N 42 84 77 126   
Antibiotic drugs: pills/syrup
No 52.0 81.6 54.1 71.2 111 176.736
Yes 48.0 18.4 45.9 28.8 65 2.024
Total 100.0 100.0 100.0 100.0 176 .
N 39 70 67 109   
Antibiotic drugs: IV/Injection
No 97.7 98.9 93.4 98.5 170 87.299
Yes 2.3 1.1 6.7 1.5 6 3.688
Total 100.0 100.0 100.0 100.0 176 .
N 39 70 67 109   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. ** indicates p<0.05 and * indi-
cates p<.0.01 for the chi2 statistic
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TABLE 7.2.6. REPORTED SIGNS AND SYMPTOMS OF PEDIATRIC PNEUMONIA
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting signs and symp-








 % % % %  
Fever
No 70.4 73.6 67.2 72.1 4,316 16.420
Yes 29.7 26.4 32.8 27.9 1,718 0.537
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Chills
No 84.1 87.3 90.2 85.8 5,262 27.544
Yes 15.9 12.7 9.8 14.2 772 1.100
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Headache
No 80.6 85.8 79.9 83.4 4,938 11.614
Yes 19.4 14.2 20.1 16.6 1,096 0.366
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Body pain
No 84.1 87.5 82.4 85.9 5,060 13.024
Yes 15.9 12.5 17.6 14.1 974 0.689
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Stiff neck
No 93.8 97.2 94.2 95.7 5,725 6.572
Yes 6.2 2.8 5.9 4.4 309 0.516
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Wheezing
No 78.2 82.4 78.4 80.5 4,839 3.742
Yes 21.8 17.6 21.6 19.5 1,195 0.169
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Cough
No 57.1 56.8 44.6 56.9 3,245 89.086
Yes 42.9 43.2 55.4 43.1 2,789 3.684
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Rapid or difficult breathing
No 75.7 68.4 62.9 71.8 4,295 50.961
Yes 24.3 31.6 37.1 28.2 1,739 1.650
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Diarrhea
No 94.5 96.7 94.1 95.7 5,728 7.194
Yes 5.5 3.3 5.9 4.3 306 0.418
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Vomiting
No 91.4 92.3 90.3 91.9 5,511 4.583
Yes 8.6 7.7 9.7 8.1 523 0.275
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Poor appetite
No 95.2 95.5 92.4 95.4 5,719 21.449
Yes 4.8 4.6 7.6 4.7 315 0.856
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Crying all the time
No 96.8 93.7 88.3 95.2 5,622 84.121
Yes 3.2 6.3 11.7 4.8 412 5.779
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Don't know
No 70.3 62.9 72.5 66.3 4,045 26.537
Yes 29.7 37.1 27.5 33.7 1,989 1.119
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.2.7. REPORTED WAYS TO PREVENT PEDIATRIC PNEUMONIA
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting ways to prevent 
pediatric pneumonia, September–October 2019






 % % % %  
Ensure child vaccinated     
No 73.7 74.1 67.6 73.9 4,355 27.882
Yes 26.3 25.9 32.4 26.1 1,679 0.714
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Keep house/surroundings clean    
No 78.8 88.8 78.1 84.2 4,905 34.250
Yes 21.2 11.2 21.9 15.8 1,129 1.442
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Only breastmilk first 6 months    
No 92.4 94.1 85.4 93.3 5,467 90.616
Yes 7.6 5.9 14.6 6.7 567 2.881
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Safe storage of drinking water    
No 91.6 93.0 83.6 92.4 5,330 99.703
Yes 8.4 7.0 16.4 7.6 704 4.946
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Don't give dirty water     
No 91.0 94.5 90.9 92.9 5,537 7.824
Yes 9.0 5.5 9.2 7.1 497 0.571
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Good nutrition      
No 87.7 92.2 87.8 90.1 5,370 7.510
Yes 12.3 7.8 12.2 9.9 664 0.311
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Handwashing      
No 93.5 95.7 94.1 94.7 5,671 0.844
Yes 6.5 4.3 5.9 5.3 363 0.045
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Other      
No 89.3 91.7 87.7 90.6 5,445 12.261
Yes 10.7 8.3 12.3 9.4 589 0.568
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Don't know      
No 62.4 47.9 68.7 54.6 3,581 122.903
Yes 37.6 52.1 31.3 45.4 2,453 5.031
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.2.8. REPORTED TREATMENT PERCEIVED AS EFFECTIVE AGAINST PEDIATRIC PNEUMONIA
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting which medicines 
are effective to treat pneumonia, September–October 2019






% % % %  
Amoxicillin     
No 71.0 82.4 71.6 77.1 4,592 22.678
Yes 29.0 17.7 28.4 22.9 1,442 0.833
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Cotrimoxazole     
No 87.4 93.0 78.3 90.4 5,313 152.736
Yes 12.7 7.0 21.7 9.6 721 5.800
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Other antibiotics     
No 98.8 98.9 97.8 98.9 5,953 9.537
Yes 1.2 1.1 2.2 1.1 81 1.567
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Anti-malarials     
No 93.2 96.1 88.5 94.7 5,591 69.809
Yes 6.8 3.9 11.5 5.3 443 2.592
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
ORS      
No 93.6 99.1 98.2 96.6 5,845 16.757
Yes 6.4 0.9 1.8 3.4 189 1.644
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Other     
No 96.9 87.6 92.7 91.9 5,612 1.233
Yes 3.1 12.4 7.3 8.1 422 0.053
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Don't know     
No 43.1 34.2 43.9 38.3 2,336 18.902
Yes 56.9 65.8 56.1 61.7 3,698 0.685
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
128    BS S IN NIGER IA: BASELINE TECHNICA L R EPORT
TABLE 7.2.9. PNEUMONIA-RELATED BELIEFS, INTENTIONS, AND SELF-EFFICACY
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting certain pneumo-
nia-related beliefs, intentions, and self-efficacy, September–October 2019






 % % % %  
Young children may get severely ill from 
pneumonia, hospitalized, or die
   
Agree 75.0 70.6 72.4 72.6 4,305 12.669
Disagree 4.3 7.6 8.3 6.1 403 0.224
Don't know 20.7 21.8 19.3 21.3 1,307 .
Total 100.0 100.0 100.0 100.0 6,015  
N 1,954 2,060 2,001 4,014   
Only weak children die from pneumonia      
Agree 53.7 51.9 51.6 52.8 2,970 4.691
Disagree 24.4 26.0 27.7 25.3 1,693 0.083
Don't know 21.9 22.0 20.7 22.0 1,347 .
Total 100.0 100.0 100.0 100.0 6,010  
N 1,952 2,059 1,999 4,011   
Most women go to drug shop for a child 
with cough, rapid breaths
   
Agree 79.9 73.9 70.2 76.6 4,424 65.029
Disagree 8.6 13.2 18.7 11.0 798 1.455
Don't know 11.6 13.0 11.1 12.3 780 .
Total 100.0 100.0 100.0 100.0 6,002  
N 1,948 2,058 1,996 4,006   
Antibiotics are the most effective treat-
ment for pneumonia
    
Agree 59.8 50.0 61.4 54.5 3,346 28.784
Disagree 7.1 7.9 6.7 7.5 443 0.737
Don't know 33.2 42.2 31.9 38.0 2,215 .
Total 100.0 100.0 100.0 100.0 6,004  
N 1,951 2,055 1,998 4,006   
Likelihood that child completes full 
course of antibiotics
    
Likely 78.7 74.8 82.7 76.6 4,728 39.780
Unlikely 10.5 10.3 6.5 10.4 529 0.934
Don't know 10.8 14.9 10.8 13.0 754 .
Total 100.0 100.0 100.0 100.0 6,011  
N 1,953 2,056 2,002 4,009   
Likelihood to seek care same/next day if 
child develops cough, rapid breaths
   
Likely 85.0 79.6 89.1 82.1 5,070 64.159
Unlikely 7.2 11.8 5.1 9.7 463 1.474
Don't know 7.8 8.6 5.8 8.2 467 .
Total 100.0 100.0 100.0 100.0 6,000  
N 1,950 2,055 1,995 4,005   
Confidence to convince husband to seek 
care for child with cough, rapid breaths
   
Confident 84.6 85.2 91.2 84.9 5,206 60.428
Uncertain 8.9 8.5 4.5 8.7 456 1.403
Don't know 6.5 6.3 4.3 6.4 344 .
Total 100.0 100.0 100.0 100.0 6,006  
N 1,951 2,057 1,998 4,008   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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7.3 Diarrheal diseases
Key findings
Diarrhea prevalence and care-seeking: Among last-born 
children in the past two years, less than one in five had 
diarrhea in the past two weeks. Among these children, 65 
percent and 74 percent were taken for any care in Kebbi/
Sokoto and Zamfara, respectively. However, 34 percent 
and 56 percent who were taken for care were brought to 
a pharmacy in Kebbi/Sokoto and Zamfara, respectively, 
which often results in poor-quality care provision. 
Reasons for source of care or not seeking any care: 
The most common reasons for choosing the source of 
care across study areas were, trust in provider (39%), 
nearby location (29%), and effective treatment (25%). 
This points to the importance of convenient, trusted, and 
high-quality care provision among respondents in these 
communities. The most important reasons for not seek-
ing care included expense or cost (31%), fatalism (“It’s up 
to God”) (29%), and symptoms not perceived as severe or 
care provided at home (25%).
Diarrhea treatment: Among children under 2 years with 
diarrhea, 36 percent and 56 percent were given ORS 
alone in Kebbi/Sokoto and Zamfara, with a statistically 
significant higher percentage in the latter area. Few 
children with diarrhea were given both ORS and zinc, 
although this proportion was again higher in Zamfara 
(27%) than in Kebbi/Sokoto (13%). Similar to other 
priority behavioral outcomes, ORS and zinc treatment for 
children with diarrhea was far lower among those living 
in the poorest households or with less-educated mothers 
as compared with their wealthier and better-educated 
counterparts. Twenty percent of children with diarrhea 
still received traditional or homemade fluids across study 
areas, which merits further investigation if these fluids 
are used as alternatives to ORS and zinc. Antibiotics were 
also commonly given to treat diarrhea despite their lack 
of indication for most diarrhea-causing pathogens. 
Diarrhea ideations: Among respondents who were 
currently pregnant or with a child under 2 years across 
study areas, 11 percent were unable to report any way 
to prevent pediatric diarrhea, while nearly half reported 
keeping surroundings clean (48%), followed by not 
giving dirty water (39%) or bad food (32%) as prevention 
methods. While more than two-thirds of respondents 
recalled ORS as a diarrhea treatment (69%), less than half 
could name zinc (42%), and nearly one-third reported 
antibiotics as an effective diarrhea treatment despite its 
lack of indication for most diarrheal conditions. Nearly 
two-thirds of respondents (63%) reported that ORS 
replaces lost water in a child with diarrhea, while 44 per-
cent incorrectly noted that it stops diarrhea. One-quarter 
of respondents (24%) had never heard of zinc, and 
approximately one-third of respondents reported that 
zinc makes diarrhea less severe and shortens its duration. 
Only 69 percent of respondents agreed that they knew 
how to prepare ORS themselves. 
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TABLE 7.3.A. ORS TREATMENT FOR PEDIATRIC DIARRHEA BY SOCIODEMOGRAPHIC  
                       CHARACTERISTICS
Percentage of last-born children under 2 years with diarrhea in past two weeks given ORS by sociodemographic charac-
teristics, September–October 2019




% N % N % N % N
Total 51.0 153 26.5 210 56.0 171 35.9 364
Household wealth         
Lowest 42.3 40 29.6 67 (..) 13 33.7 107
Second 62.9 32 22.5 43 38.0 31 37.4 75
Middle 49.7 33 20.4 49 48.2 38 30.5 82
Fourth (..) 16 34.8 24 70.2 32 40.9 41
Highest 54.3 32 33.7 27 64.5 57 45.4 59
Maternal age (in years)        
15–24 years 50.9 54 32.8 92 57.8 73 38.5 146
25–34 years 52.6 74 22.3 98 55.6 72 34.8 172
35–49 years 46.5 25 (..) 20 52.0 26 32.7 46
Maternal education  
(highest level attended)
     
None 53.0 120 19.6 174 53.3 110 30.9 295
Primary (..) 6 (..) 11 (..) 11 (..) 17
Secondary or higher (..) 16 (..) 6 70.1 28 57.2 22
Islamic (..) 11 (..) 19 53.0 22 60.8 30
(..) Value not shown due to low number of observations. Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be 
interpreted with caution. *** indicates p<0.001, ** indicates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only 
study areas.
TABLE 7.3.B. ORS AND ZINC TREATMENT FOR PEDIATRIC DIARRHEA BY SOCIODEMOGRAPHIC 
                       CHARACTERISTICS
Percentage of last-born children under 2 years with diarrhea in past two weeks given ORS and zinc by sociodemo-
graphic characteristics, September–October 2019




 % N % N % N % N
Total 16.1 153 11.5 210 27.1 171 13.3 364
Household wealth         
Lowest 32.2 40 12.6 67 (..) 13 19.0 107
Second 1.5 32 6.3 43 8.2 31 4.6 75
Middle 16.2 33 11.4 49 30.3 38 13.1 82
Fourth (..) 16 14.3 24 45.2 32 10.4 41
Highest 14.6 32 16.6 27 33.9 57 15.5 59
Maternal age (in years)
15–24 years 23.8 54 11.2 92 19.2 73 15.2 146
25–34 years 14.4 74 10.6 98 37.2 72 12.2 172
35–49 years 7.7 25 (..) 20 20.8 26 12.0 46
Maternal education  
(highest level attended)
None 17.5 120 (..) 17 2.5 110 10.8 295
Primary (..) 6 (..) 11 (..) 11 12.6 17
Secondary or higher (..) 16 (..) 6 46.0 28 22.8 22
Islamic (..) 11 (..) 19 24.2 22 28.5 30
(..) Value not shown due to low number of observations. Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be 
interpreted with caution. *** indicates p<0.001, ** indicates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only 
study areas.
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TABLE 7.3.1. CARE-SEEKING FOR PEDIATRIC DIARRHEA 
Percentage of last-born children under 2 years with diarrhea in the past two weeks who were taken for any advice or 
treatment by source of care, September–October 2019






 % % % %  
Has child had diarrhea at any time 
in the last 2 weeks?
    
No 81.9 78.5 84.2 80.0 2,477 12.381
Yes 17.2 20.6 15.6 19.2 534 1.486
Don't know 0.9 0.9 0.3 0.9 28 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Did you seek advice or treatment 
from any source for the diarrhea?
   
No 26.8 39.8 25.8 34.8 148 5.131
Yes 73.2 60.2 74.2 65.2 386 1.991
Total 100.0 100.0 100.0 100.0 534 .
N 153 210 171 363   
Where did you seek advice or treatment?
Government hospital    
No 67.9 92.3 79.0 81.7 305 0.426
Yes 32.1 7.7 21.0 18.3 81 0.086
Total 100.0 100.0 100.0 100.0 386 .
N 119 135 132 254   
Governmental PHC    
No 79.2 70.3 88.3 74.2 311 12.957
Yes 20.8 29.7 11.7 25.8 75 3.706
Total 100.0 100.0 100.0 100.0 386 .
N 119 135 132 254   
Dispensary/health post    
No 98.4 88.8 96.9 93.0 362 3.217
Yes 1.6 11.2 3.1 7.0 24 1.451
Total 100.0 100.0 100.0 100.0 386 .
N 119 135 132 254   
Community health outreach post   
No 94.9 96.4 98.6 95.7 375 2.980
Yes 5.1 3.6 1.4 4.3 11 1.570
Total 100.0 100.0 100.0 100.0 386 .
N 119 135 132 254   
Private hospital/clinic    
No 97.4 94.1 96.7 95.5 374 0.378
Yes 2.6 5.9 3.3 4.5 12 0.092
Total 100.0 100.0 100.0 100.0 386 .
N 119 135 132 254   
Pharmacy/chemist    
No 63.2 68.5 44.5 66.2 218 17.728
Yes 36.9 31.5 55.5 33.8 168 9.273
Total 100.0 100.0 100.0 100.0 386 **
N 119 135 132 254   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.3.2. REASONS FOR CHOOSING SOURCE OF CARE FOR PEDIATRIC DIARRHEA 
Percentage of last-born children under 2 years with diarrhea in the past two weeks taken to any source of care by 
reason for choosing treatment location, September–October 2019






% % % %  
Free or inexpensive    
No 83.9 77.1 93.9 80.1 342 17.285
Yes 16.1 22.9 6.1 19.9 44 6.652
Total 100.0 100.0 100.0 100.0 386 *
N 119 135 132 254   
Nearby/transportation avail   
No 62.5 59.4 78.2 60.7 262 13.856
Yes 37.5 40.6 21.8 39.3 124 4.114
Total 100.0 100.0 100.0 100.0 386 *
N 119 135 132 254   
Medicines often in stock    
No 89.0 86.5 95.2 87.6 356 7.456
Yes 11.0 13.5 4.8 12.4 30 3.173
Total 100.0 100.0 100.0 100.0 386 .
N 119 135 132 254   
Respectful care    
No 94.4 91.7 80.0 92.9 347 12.375
Yes 5.6 8.3 20.0 7.1 39 6.581
Total 100.0 100.0 100.0 100.0 386 *
N 119 135 132 254   
Trust to care for my child    
No 71.0 75.9 52.4 73.8 248 18.059
Yes 29.0 24.1 47.6 26.2 138 6.516
Total 100.0 100.0 100.0 100.0 386 *
N 119 135 132 254   
Effective treatment    
No 88.9 79.7 69.8 83.7 304 9.812
Yes 11.1 20.3 30.2 16.3 82 5.321
Total 100.0 100.0 100.0 100.0 386 *
N 119 135 132 254   
Short wait time    
No 95.2 85.5 90.7 89.7 344 0.099
Yes 4.8 14.5 9.3 10.3 42 0.045
Total 100.0 100.0 100.0 100.0 386 .
N 119 135 132 254   
Privacy     
No 99.5 97.6 99.3 98.4 380 0.813
Yes 0.5 2.4 0.7 1.6 6 0.592
Total 100.0 100.0 100.0 100.0 386 .
N 119 135 132 254   
Family/friends    
No 92.3 90.3 85.3 91.1 340 2.971
Yes 7.8 9.7 14.71 8.9 46 1.443
Total 100.0 100.0 100.0 100.0 386 .
N 119 135 132 254   
Religious/community leaders   
No 91.4 100.0 100.0 96.3 374 8.535
Yes 8.6 0.0 0.0 3.7 12 1.509
Total 100.0 100.0 100.0 100.0 386 .
N 119 135 132 254   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.3.3. REASONS FOR NOT SEEKING CARE FOR PEDIATRIC DIARRHEA
Percentage of last-born children under 2 years with diarrhea in the past two weeks not taken to any source of care by 
reason for no care-seeking, September–October 2019






 % % % %  
Too expensive/could not find money    
No 61.9 77.8 63.6 73.0 102 1.531
Yes 38.1 22.3 36.5 27.0 46 0.599
Total 100.0 100.0 100.0 100.0 148 .
N 34 75 39 109   
Facility closed/no one there     
No 91.1 100.0 96.8 97.3 143 0.034
Yes 8.9 0.0 3.2 2.7 5 0.021
Total 100.0 100.0 100.0 100.0 148 .
N 34 75 39 109   
Distance/no transportation     
No 91.8 98.6 92.1 96.6 143 1.402
Yes 8.2 1.4 7.9 3.4 5 0.879
Total 100.0 100.0 100.0 100.0 148 .
N 34 75 39 109   
No female provider at facility     
No 100.0 100.0 98.4 100.0 147 1.287
Yes 0.0 0.0 1.7 0.0 1 0.922
Total 100.0 100.0 100.0 100.0 148 .
N 34 75 39 109   
Poor quality service      
No 100.0 97.9 100.0 98.5 146 1.077
Yes 0.0 2.2 0.0 1.5 2 1.821
Total 100.0 100.0 100.0 100.0 148 .
N 34 75 39 109   
Treatment not effective     
No 94.8 100.0 100.0 98.5 146 1.103
Yes 5.2 0.0 0.0 1.5 2 1.573
Total 100.0 100.0 100.0 100.0 148 .
N 34 75 39 109   
Not severe/provided home care     
No 91.5 72.1 72.3 77.9 118 0.607
Yes 8.6 27.9 27.7 22.1 30 0.160
Total 100.0 100.0 100.0 100.0 148 .
N 34 75 39 109   
Husband/partner oppose     
No 97.7 96.6 97.7 96.9 142 0.087
Yes 2.3 3.4 2.3 3.1 6 0.072
Total 100.0 100.0 100.0 100.0 148 .
N 34 75 39 109   
Unable to leave work/home     
No 98.7 95.8 86.5 96.7 142 5.122
Yes 1.3 4.2 13.5 3.3 6 2.614
Total 100.0 100.0 100.0 100.0 148 .
N 34 75 39 109   
Up to God      
No 84.6 62.9 73.0 69.4 96 0.243
Yes 15.5 37.1 27.0 30.7 52 0.105
Total 100.0 100.0 100.0 100.0 148 .
N 34 75 39 109   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.3.4. FLUIDS OR TREATMENTS GIVEN FOR PEDIATRIC DIARRHEA
Percentage of last-born children under 2 years with diarrhea in the past two weeks who were given treatments or fluids 








 % % % %  
Has child had diarrhea at any time in the 
last 2 weeks?     
No 81.9 78.5 84.2 80.0 2,477 12.381
Yes 17.2 20.6 15.6 19.2 534 1.486
Don't know 0.9 0.9 0.3 0.9 28 .
Total 100.0 100.0 100.0 100.0 3,039  
N 892 1,078 1,069 1,970   
Was child given the following for diarrhea:
ORS and zinc     
No 82.4 88.2 72.8 86.0 409 13.019
Yes 17.6 11.8 27.2 14.0 104 5.050
Total 100.0 100.0 100.0 100.0 513 *
N 137 206 170 343   
ORS prepack fluid or mix    
No 48.2 72.8 44.0 63.3 276 19.325
Yes 51.8 27.2 56.0 36.7 252 5.563
Total 100.0 100.0 100.0 100.0 528 *
N 150 207 171 357   
Zinc     
No 62.0 78.7 63.1 72.2 358 23.574
Yes 29.9 18.2 36.8 22.7 154 5.659
Don't know 8.1 3.1 0.2 5.0 22 *
Total 100.0 100.0 100.0 100.0 534  
N 153 210 171 363   
Traditional/homemade fluid    
No 72.3 79.1 77.8 76.5 407 0.989
Yes 25.6 17.5 20.6 20.7 115 0.158
Don't know 2.1 3.3 1.6 2.9 12 .
Total 100.0 100.0 100.0 100.0 534  
N 153 210 171 363   
How much was child given to drink during 
the diarrhea including breastmilk   
Much less 16.6 18.4 28.6 17.7 114 12.595
Somewhat less 15.4 35.3 27.8 27.6 151 0.764
About the same 35.7 27.6 21.6 30.7 141 .
More to drink 15.4 16.3 12.5 15.9 80  
Nothing to drink 16.6 2.4 9.0 7.9 45  
Don't know 0.4 0.1 0.5 0.2 3  
Total 100.0 100.0 100.0 100.0 534  
N 153 210 171 363   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.3.5. REPORTED WAYS TO PREVENT A CHILD FROM GETTING DIARRHEA
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting ways to prevent 
pediatric diarrhea, September–October 2019






 % % % %  
Ensure child is vaccinated     
No 75.9 79.7 68.9 78.0 4,502 60.227
Yes 24.1 20.3 31.1 22.1 1,532 1.495
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Use toilet/no open waste     
No 79.9 90.7 79.9 85.7 4,994 34.018
Yes 20.1 9.3 20.1 14.3 1,040 1.354
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Keep house/surroundings clean     
No 53.8 67.2 46.6 61.0 3,267 120.214
Yes 46.3 32.8 53.4 39.0 2,767 3.887
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Only breastmilk for first 6 months     
No 90.2 92.1 80.5 91.3 5,299 130.291
Yes 9.8 7.9 19.5 8.8 735 4.507
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Safe storage of drinking water     
No 72.9 85.0 68.9 79.4 4,543 81.764
Yes 27.1 15.0 31.1 20.6 1,491 3.554
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Don't give dirty water     
No 62.6 68.1 58.6 65.6 3,874 29.999
Yes 37.4 31.9 41.4 34.4 2,160 1.227
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Don't eat bad food      
No 73.2 66.1 66.4 69.4 4,141 6.217
Yes 26.8 33.9 33.7 30.6 1,893 0.211
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Good nutrition      
No 85.8 90.3 84.4 88.3 5,233 17.779
Yes 14.2 9.7 15.6 11.8 801 0.888
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Handwashing      
No 82.3 89.3 77.7 86.1 4,964 66.386
Yes 17.7 10.7 22.3 13.9 1,070 2.886
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Proper disposal of infant stool     
No 88.4 93.8 88.3 91.3 5,424 13.791
Yes 11.6 6.2 11.7 8.7 610 0.617
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Other      
No 99.8 99.0 98.9 99.4 5,979 4.726
Yes 0.2 1.0 1.1 0.6 55 1.430
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Don't know      
No 83.7 78.8 94.2 81.0 5,167 257.108
Yes 16.4 21.2 5.8 19.0 867 13.854
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.3.6. REPORTED TREATMENTS PERCEIVED AS EFFECTIVE AGAINST PEDIATRIC DIARRHEA
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting effective treat-
ments for pediatric diarrhea, September–October 2019






% % % %  
ORS     
No 43.6 56.9 17.7 50.7 2,417 739.898
Yes 56.4 43.2 82.3 49.3 3,617 21.421
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Zinc     
No 62.5 77.5 50.2 70.5 3,838 247.764
Yes 37.5 22.5 49.8 29.5 2,196 7.687
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Breastmilk     
No 86.0 93.6 80.6 90.1 5,281 99.915
Yes 14.0 6.4 19.4 9.9 753 3.330
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Other fluids    
No 97.6 98.6 95.7 98.2 5,893 27.300
Yes 2.4 1.4 4.3 1.9 141 1.023
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Antibiotics     
No 75.4 67.2 68.2 71.0 4,249 5.060
Yes 24.6 32.8 31.8 29.0 1,785 0.153
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Other     
No 97.7 90.2 97.3 93.7 5,734 49.013
Yes 2.3 9.8 2.7 6.3 300 5.675
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Don't know     
No 74.4 75.6 90.8 75.0 4,799 274.009
Yes 25.6 24.5 9.2 25.0 1,235 8.328
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.3.7. REPORTED WAYS ORS MAY HELP A CHILD WITH DIARRHEA
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting ways ORS may 
help a child with diarrhea, September–October 2019






% % % %  
Never heard of it    
No 89.2 84.9 95.4 86.9 5,455 142.473
Yes 10.8 15.2 4.6 13.2 579 3.784
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Replaces water lost    
No 46.1 50.0 29.6 48.2 2,573 217.403
Yes 53.9 50.0 70.4 51.8 3,461 7.588
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Stops diarrhea    
No 61.1 73.5 48.1 67.8 3,685 227.488
Yes 38.9 26.5 51.9 32.3 2,349 8.292
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Prevents dehydration   
No 76.0 88.9 60.8 83.0 4,619 340.023
Yes 24.0 11.1 39.2 17.0 1,415 14.453
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Replaces salt/electrolyte    
No 88.5 92.8 73.3 90.8 5,136 282.720
Yes 11.5 7.2 26.7 9.2 898 11.158
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Restores energy    
No 73.6 80.9 60.1 77.5 4,375 199.122
Yes 26.4 19.2 39.9 22.5 1,659 6.374
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Other    
No 100.0 99.7 99.7 99.8 6,021 1.352
Yes 0.1 0.3 0.4 0.2 13 0.727
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Don't know    
No 84.2 81.5 93.4 82.7 5,172 170.813
Yes 15.8 18.5 6.6 17.3 862 8.227
Total 100.0 100.0 100.0 100.0 6,034 **
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.3.8. REPORTED WAYS ZINC MAY HELP A CHILD WITH DIARRHEA
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting ways zinc may 
help a child with diarrhea, September–October 2019






% % % %  
Never heard of it    
No 73.4 64.8 80.4 68.8 4,497 107.134
Yes 26.6 35.3 19.6 31.2 1,537 3.499
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Make less severe    
No 70.7 80.9 62.5 76.2 4,288 124.634
Yes 29.3 19.1 37.5 23.8 1,746 5.076
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Shorter duration    
No 70.4 78.3 52.9 74.7 4,085 292.191
Yes 29.6 21.7 47.1 25.3 1,949 11.623
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Prevent dehydration    
No 83.0 89.2 67.0 86.3 4,824 290.22
Yes 17.0 10.8 33.0 13.7 1,210 13.484
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Less likely to reoccur    
No 95.0 96.1 82.7 95.6 5,524 228.305
Yes 5.0 3.9 17.3 4.4 510 11.527
Total 100.0 100.0 100.0 100.0 6,034 ***
N 1,960 2,062 2,012 4,022   
Restore energy    
No 80.5 87.1 72.6 84.0 4,800 108.909
Yes 19.5 12.9 27.5 16.0 1,234 4.545
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Other    
No 99.8 100.0 99.8 99.9 6,027 0.345
Yes 0.2 0.0 0.2 0.1 7 0.193
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Don't know    
No 78.2 76.4 84.4 77.2 4,724 48.944
Yes 21.8 23.6 15.7 22.8 1,310 2.121
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.3.9. DIARRHEA-RELATED BELIEFS, INTENTIONS, AND SELF-EFFICACY
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting certain diarrhea- 
related beliefs, intentions, and self-efficacy, September–October 2019






 % % % %  
It is very common for children to get 
diarrhea in my community
   
Agree 69.0 78.0 67.4 73.8 4,273 118.281
Disagree 23.1 14.0 28.7 18.2 1,339 2.348
Don't know 7.8 8.1 3.9 8.0 421 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
In young children diarrhea can lead 
to dehydration and even death
   
Agree 81.5 87.3 93.8 84.6 5,227 203.744
Disagree 5.7 6.4 4.6 6.1 362 7.340
Don't know 12.8 6.4 1.6 9.4 444 **
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
I know how to prepare ORS       
Agree 50.5 53.1 80.8 51.9 3,674 568.968
Disagree 24.3 23.0 8.8 23.6 1,145 10.686
Don't know 25.2 23.9 10.4 24.5 1,214 ***
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Likelihood to continue breastfeeding 
if child develops diarrhea
   
Likely 89.3 89.2 97.3 89.3 2,682 82.268
Unlikely 6.0 4.9 1.7 5.4 129 6.385
Don't know 4.7 5.8 1.0 5.3 102 **
Total 100.0 100.0 100.0 100.0 2,913  
N 864 1,045 1,004 1,909   
Likelihood to continue ORS the next 
time child develops diarrhea
    
Likely 85.0 73.7 92.8 78.9 5,042 254.019
Unlikely 6.2 16.4 4.5 11.6 529 6.685
Don't know 8.9 10.0 2.7 9.5 462 **
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Likelihood to give zinc the next time 
child develops diarrhea
   
Likely 79.1 59.8 81.2 68.8 4,418 125.621
Unlikely 8.5 23.1 10.3 16.3 786 2.095
Don't know 12.4 17.1 8.5 14.9 829 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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7.4 Child health ideations
Key findings
Among respondents, nearly all (90%) agreed that a health 
provider was the best person to consult when a child is 
sick. Approximately 70 percent agreed that facilities in 
their community frequently have necessary treatment 
for sick children. Nearly all respondents (92%) also felt 
confident that they could convince their partner to seek 
care or advice for a sick child. The most common influ-
encers of decisions about seeking care for a sick child 
were spouses (81%) followed by no one else (16%) and 
mothers-in-law (10%). Nevertheless, reported percep-
tions of quality care at health facilities do not appear to 
translate into correct behaviors; significant proportions 
of respondents choose pharmacies for care over health 
facilities, which merits further investigation. 
TABLE 7.4.1. PERCEPTIONS OF HEALTH SERVICES QUALITY FOR SICK CHILDREN
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting perceptions of 








 % % % %  
Health provider is always the best 
person to talk to when child is sick    
Agree 88.0 84.0 92.2 85.8 5,335 91.895
Disagree 9.0 12.2 7.2 10.7 544 2.398
Don't know 3.0 3.8 0.7 3.4 154 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Facilities in my community often 
have treatment needed for sick child    
Agree 67.9 65.7 72.8 66.7 4,184 56.050
Disagree 26.2 25.5 23.8 25.9 1,481 1.267
Don't know 5.9 8.7 3.4 7.4 368 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
TABLE 7.4.2. SELF-EFFICACY IN CONVINCING PARTNER TO SEEK CARE FOR A SICK CHILD
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting confidence to 








% % % %  
Confidence to convince partner to 
seek care for a sick child
Confident 87.7 88.2 95.0 88.0 5,467 114.650
Uncertain 9.2 8.2 4.5 8.7 430 2.846
Don't know 3.1 3.6 0.6 3.4 136 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 7.4.3. WHO ELSE INFLUENCES DECISIONS ABOUT SEEKING CARE FOR A SICK CHILD?
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting who else influ-
ences a woman’s decision or seek care for a sick child, September–October 2019






% % % %  
No one else     
No 82.1 86.8 83.0 84.7 5,032 3.047
Yes 17.9 13.2 17.0 15.3 1,002 0.084
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Husband/partner    
No 20.6 17.5 19.1 18.9 1,192 0.016
Yes 79.4 82.5 81.0 81.1 4,842 0.000
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Mother-in-law     
No 87.3 84.2 92.7 85.6 5,360 79.201
Yes 12.8 15.8 7.3 14.4 674 5.187
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Mother     
No 89.6 93.7 93.0 91.8 5,535 2.806
Yes 10.4 6.3 7.0 8.2 499 0.167
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Friends     
No 99.0 98.4 95.8 98.7 5,885 42.471
Yes 1.0 1.6 4.2 1.3 149 4.158
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Health provider    
No 98.4 97.0 95.8 97.6 5,859 15.493
Yes 1.6 3.0 4.3 2.4 175 1.202
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Religious/community leader    
No 99.5 99.9 99.6 99.8 6,017 0.865
Yes 0.5 0.1 0.4 0.3 17 0.279
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Partner’s other family members    
No 99.9 99.2 99.2 99.5 6,002 2.505
Yes 0.1 0.8 0.8 0.5 32 0.389
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Own other family members    
No 99.6 99.4 99.8 99.5 6,007 3.024
Yes 0.4 0.7 0.2 0.5 27 1.487
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Other     
No 99.8 99.7 99.9 99.8 6,017 1.264
Yes 0.2 0.3 0.1 0.2 17 0.645
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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Gender 
Key findings
Community participation: Among respondents, most 
(88%) reported regularly attending group or community 
meetings. Among those who reported regular meeting 
attendance, 44 percent participated in women’s meet-
ings, with slightly higher attendance in Zamfara (49%) 
than in Kebbi/Sokoto (35%). Attendance at other types 
of community meetings (e.g., agricultural, civic) was very 
low. This result could indicate potentially low participa-
tion of respondents in community meetings organized 
by Breakthrough ACTION/Nigeria to disseminate health 
messages, with possibly lower participation rates in 
Kebbi/Sokoto than in Zamfara. This should be considered 
during the planning of household visits and community 
events to ensure outreach targets women who may not 
be prone to community meeting participation, such as 
by engaging men and local leaders to support reticent 
women to attend these gatherings.
Household decision-making: Across study areas, many 
respondents reported that their spouse mainly makes 
decisions for the household, except in the case of how to 
use the respondents’ own money, where half said they 
make that decision alone. Half (50%) of respondents said 
that household decisions about major purchases, school-
ing, work outside the home, and how to use the partner’s 
money were made exclusively by their partner. In these 
cases, approximately one-quarter of respondents 
reported joint decision-making between themselves and 
their spouse, with significantly higher joint decision-mak-
ing in Zamfara than in Kebbi/Sokoto for nearly all of these 
decisions. 
Gender roles: Across study areas, most respondents 
agreed that it is a woman’s job to mainly take care of the 
home and cook for her family (88%), that a good mar-
riage is more important for a girl than a good education 
(79%), and that it is more important for boys to get an 
education than it is for girls (71%). Nevertheless, nearly 
all respondents (94%) agreed that it is also important for 
couples to discuss and make decisions about child health 
together, and 85 percent agreed that a woman should 
play a role in making decisions about the household, even 
though reported joint decision-making was relatively low. 
8
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TABLE 8.1.1. WOMEN’S COMMUNITY PARTICIPATION
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting regular atten-
dance at group or community meetings by meeting type, September–October 2019






 % % % %  
Do you regularly attend any  
meetings in your community?
No 10.8 6.6 8.6 10.5 579 6.343
Yes 89.2 93.4 91.4 89.5 5,382 0.255
Total 100.0 100.0 100.0 100.0 5,961 .
N 1,942 2,042 3,984 1,977   
What types of community meetings 
do you attend?
Women's group
No 97.5 96.6 97.0 94.8 5,741 17.211
Yes 2.5 3.4 3.0 5.2 220 0.838
Total 100.0 100.0 100.0 100.0 5,961 .
N 1,942 2,042 3,984 1,977   
Civic group 
No 96.7 99.8 98.4 98.5 5,878 0.049
Yes 3.3 0.2 1.6 1.5 83 0.001
Total 100.0 100.0 100.0 100.0 5,961 .
N 1,942 2,042 3,984 1,977   
Religious/church 
No 96.6 98.3 97.5 98.8 5,821 14.043
Yes 3.4 1.7 2.5 1.2 140 0.873
Total 100.0 100.0 100.0 100.0 5,961 .
N 1,942 2,042 3,984 1,977   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 8.1.2. WOMEN’S ROLE IN HOUSEHOLD DECISION-MAKING
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years reporting household deci-
sion-making roles by decision type, September–October 2019 






% % % %  
How your money will be used     
Respondent 35.8 56.2 54.4 46.8 2,920 148.221
Spouse 29.5 24.3 28.6 26.7 1,628 1.830
Both 27.0 15.1 15.8 20.6 1,153 .
Other 0.9 0.3 0.4 0.6 39  
Don't know 6.8 4.1 0.8 5.4 221  
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
How husband's money will be used     
Respondent 4.2 4.2 17.5 4.2 549 345.879
Spouse 58.6 75.9 49.8 67.9 3,605 4.515
Both 29.6 19.3 30.7 24.1 1,601 **
Other 1.1 0.4 0.9 0.7 53  
Don't know 6.5 0.2 1.2 3.2 153  
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
Major household purchases     
Respondent 4.2 3.5 11.7 3.8 416 246.854
Spouse 62.8 75.2 50.9 69.4 3,717 2.685
Both 24.1 20.1 32.4 22.0 1,532 *
Other 1.2 0.8 0.9 1.0 59  
Don't know 7.7 0.4 4.2 3.8 237  
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
Schooling      
Respondent 3.5 2.7 7.9 3.1 306 347.146
Spouse 51.1 50.9 43.1 51.0 2,966 3.382
Both 17.4 9.3 29.2 13.1 1,072 *
Other 1.4 0.7 1.1 1.0 66  
Don't know 26.6 36.4 18.7 31.9 1,551  
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
Working outside home     
Respondent 5.5 2.9 19.9 4.1 561 427.573
Spouse 59.2 70.7 48.9 65.4 3,544 3.863
Both 16.4 9.8 16.0 12.9 851 **
Other 1.6 0.9 4.3 1.2 127  
Don't know 17.4 15.7 10.9 16.5 878  
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 8.1.3. GENDER-RELATED BELIEFS, ATTITUDES, AND PERCEPTIONS
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who agreed with certain 
gender-related beliefs, attitudes, or perceptions, September–October 2019






 % % % %  
Important for couples to discuss and 
decide together about child health
   
Agree 93.8 92.9 96.6 93.3 5,653 55.394
Disagree 4.3 3.4 2.8 3.8 205 1.930
Don't know 1.9 3.7 0.6 2.9 103 .
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
A woman should play a role in making 
decisions about the household
   
Agree 84.7 84.3 87.1 84.5 5,135 42.484
Disagree 13.9 12.2 12.4 13.0 732 0.848
Don't know 1.4 3.5 0.6 2.5 94 .
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
It is more important for boys to get an 
education than it is for girls
   
Agree 73.1 75.0 71.1 74.1 4,292 49.659
Disagree 25.1 21.4 28.0 23.1 1,554 1.392
Don't know 1.8 3.7 0.8 2.8 115 .
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
A good marriage is more important for 
a girl than a good education
   
Agree 78.3 86.7 77.9 82.9 4,841 62.878
Disagree 19.9 10.9 21.5 15.1 1,038 1.695
Don't know 1.8 2.3 0.6 2.1 82 .
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
It is a woman's job to mainly take care 
of the home and cook for her family
   
Agree 92.9 92.2 86.8 92.5 5,405 146.210
Disagree 5.5 5.3 13.0 5.4 486 6.481
Don't know 1.6 2.5 0.2 2.1 70 **
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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Media exposure 
Key findings
Media exposure: Radio listening is the most common 
form of media exposure, with about one-third of respon-
dents reporting regular radio listening across study areas. 
Only a small percentage of respondents—less than 10 
percent—report regularly viewing television. Beyond 
radio and television, exposure to other media sources is 
extremely low, with less than one percent of respondents 
reporting regular reading of newspapers or magazines or 
regular Internet use. 
Radio health messages: Radio is, therefore, the most 
viable communication channel for widespread dis-
semination of health messages. Approximately one in 
three respondents—28 percent in Kebbi/Sokoto and 38 
percent in Zamfara—report that they listen to the radio. 
As a result, a much higher proportion of respondents 
(28%) across study areas report that they have heard 
any health messages or advertisements on the radio in 
the past 12 months compared with messages seen in 
other media forms. Among respondents who had heard 
any health messages, the most common topics were 
malaria (70%), importance of ANC (61%), and childhood 
immunizations (52%). Unsurprisingly, reporting of malaria 
messages was significantly higher in Zamfara (75%), 
where Breakthrough ACTION/Nigeria malaria programs 
have been ongoing, than in Kebbi/Sokoto (59%). The 
least commonly noted messages related to maternal care 
after birth (7%), newborn care (8%), cough with rapid or 
difficult breathing (9%), and maternal nutrition (9%).
Albishirin Ku! radio program exposure: Awareness of 
Breakthrough ACTION/Nigeria’s Albishirin Ku! campaign is 
already apparent, even as Breakthrough ACTION/Nigeria 
interventions are just beginning to roll out. In Kebbi/
Sokoto, nearly one-quarter of respondents have heard 
the Albishirin Ku! slogan on the radio, as have 13 percent 
of respondents in Zamfara. Furthermore, 15 percent 
of respondents in Kebbi/Sokoto have heard the radio 
program with Frank and Jamila, 26 percent have heard 
”iWannan Sakone Daga Ma’aikatar Lafiya Ta Kasa, Da Ta 
Jiha, Da Kuma,” and 23 percent have heard the Albishirin 
Ku! song. In Zamfara, more than one-quarter of respon-
dents have heard the radio jingle about a mechanic and 
driver discussing malaria. A similar percentage have 
heard the radio jingle involving a football coach and his 
son discussing malaria. 
Nevertheless, awareness of Breakthrough ACTION/
Nigeria’s Albishirin Ku! campaign in Kebbi/Sokoto is lower 
among respondents living in the poorest households 
(12%) than in the wealthiest households (42%), and lower 
among respondents with no education (23%) or Islamic 
education (20%) compared with those having attended 
primary (37%) or at least secondary (35%) education. 
BSS baseline results point to the need for more focused 
Breakthrough ACTION/Nigeria outreach to these commu-
nities through other methods (e.g., household visits or 
community events) going forward since radio program-
ming may not fully penetrate the poorest areas who also 
have worse health behaviors and outcomes. 
Breakthrough ACTION/Nigeria community volun-
teer (CV) household visits or community events: 
Participation in a Breakthrough ACTION/Nigeria commu-
nity volunteer (CV) community event or household visit 
was largely non-existent at the start of Breakthrough 
ACTION/Nigeria program implementation, as expected. 
Prior to Breakthrough ACTION/Nigeria program imple-
mentation, only 18 percent of respondents reported 
attending a community event in the past six months 
where a CV was present. These events included com-
munity dialogues, compound meetings, and naming 
ceremonies. Among all respondents, less than one 
percent reported participating in a community event 
in the past six months where a CV wearing either a 
Breakthrough ACTION/Nigeria, USAID, Albishirin Ku!, 
or Know Talk Go logo was present. Less than 2 percent 
reported participating in a household visit in the past 
six months with a CV wearing either a Breakthrough 
ACTION/Nigeria, USAID, Albishirin Ku!, or Know Talk Go 
logo.
9
BR E A K THROUGH R ESE A RCH  |  JUNE 2020     147 
TABLE 9.1. ALBISHIRIN KU! RADIO PROGRAM EXPOSURE BY SOCIODEMOGRAPHIC  
                   CHARACTERISTICS
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who reported hearing 
Albishirin Ku! radio programming by sociodemographic characteristics, September–October 2019




 % N % N % N % N
Total 18.6 1,960 28.4 2,062 12.7 2,012 23.9 4,022
Household wealth         
Lowest 8.4 541 13.7 618 3.1 208 11.5 1,159
Second 14.5 419 27.1 407 5.6 341 21.1 826
Middle 23.9 63 36.1 408 9.9 407 30.7 771
Fourth 15.8 276 40.4 286 17.5 488 28.3 563
Highest 38.9 361 45.8 343 20.7 568 42.2 703
Maternal age (in years)        
15–24 years 19.7 866 28.1 1,015 10.3 834 24.4 1,880
25–34 years 17.5 850 27.4 837 13.7 888 22.7 1,687
35–49 years 19.0 244 33.3 210 16.9 289 26.1 455
Maternal education  
(highest level attended)
     
None 17.1 1,487 27.2 1,624 10.2 1,300 22.7 3111
Primary 21.7 99 50.2 101 22.9 119 37.1 200
Secondary or higher 34.7 210 35.0 141 16.0 341 34.8 351
Islamic 13.9 164 25.0 196 19.4 251 19.8 360
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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9.1 Radio 
TABLE 9.1.1. RADIO EXPOSURE
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who reported listening to 
the radio and hearing health messages on the radio, September–October 2019






 % % % %  
Do you ever listen to the radio?       
No 76.1 68.7 62.6 72.1 4,079 59.730
Yes 23.9 31.3 37.5 27.9 1,954 2.134
Total 100.0 100.0 100.0 100.0 6,033 .
N 1,960 2,062 2,011 4,022   
How frequently do you listen to the radio?
Never 76.1 68.7 62.6 72.1 4,080 75.721
<1 time a week 6.4 7.4 9.1 6.9 461 1.347
Once a week 2.9 6.8 4.5 5.0 297 .
2–3 times a week 6.2 10.1 11.2 8.3 586  
4+ times a week 8.4 7.0 12.7 7.7 610  
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
In the last 12 months, did you hear any 
health advertisements/messages on the 
radio
No 82.0 73.4 68.8 77.4 4,421 53.284
Yes 18.0 26.7 31.2 22.7 1,602 2.025
Total 100.0 100.0 100.0 100.0 6,023 .
N 1,956 2,060 2,007 4,016   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 9.1.2. HEALTH MESSAGES HEARD ON THE RADIO
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years having heard health messages on 
radio in past 12 months by type, September–October 2019






% % % %  
Using contraception to space births    
No 52.6 69.8 69.8 63.5 1,043 6.451
Yes 47.4 30.2 30.2 36.5 559 0.296
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Using contraception for limiting births   
No 66.5 85.3 76.8 78.4 1,242 0.534
Yes 33.5 14.7 23.2 21.6 360 0.019
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Giving birth in a health facility with 
SBA   
No 62.5 85.9 74.0 77.3 1,212 2.049
Yes 37.5 14.2 26.0 22.7 390 0.089
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Formulating a birth plan    
No 76.6 91.1 85.5 85.8 1,350 0.018
Yes 23.4 8.9 14.5 14.2 252 0.001
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Antenatal care     
No 46.7 37.6 37.7 40.9 640 1.575
Yes 53.3 62.4 62.3 59.1 962 0.164
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Diarrhea     
No 66.8 81.9 76.6 76.4 1,239 0.014
Yes 33.2 18.1 23.4 23.6 363 0.001
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Malaria     
No 47.2 37.3 25.4 40.9 583 40.578
Yes 52.8 62.7 74.6 59.1 1,019 3.957
Total 100.0 100.0 100.0 100.0 1,602 *
N 357 583 662 940   
Cough with rapid/difficult breathing    
No 78.9 91.8 93.5 87.1 1,418 18.477
Yes 21.1 8.2 6.5 12.9 184 0.680
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Child nutrition     
No 79.2 89.9 86.9 86.0 1,378 0.256
Yes 20.8 10.1 13.1 14.0 224 0.017
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Immunizations     
No 59.8 60.2 42.1 60.1 850 45.780
Yes 40.2 39.8 57.9 40.0 752 3.607
Total 100.0 100.0 100.0 100.0 1,602 .
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N 357 583 662 940   
Breastfeeding     
No 74.8 83.8 68.7 80.5 1,233 24.695
Yes 25.2 16.2 31.3 19.5 369 1.369
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Maternal nutrition     
No 86.6 93.4 90.9 90.9 1,447 0.001
Yes 13.4 6.6 9.1 9.1 155 0.000
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Newborn care     
No 93.3 95.1 91.2 94.4 1,484 5.258
Yes 6.7 4.9 8.9 5.6 118 0.458
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Maternal care after giving birth    
No 98.0 96.2 91.3 96.8 1,500 16.902
Yes 2.1 3.9 8.7 3.2 102 2.678
Total 100.0 100.0 100.0 100.0 1,602 .
N 357 583 662 940   
Water, sanitation and hygiene    
No 98.1 96.5 74.2 97.1 1,408 124.669
Yes 1.9 3.5 25.8 2.9 194 22.959
Total 100.0 100.0 100.0 100.0 1,602 ***
N 357 583 662 940   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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9.2 Albishirin Ku!
TABLE 9.2.1. ALBISHIRIN KU! RADIO PROGRAM EXPOSURE
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who reported hearing the 
Albishirin Ku! slogan on the radio, September–October 2019






 % % % %  
Have you heard the slogan Albishirin 
Ku! on the radio?
No 75.7 65.9 83.7 70.4 4,447 152.812
Yes 18.6 28.4 12.7 23.9 1,278 3.320
Don't know 5.7 5.7 3.5 5.7 308 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Heard radio program with couple 
Faruk and Jamila
No 87.5 76.8 88.3 81.8 4,986 60.924
Yes 9.2 19.1 8.2 14.5 822 1.312
Don't know 3.3 4.1 3.5 3.7 225 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Heard iWannan Sakone Daga 
Ma'aikatar Lafiya Ta Kasa, Da Ta Jiha, 
Da Kuma
No 77.0 63.0 65.0 69.5 4,079 20.676
Yes 18.7 33.0 31.7 26.4 1,733 0.353
Don't know 4.3 4.0 3.4 4.1 221 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Have you heard this song on the radio?
No 79.7 68.0 80.3 73.4 4,509 43.130
Yes 17.1 28.1 17.8 23.0 1,346 1.589
Don't know 3.1 3.9 1.9 3.5 178 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 9.2.2. ALBISHIRIN KU! HEALTH MESSAGES HEARD ON THE RADIO
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who had heard the Albishirin Ku! 
messages on the radio by type, September–October 2019






% % % %  
Health     
No 45.3 79.3 82.2 67.6 934 38.555
Yes 54.7 20.7 17.8 32.4 412 3.153
Total 100.0 100.0 100.0 100.0 1,346 .
N 345 626 375 971   
Albishirin Ku!     
No 63.2 57.1 43.2 59.2 745 34.514
Yes 36.8 42.9 56.8 40.8 601 1.733
Total 100.0 100.0 100.0 100.0 1,346 .
N 345 626 375 971   
Pregnant women going to antenatal 
care
  
No 48.6 75.8 70.7 66.4 877 2.798
Yes 51.5 24.2 29.4 33.6 469 0.148
Total 100.0 100.0 100.0 100.0 1,346 .
N 345 626 375 971   
Childbirth spacing/family planning   
No 65.5 82.2 76.7 76.5 1,001 0.009
Yes 34.5 17.8 23.3 23.5 345 0.000
Total 100.0 100.0 100.0 100.0 1,346 .
N 345 626 375 971   
Nutrition for children    
No 74.1 92.1 85.6 85.9 1,118 0.017
Yes 26.0 8.0 14.4 14.1 228 0.001
Total 100.0 100.0 100.0 100.0 1,346 .
N 345 626 375 971   
Prompt care for malaria    
No 76.0 97.4 85.2 90.1 1,164 7.316
Yes 24.0 2.6 14.9 10.0 182 0.282
Total 100.0 100.0 100.0 100.0 1,346 .
N 345 626 375 971   
Maternal nutrition during pregnancy   
No 80.7 90.4 86.0 87.1 1,137 0.363
Yes 19.3 9.6 14.0 12.9 209 0.015
Total 100.0 100.0 100.0 100.0 1,346 .
N 345 626 375 971   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 9.2.3. ALBISHIRIN KU! JINGLES OR SHOWS HEARD ON THE RADIO
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who had heard the Albishirin Ku! 
radio jingles or shows by type, September–October 2019






 % % % %  
Have you heard a radio jingle featuring an auto 
mechanic and a driver talking about malaria?
  
No 86.4 76.4 71.6 81.0 4,650 124.067
Yes 9.1 19.4 26.1 14.7 1,176 2.701
Don't know 4.5 4.2 2.4 4.3 207 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Have you heard this radio jingle on the radio?     
No 86.1 71.4 69.5 78.2 4,520 141.258
Yes 9.8 24.9 29.3 17.9 1,348 4.403
Don't know 4.0 3.7 1.1 3.9 165 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Heard radio jingle about football coach and 
son discussing malaria?
   
No 87.7 78.4 71.6 82.7 4,725 157.389
Yes 8.3 17.9 26.5 13.5 1,119 3.529
Don't know 4.0 3.7 2.0 3.8 189 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Have you heard this song on the radio?      
No 86.0 72.2 64.4 78.6 4,431 232.317
Yes 10.2 24.4 34.5 17.8 1,446 6.617
Don't know 3.8 3.4 1.0 3.6 156 **
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Have you heard of the following radio shows?
Taka Naka Rawan     
No 87.3 81.7 87.3 84.3 5,150 34.136
Yes 7.5 12.9 10.2 10.4 631 0.866
Don't know 5.2 5.4 2.5 5.3 252 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Don Tuwon Gobe     
No 87.0 81.5 86.0 84.0 5,095 28.607
Yes 8.9 13.3 11.8 11.3 710 0.755
Don't know 4.1 5.3 2.3 4.7 228 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Kai da lafiya     
No 83.2 77.2 83.4 80.0 4,862 44.832
Yes 12.9 17.6 14.9 15.4 959 1.309
Don't know 4.0 5.2 1.7 4.6 212 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Lafiyar mata da kananan yara    
No 79.7 69.0 68.6 74.0 4,323 117.426
Yes 15.9 25.7 30.1 21.2 1,506 3.848
Don't know 4.4 5.3 1.3 4.9 204 *
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Lafiyar Uwar Komai     
No 80.5 70.1 77.1 74.9 4,554 44.572
Yes 15.7 24.3 21.1 20.3 1,259 1.324
Don't know 3.8 5.7 1.8 4.8 220 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 9.2.4. ALBISHIRIN KU! LOGO SEEN DURING HOUSEHOLD VISIT WITH COMMUNITY VOLUNTEER
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who had a household visit with 
a CV in the past six months and saw the Albishirin Ku!, Know Talk Go, USAID or Breakthrough ACTION/Nigeria logos on 
their clothing, Sep–Oct 2019






 % % % %  
CV household visit in past 6 months
No 84.2 85.5 89.1 84.9 5,245 33.963
Yes 11.1 10.7 9.0 10.9 521 0.759
Don't know 4.7 3.8 1.9 4.2 195 .
Total 100.0 100.0 100.0 100.0 5,961  
N 1,942 2,042 1,977 3,984   
Type of branding on CV clothing at  
household visit
No special branding 44.4 12.4 19.8 26.3 117 195.934
Albishirin Ku! 11.8 6.5 0.0 8.8 27 5.320
Know Talk Go 0.0 0.0 0.4 0.0 1 ***
Nigerian or state government 4.5 0.6 0.2 2.3 7  
USAID 3.2 2.2 7.0 2.6 22  
Breakthrough ACTION 11.8 2.1 0.4 6.3 22  
UNICEF 0.5 11.8 8.9 6.9 34  
Plan International 0.0 27.0 0.0 15.3 55  
Other 0.7 2.5 49.5 1.7 61  
Don't know 23.0 34.9 13.9 29.7 119  
Total 100.0 100.0 100.0 100.0 465  
N 140 208 117 348   
Participation in household visit with 
Breakthrough ACTION CV in past 6 
months
No 97.6 98.9 99.4 98.3 5,962 18.407
Yes 2.4 1.1 0.6 1.7 72 2.407
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Main messages discussed by Break-
through ACTION CV during household 
visit
Childbirth spacing/FP 74.7 39.6 63.9 63.0 37 17.530
Antenatal care 18.3 12.5 7.9 16.4 11 1.351
Pregnancy health/nutrition 0.8 1.9 0.0 1.2 2 .
Birth planning/delivery care 4.9 0.0 0.0 3.3 2  
Newborn care 0.0 4.5 0.0 1.5 2  
Breastfeeding 1.2 0.0 0.0 0.8 1  
Immunizations 0.0 35.3 0.0 11.7 7  
Malaria preventing/using mosquito nets 0.0 1.9 28.2 0.6 6  
Malaria diagnosis and treatment 0.0 2.6 0.0 0.9 1  
Malaria prevention during pregnancy/IPTp 0.0 1.9 0.0 0.6 1  
Total 100.0 100.0 100.0 100.0 70  
N 30 28 12 58   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 9.2.5. ALBISHIRIN KU! LOGO SEEN DURING COMMUNITY EVENT WITH CV
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who attended a community event 
with a CV in the past six months and saw Albishirin Ku!, Know Talk Go, USAID or Breakthrough ACTION/Nigeria logos on 








 % % % %  
Participation in event with CV in the last 
6 months     
No 51.0 72.7 89.6 64.0 243 31.535
Yes 44.8 25.7 10.2 33.4 75 3.925
Don't know 4.2 1.5 0.3 2.6 9 *
Total 100.0 100.0 100.0 100.0 327  
N 94 119 114 213   
Type of CV event in past 6 months      
Compound meeting 51.7 18.3 0.0 36.4 20 44.455
Community dialogue 22.0 0.0 68.0 11.9 16 2.652
Marriage ceremony 0.0 14.3 19.8 6.6 7 .
Naming ceremony 9.4 62.2 0.0 33.7 19  
Religious gathering 10.6 0.0 0.0 5.7 5  
Household visit 0.0 5.2 9.6 2.4 4  
Other event 1.4 0.0 2.6 0.8 2  
Don't know 4.9 0.0 0.0 2.6 2  
Total 100.0 100.0 100.0 100.0 75  
N 35 29 11 64   
Type of branding on CV clothing at event      
No special branding 36.2 75.8 88.6 56.4 35 7.125
Albishirin Ku! 22.5 11.9 0.0 17.1 6 0.677
Know Talk Go 20.9 0.0 0.0 10.2 3 .
Nigerian or state government 2.7 0.0 0.0 1.3 1  
Don't know 17.7 12.3 11.4 15.0 11  
Total 100.0 100.0 100.0 100.0 56  
N 24 25 7 49   
Participation in community event with 
Breakthrough ACTION CV in past 6 
months    
No 99.5 99.9 100.0 99.7 6,025 11.404
Yes 0.5 0.1 0.0 0.3 9 3.824
Total 100.0 100.0 100.0 100.0 6,034 .
N 1,960 2,062 2,012 4,022   
Main messages discussed by Break-
through ACTION CV at community event     
Childbirth spacing/FP 100.0 0.0 77.8 77.8 .  
Postpartum care for mothers 0.0 50.0 11.1 11.1 .  
Breastfeeding 0.0 50.0 11.1 11.1 .  
Total 100.0 100.0 100.0 100.0   
N 7 2 9 9   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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9.3 Television 
TABLE 9.3.1. TELEVISION EXPOSURE
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who reported watching TV 
and seeing health messages on TV, September–October 2019






 % % % %  
Do you currently watch TV?       
No 92.2 95.0 89.4 93.7 5,411 34.114
Yes 7.8 5.0 10.6 6.3 622 2.026
Total 100.0 100.0 100.0 100.0 6,033 .
N 1,960 2,062 2,011 4,022   
About how many days in a normal week 
do you watch TV?
    
0 times 92.2 95.0 89.4 93.7 5,412 62.407
1–2 days 1.2 1.7 1.2 1.5 108 2.744
3–4 days 3.5 0.9 2.0 2.1 168 .
5–7 days 3.1 2.4 7.5 2.7 346  
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
In past 12 months, have you seen any 
health messages/ads on TV?
   
No 97.3 97.4 93.7 97.4 5,717 41.843
Yes 2.7 2.6 6.3 2.7 317 4.005
Total 100.0 100.0 100.0 100.0 6,034 *
N 1,960 2,062 2,012 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 9.3.2. HEALTH MESSAGES SEEN ON TELEVISION
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who had seen health messages 
on TV in the past 12 months by type, September–October 2019






% % % %  
Using contraception for birth spacing   
No 58.0 63.7 78.7 61.0 223 9.168
Yes 42.0 36.3 21.3 39.0 94 2.966
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Using contraception for limiting births   
No 69.1 79.3 87.4 74.4 256 7.080
Yes 31.0 20.7 12.6 25.6 61 2.364
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Giving birth in a health facility with 
SBA
  
No 63.8 69.9 89.1 67.0 254 20.240
Yes 36.2 30.1 10.9 33.0 63 10.788
Total 100.0 100.0 100.0 100.0 317 **
N 70 79 168 149   
Birth plans     
No 81.5 81.2 85.1 81.3 273 0.591
Yes 18.6 18.8 14.9 18.7 44 0.387
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Antenatal care     
No 58.2 62.0 62.6 60.2 194 0.139
Yes 41.8 38.0 37.4 39.8 123 0.071
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Diarrhea     
No 77.0 96.1 88.3 87.0 283 0.089
Yes 23.0 3.9 11.7 13.0 34 0.044
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Malaria     
No 58.0 50.8 46.9 54.3 161 1.190
Yes 42.0 49.2 53.1 45.8 156 0.332
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Cough with rapid or difficult breathing   
No 98.1 81.0 93.8 89.2 295 1.748
Yes 1.9 19.0 6.2 10.9 22 0.580
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Child nutrition     
No 91.5 86.9 89.0 89.1 280 0.001
Yes 8.5 13.1 11.1 10.9 37 0.001
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
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Immunizations     
No 75.7 70.2 66.5 72.8 214 0.985
Yes 24.4 29.8 33.5 27.2 103 0.348
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Breastfeeding     
No 90.9 85.2 81.6 87.9 266 1.527
Yes 9.1 14.9 18.4 12.1 51 0.947
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Maternal nutrition     
No 97.6 90.3 91.9 93.8 289 0.292
Yes 2.4 9.7 8.1 6.2 28 0.121
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Newborn care     
No 99.2 97.3 96.7 98.2 305 0.442
Yes 0.8 2.7 3.4 1.8 12 0.581
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Maternal care after giving birth    
No 100.0 95.1 92.4 97.4 296 2.333
Yes 0.0 4.9 7.6 2.6 21 1.286
Total 100.0 100.0 100.0 100.0 317 .
N 70 79 168 149   
Water, sanitation, and hygiene    
No 93.5 92.6 77.7 93.1 267 8.473
Yes 6.5 7.4 22.3 7.0 50 4.159
Total 100.0 100.0 100.0 100.0 317 *
N 70 79 168 149   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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9.4 Newspaper or magazine 
TABLE 9.4.1. NEWSPAPER OR MAGAZINE EXPOSURE
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who had read newspapers or 








 % % % %  
Do you ever read the newspaper or 
magazines?     
No 99.0 99.4 99.7 99.3 5,983 6.064
Yes 1.0 0.6 0.3 0.8 50 2.159
Total 100.0 100.0 100.0 100.0 6,033 .
N 1,960 2,062 2,011 4,022   
How frequently do you read the news-
paper or magazines?   
4 or more times a week 32.0 20.7 52.0 27.5 10 8.097
2–3 times a week 15.1 3.4 20.6 10.4 6 0.819
Once a week 4.4 26.3 0.0 13.1 7 .
Less than once a week 16.6 49.6 6.9 29.8 18  
Never reads newspapers/magazines 32.0 0.0 20.5 19.2 9  
Total 100.0 100.0 100.0 100.0 50  
N 22 21 7 43   
In the last 12 months, did you read any 
health advertisements or message   
No 99.5 98.7 96.4 99.1 5,927 42.822
Yes 0.5 1.3 3.6 0.9 106 2.474
Total 100.0 100.0 100.0 100.0 6,033 .
N 1,960 2,062 2,011 4,022   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 9.4.2. HEALTH MESSAGES SEEN IN NEWSPAPERS OR MAGAZINES
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who had seen health messages in 
newspapers or magazines in the past 12 months by type, September–October 2019






% % % %  
Using contraception to space births    
No 23.8 46.0 11.8 40.2 34 8.029
Yes 76.2 54.0 88.2 59.8 72 2.359
Total 100.0 100.0 100.0 100.0 106 .
N 14 33 59 47   
Using contraception for limiting births   
No 65.0 77.9 12.7 74.5 49 29.862
Yes 35.0 22.1 87.3 25.5 57 10.170
Total 100.0 100.0 100.0 100.0 106 **
N 14 33 59 47   
Giving birth in a health facility with 
SBA
  
No 60.4 93.3 15.6 84.7 51 33.348
Yes 39.6 6.7 84.4 15.3 55 27.795
Total 100.0 100.0 100.0 100.0 106 ***
N 14 33 59 47   
Birth plans     
No 41.6 90.9 97.0 78.0 95 8.816
Yes 58.4 9.1 3.0 22.0 11 3.339
Total 100.0 100.0 100.0 100.0 106 .
N 14 33 59 47   
Antenatal care     
No 33.0 43.6 16.4 40.8 37 5.006
Yes 67.0 56.4 83.6 59.2 69 3.027
Total 100.0 100.0 100.0 100.0 106 .
N 14 33 59 47   
Diarrhea     
No 67.0 93.9 48.9 86.9 73 7.813
Yes 33.0 6.1 51.1 13.1 33 12.704
Total 100.0 100.0 100.0 100.0 106 ***
N 14 33 59 47   
Malaria     
No 80.9 58.3 14.6 64.2 42 19.244
Yes 19.1 41.7 85.4 35.8 64 18.341
Total 100.0 100.0 100.0 100.0 106 ***
N 14 33 59 47   
Cough with rapid or difficult breathing   
No 89.7 89.3 98.1 89.4 100 3.200
Yes 10.3 10.7 2.0 10.6 6 10.566
Total 100.0 100.0 100.0 100.0 106 **
N 14 33 59 47   
Child nutrition     
No 96.1 91.7 96.4 92.9 100 0.430
Yes 4.0 8.3 3.6 7.2 6 1.473
Total 100.0 100.0 100.0 100.0 106 .
N 14 33 59 47   
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Immunizations     
No 93.0 60.1 1.8 68.7 37 58.026
Yes 7.0 39.9 98.2 31.3 69 37.493
Total 100.0 100.0 100.0 100.0 106 ***
N 14 33 59 47   
Breastfeeding     
No 93.0 85.3 14.0 87.4 52 38.555
Yes 7.0 14.7 86.0 12.7 54 33.744
Total 100.0 100.0 100.0 100.0 106 ***
N 14 33 59 47   
Water, sanitation, and hygiene    
No 100.0 100.0 13.2 100.0 59 52.378
Yes 0.0 0.0 86.8 0.0 47 63.498
Total 100.0 100.0 100.0 100.0 106 ***
N 14 33 59 47   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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9.5 Internet 
TABLE 9.5.1. INTERNET EXPOSURE
Percentage of women aged 15 to 49 years currently pregnant or with a child under 2 years who report using the inter-








 % % % %  
Have you ever used the internet?
No 99.3 98.5 99.4 98.9 5,949 4.232
Yes 0.7 1.5 0.6 1.1 84 0.884
Total 100.0 100.0 100.0 100.0 6,033 .
N 1,960 2,062 2,011 4,022   
About how many days in a normal 
week do you use the internet?
0 times 99.3 98.5 99.4 98.9 5,950 9.342
1–2 days 0.3 0.2 0.0 0.2 12 1.274
3–4 days 0.1 0.1 0.2 0.1 15 .
5–7 days 0.4 1.1 0.4 0.8 57  
Total 100.0 100.0 100.0 100.0 6,034  
N 1,960 2,062 2,012 4,022   
How do you access the internet?
Public computer 3.2 1.1 0.0 1.7 2 2.472
Own phone 86.5 96.7 100.0 93.7 79 1.581
Someone else's phone 10.3 2.2 0.0 4.6 3 .
Total 100.0 100.0 100.0 100.0 84  
N 17 52 15 69   
How easy for you to access internet to 
look up health info
Very easy 42.9 72.9 55.9 64.2 57 10.952
Somewhat easy 46.5 15.5 14.6 24.5 16 1.372
Somewhat difficult 10.6 8.1 3.5 8.9 8 .
Very difficult 0.0 3.5 26.0 2.5 3  
Total 100.0 100.0 100.0 100.0 84  
N 17 52 15 69   
In the last 12 months, did you see any 
health messages on internet?
No 61.4 45.2 27.3 50.0 35 5.323
Yes 38.6 52.6 72.7 48.5 47 1.868
Don't know 0.0 2.2 0.0 1.6 2 .
Total 100.0 100.0 100.0 100.0 84  
N 17 52 15 69   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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9.6 Other information sources
TABLE 9.6.1. HEALTH INFORMATION RECEIVED FROM OTHER SOURCES
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who report receiving health 








 % % % %  
Last 12 months received/heard/seen 
health information from other sources   
No 85.0 87.3 92.0 86.2 5,266 52.302
Yes 11.3 9.6 5.8 10.4 570 0.676
Don't know 3.8 3.1 2.3 3.4 197 .
Total 100.0 100.0 100.0 100.0 6,033  
N 1,960 2,062 2,011 4,022   
Health info source in the past 3 
months
Billboards     
No 70.8 86.3 27.6 78.6 390 148.210
Yes 29.2 13.7 72.4 21.4 180 5.756
Total 100.0 100.0 100.0 100.0 570 *
N 235 224 111 459   
Mobile phone/SMS     
No 96.3 95.1 99.7 95.7 545 9.428
Yes 3.8 4.9 0.3 4.3 25 8.415
Total 100.0 100.0 100.0 100.0 570 **
N 235 224 111 459   
Cinema      
No 99.3 100.0 100.0 99.7 569 0.850
Yes 0.7 0.0 0.0 0.3 1 0.847
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Live drama/puppet show    
No 98.9 98.9 99.1 98.9 565 0.029
Yes 1.1 1.1 1.0 1.1 5 0.011
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Leaflet/brochure     
No 98.3 98.8 98.3 98.5 562 0.042
Yes 1.7 1.2 1.7 1.5 8 0.013
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 9.6.2. HEALTH INFORMATION RECEIVED FROM HEALTH SYSTEM SOURCES
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who received health messages 
from health system sources by type, September–October 2019






% % % %  
Government hospital/health center    
No 57.3 68.6 16.8 63.0 298 123.298
Yes 42.7 31.4 83.2 37.1 272 5.101
Total 100.0 100.0 100.0 100.0 570 *
N 235 224 111 459   
Government post/dispensary    
No 96.7 99.2 33.3 97.9 497 275.033
Yes 3.3 0.8 66.7 2.1 73 37.753
Total 100.0 100.0 100.0 100.0 570 ***
N 235 224 111 459   
Women and children hospital    
No 98.3 98.8 68.7 98.5 533 99.190
Yes 1.8 1.2 31.3 1.5 37 43.198
Total 100.0 100.0 100.0 100.0 570 ***
N 235 224 111 459   
Child welfare clinic     
No 99.6 99.5 100.0 99.5 567 1.179
Yes 0.4 0.5 0.0 0.5 3 1.229
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Church/mission/hospital    
No 100.0 99.8 100.0 99.9 569 0.257
Yes 0.0 0.2 0.0 0.1 1 0.655
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Private hospital/clinic     
No 100.0 97.4 100.0 98.7 565 3.388
Yes 0.0 2.6 0.0 1.3 5 0.932
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Nursing/maternity home    
No 98.5 100.0 99.7 99.2 565 0.609
Yes 1.5 0.0 0.3 0.8 5 0.469
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Kiosk      
No 95.9 100.0 100.0 97.9 560 5.363
Yes 4.1 0.0 0.0 2.1 10 1.165
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Community health worker    
No 93.5 92.0 94.2 92.7 527 0.498
Yes 6.5 8.1 5.8 7.3 43 0.088
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Traditional birth attendant/healer    
No 95.7 96.6 96.4 96.2 551 0.018
Yes 4.3 3.4 3.6 3.8 19 0.003
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Mobile clinic     
No 100.0 99.8 100.0 99.9 569 0.231
Yes 0.0 0.2 0.0 0.1 1 0.633
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Pharmacy     
No 97.3 98.6 94.5 97.9 550 4.623
Yes 2.7 1.5 5.5 2.1 20 0.600
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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TABLE 9.6.3. HEALTH INFORMATION RECEIVED FROM OTHER PERSONS OR SOURCES
Percentage of women 15 to 49 years currently pregnant or with a child under 2 years who received health messages 
from other persons or influencers, September–October 2019






% % % %  
Parents      
No 85.4 85.2 99.5 85.3 501 37.653
Yes 14.6 14.8 0.5 14.7 69 20.064
Total 100.0 100.0 100.0 100.0 570 ***
N 235 224 111 459   
Sisters/brothers     
No 81.9 96.5 99.7 89.2 515 27.255
Yes 18.1 3.6 0.3 10.8 55 19.596
Total 100.0 100.0 100.0 100.0 570 ***
N 235 224 111 459   
Teacher/peer educator    
No 97.4 99.7 100.0 98.5 561 3.791
Yes 2.6 0.4 0.0 1.5 9 1.473
Total 100.0 100.0 100.0 100.0 570 .
N 235 224 111 459   
Spouse/partner     
No 71.9 79.4 98.5 75.6 452 60.996
Yes 28.1 20.6 1.5 24.4 118 14.373
Total 100.0 100.0 100.0 100.0 570 ***
N 235 224 111 459   
Friends/neighbors     
No 58.1 56.8 96.2 57.5 380 112.824
Yes 41.9 43.2 3.8 42.6 190 12.512
Total 100.0 100.0 100.0 100.0 570 ***
N 235 224 111 459   
Estimates based on low Ns (approx. <30 obs) have large relative standard errors and should be interpreted with caution. *** indicates p<0.001, ** indi-
cates p<0.05 and * indicates p<.0.01 for the chi2 statistic comparing integrated versus malaria-only study areas.
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Discussion
This technical report presents complete results of the baseline BSS survey undertaken between September and 
October 2019. Over the period from 2019 to 2021, baseline, midline, and endline waves of the BSS will be used to 
assess the effectiveness of the Breakthrough ACTION/Nigeria integrated SBC activities for malaria, family planning, and 
MNCH+N in Kebbi and Sokoto relative to malaria-only SBC activities in Zamfara. 
As part of this evaluation, the BSS not only measures changes in behavioral outcomes across family planning, malaria, 
and MNCH+N, but also measures whether certain behavioral drivers, or ideations, have been modified by SBC activities 
over the life of the Breakthrough ACTION/Nigeria project. Indeed, the BSS is unique in its focus on measuring these 
psychosocial influences—or emotional, social, and cognitive domains—that have been posited by various theories as 
intermediate determinants of behavioral outcomes. For some health areas, the BSS is pioneering in its collection of 
new metrics for behavioral drivers (e.g., pneumonia, breastfeeding, ANC, delivery care) while in other areas, the BSS 
has adapted published metrics for the Nigerian context (e.g., vaccination, diarrhea). 
Based on this new data collection work, the BSS baseline report provides important program-relevant evidence to 
inform Breakthrough ACTION/Nigeria SBC adaption and scale-up during this early implementation period. In this 
report, we answer some key learning questions for Breakthrough ACTION/Nigeria programs, including: To what extent 
are respondents aware of health behaviors being promoted (e.g., how to prevent and treat certain diseases); To what 
extent are certain myths or beliefs held by respondents that could impede progress across health areas; How do 
respondents view health services in their communities, and what are the main reasons for choosing certain treatment 
locations or for not seeking care at all; Who mainly influences decisions and practices across health areas; What are key 
social norms around health behaviors; and Do respondents feel confident in their ability to take up promoted practices. 
Key findings and recommendations for different health areas are outlined in the following sections. Going forward, 
in-depth analyses of the BSS baseline dataset will provide further evidence about the relative importance of different 
ideations on behavioral outcomes across health areas. We will also examine the differences among doers and non-do-
ers of promoted behaviors, and take a deeper dive into the role of spousal communication, or other important topic 
areas, in the uptake of promoted behaviors by Breakthrough ACTION/Nigeria. 
Key Findings and Recommendations 
Albishirin Ku! 
• Awareness of Breakthrough ACTION/Nigeria’s Albishirin Ku! radio programming was already apparent even at this 
baseline period. In Kebbi/Sokoto, 24 percent of respondents had heard the Albishirin Ku! radio slogan as have 13 
percent in Zamfara. 
• Albishirin Ku! radio program awareness in Kebbi/Sokoto was significantly lower among respondents in the poorest 
households (12%) than in wealthiest households (42%) across study areas.
• This result suggests that Breakthrough ACTION/Nigeria radio programming may not penetrate to the poorest 
households that have demonstrably worse health outcomes according to BSS results (see below sections). 
Breakthrough ACTION/Nigeria may need to assure that additional outreach efforts through other channels or 
methods (e.g., household visits or community events) are targeted at the poorest areas, or consider ways to bring 
radios to communities (e.g., listening or discussion groups).
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Family planning
• Modern contraceptive use: There was low modern 
contraceptive use among non-pregnant respondents, 
with higher use in Zamfara (15%) than in Kebbi/
Sokoto (11%). Modern contraceptive use was lower 
among respondents in poorest households (6% and 
7%) than in wealthiest households (24% and 34%). 
Most respondents had heard of at least one modern 
method, with the most recognized methods being 
injectables, implants, and daily pills. Higher recall of 
methods was noted in Kebbi/Sokoto (30%, 38%, 33%) 
than in Zamfara (16%, 23%, 19%). Unsurprisingly, 
the most common methods used by non-pregnant 
respondents were injectables (48%) and implants 
(25%), with similar proportions across study areas.
• Reasons for non-use, attitudes, and social norms: 
The most common reasons for not using contracep-
tion among current non-users were that “It’s up to 
God” (25%), currently breastfeeding (23%), partner 
opposition (21%), and respondent opposition (18%). 
In line with this result, approximately half (52%) of 
respondents agreed that they do not personally 
approve of using contraception for birth spacing, 
underscoring a critical hurdle to Breakthrough 
ACTION/Nigeria SBC messaging for changing family 
planning practices. In addition, one in five respon-
dents believed that people in their community 
would call them bad names or avoid their company if 
others knew they were using contraception for birth 
spacing, which further highlights the importance of 
addressing social norms in family planning. About 
half of respondents agreed that religious leaders 
should speak publicly about using modern contra-
ceptives, which is a pillar of Breakthrough ACTION/
Nigeria programming. 
• Contraceptive myths: CCommon contraceptive 
myths also persist across study areas with firmer 
belief in these myths in Kebbi/Sokoto than in 
Zamfara. About one in three respondents in Kebbi/
Sokoto agreed that contraception could make a 
woman permanently infertile, harm a woman’s 
womb, or lead to health problems, compared with 
about one-quarter of respondents in Zamfara. About 
one in five respondents in Kebbi/Sokoto agreed that 
contraceptives cause cancer, give you deformed 
babies, increase promiscuity, or reduce sexual urges 
of women and men. SBC programming needs to 
actively work to dispel these specific myths going 
forward to help promote behavior change. 
• Spousal communication and decision-making: 
There were low rates of spousal communication 
about contraceptive use, although rates were 
higher in Zamfara (22%) than in Kebbi/Sokoto 
(6%). Unsurprisingly, respondents also noted that 
contraceptive decisions were mainly made by their 
partners, with higher reports in Kebbi/Sokoto (30%) 
than in Zamfara (17%). When respondents were 
asked who else influences a woman’s decision about 
contraceptive use, the most commonly mentioned 
influencers were no one else (61%) and partners/
spouses (30%). Self-efficacy for negotiating contra-
ceptive use with a partner was low. Only about half 
of respondents across study areas were confident in 
their ability to convince their partner to use modern 
contraception for spacing births. Finally, among 
non-users, only 15 percent intended to start con-
traceptive use in the next six months, representing 
another barrier to raising contraceptive use rates.
Malaria
• Malaria prevention: Overall, there was high 
long-lasting insecticide nets (LLIN) ownership. 
Approximately 75 percent and 69 percent of house-
holds in Zamfara and Kebbi/Sokoto, respectively, 
own at least one LLIN. However, fewer households 
had the recommended ratio of at least one LLIN for 
every two household members, with slightly higher 
proportions in Kebbi/Sokoto (25%) than in Zamfara 
(18%). In households where there were sufficient 
nets (at least one LLIN for every two household 
members), 81 percent and 88 percent of pregnant 
respondents slept under an LLIN the previous night 
in Kebbi/Sokoto and Zamfara, respectively, with 
little difference across wealth quintiles or maternal 
education. Similarly, in households with sufficient 
nets, over 90 percent of children under 2 years slept 
under an LLIN the previous night in integrated and 
malaria-only areas, with limited differences across 
sociodemographics. There was also extremely 
high overall awareness about the importance of 
LLINs in malaria prevention. Among respondents 
who were currently pregnant or with a child under 
2 years, nearly all (97%) agreed that malaria was 
caused by mosquito bites and 93 percent reported 
that sleeping under mosquito nets was an effective 
malaria prevention method. In addition, there was 
also strong intent to get all children under 5 sleeping 
under a mosquito net (93%). The results suggest 
that resources building additional knowledge of the 
168    BS S IN NIGER IA: BASELINE TECHNICA L R EPORT
modes of transmission are not needed, but improv-
ing access, acceptability, and efficacy of LLIN may be 
a useful programmatic focus.
• Malaria during pregnancy: Malaria prevention 
efforts during pregnancy are substantially lacking in 
all three states. Less than one in five respondents in 
study areas took intermittent preventive treatment 
(three or more SP/Fansidar doses) during their last 
pregnancy, with lower rates among respondents in 
the poorest households (10% and 12%), as compared 
with the wealthiest (33% and 34%) in Kebbi/Sokoto 
and Zamfara, respectively. Lower percentages were 
also observed among the less educated (15% and 
14%) compared to respondents who attended at 
least some primary school (36% and 25%). The most 
common reasons for not taking SP/Fansidar during 
the last pregnancy were opposition by respondent 
(34%) or spouse (33%), which underscores a major 
barrier to increasing uptake. Among respondents 
attending ANC, few in Kebbi/Sokoto (11%) and 
Zamfara (18%) were given a mosquito net during the 
ANC visit. While 91 percent of respondents agreed 
that malaria in pregnancy can affect the fetus, far 
fewer could state the specific risks to the baby. 
Only about half across the study area reported fetal 
death (45%) or miscarriage (44%) as specific risks 
from malaria in pregnancy, while far fewer reported 
premature birth (26%) and low birth weight (17%) 
as specific risks. Building knowledge of malaria risks 
and specific health consequences for the fetus may 
be a driver toward greater adoption of prevention 
behaviors.
• Malaria treatment: While there were high rates of 
care-seeking for children under 2 years of age with 
fever, many respondents (33% and 54% of those 
who sought care in Kebbi/Sokoto and Zamfara, 
respectively) went to a pharmacy where poor-qual-
ity care persists. The most important reasons for 
choosing the treatment location for pediatric fever 
care were trust (36%), nearby location (33%), and 
effective treatment (28%). These findings under-
score the importance to women of convenient 
and high-quality health services provision in their 
communities. Importantly, few febrile children were 
tested for malaria (19% and 24%), and few were 
given ACT treatment (22% and 36%) in Kebbi/Sokoto 
and Zamfara. The low prevalence of testing may be 
due in large part to care-seeking from pharmacies. 
Nearly all respondents reported intentions to take a 
child with fever to care the same/next day (92%) and 
to make sure the child takes the entire treatment 
course (92%), suggesting motivation is not a primary 
barrier to care-seeking. However, while 74 percent 
agreed that a blood test is the only way to know 
whether a person has malaria, most respondents 
(61%) agreed that they still worry the illness could 
be malaria even if the test result is negative. This 
implies some lack of confidence in negative malaria 
test results, which points to an area for future SBC 
programming. 
MNCH+N
• Antenatal care: There is low ANC attendance across 
the three states, with approximately one-third (32% 
and 38%) of respondents attending ANC one or more 
times and one-quarter (20% and 26%) attending 
ANC four or more times during the last pregnancy 
in Kebbi/Sokoto and Zamfara, respectively. The 
most common reasons for not attending ANC were 
lack of perceived need (42%), spousal opposition 
(25%), fatalism (“It’s up to God”) (20%), and percep-
tions that ANC is not the norm (13%). More than 
two-thirds (67%) of respondents said their spouses 
influence their decision to go to ANC four or more 
times, making spousal support or opposition a critical 
facilitator or barrier to uptake. The strong influence 
of spouses on pregnancy and other health-related 
decisions underscores the need for continued and 
sustained engagment with men to improve the 
uptake of essential services for women and children 
in this area. There are also common ANC myths 
among respondents that persist. Overall, 48 percent 
and 35 percent of respondents agreed that pregnant 
women need ANC only when sick, and one-quarter 
of respondents agreed that only first-time mothers 
need ANC. A significant percentage of respon-
dents—40 percent and 30 percent in Kebbi/Sokoto 
and Zamfara, respectively—noted that it is better to 
use a traditional provider than a health facility for 
ANC. Birth planning with a health worker during ANC 
does not appear to be standard practice, and only 
one in three respondents reported having discussed 
birth plans. These perceptions point to areas for SBC 
messaging to improve awareness of the benefits of 
ANC even for healthy pregnancies that could lead to 
additional ANC uptake going forward.
• Facility delivery: Facility delivery was an uncommon 
practice in Kebbi/Sokoto (14%) and Zamfara (16%) 
among respondents during their last pregnancy. 
More than 80 percent of respondents delivered at 
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their own or another home, and births are commonly 
assisted by family members (36%) or traditional 
birth attendants (29%). The most common reasons 
for not delivering at a facility were that they did not 
feel it was necessary (75% and 61%) followed by 
spousal opposition (15% and 36%) in Kebbi/Sokoto 
and Zamfara, respectively. When respondents were 
asked who influences the decision to have a facility 
delivery, partner/spouse (57%) was the most com-
mon response, making spousal opposition a critical 
barrier to service utilization. Only about half (54%) 
of respondents agreed that the health facility is the 
best place to deliver a baby, and even fewer (44%) 
felt confident that they could get to a health facility 
for delivery. Only about half (55%) were confident 
that they could start a conversation with their hus-
band about facility delivery, and a similar proportion 
(51%) intended to deliver their next child at a health 
facility.  
• Breastfeeding: Nearly all respondents (96%) 
reported ever breastfeeding their last-born child 
under 2 years. Yet initiating breastfeeding within one 
hour of birth was low across study areas, although 
higher in Zamfara (46%) than in Kebbi/Sokoto (36%). 
Exclusive breastfeeding for the first six months of 
life was also low across study areas, with higher 
rates in Zamfara (46%) than in Kebbi/Sokoto (26%). 
This low coverage is in large part due to high rates 
of giving non-breastmilk liquids to a child in the first 
three days after birth, with much higher practice 
rates in Kebbi/Sokoto (73%) than in Zamfara (50%). In 
relation to this practice, 23 percent of respondents 
also agreed that mother’s breastmilk after birth is 
bad, suggesting an area for future SBC messaging. 
Taken together, these responses suggest ways SBC 
messaging may help promote exclusive breastfeeding 
in this study area. In addition, while there was high 
awareness of breastfeeding and its benefits among 
respondents, only 55 percent of respondents felt 
confident to exclusively breastfeed their child for the 
first six months, with higher confidence in Zamfara 
(64%) than Kebbi/Sokoto (42%). Forty-one percent of 
respondents believed that most other respondents 
in their communities gave breastmilk exclusively 
to their infants, suggesting perceived social norms 
about breastfeeding. There was also relatively low 
intent to exclusively breastfeed their next child in 
Zamfara (59%) and Kebbi/Sokoto (46%). 
• Vaccination: There was very low vaccination cover-
age in study areas, with 4 percent and 8 percent of 
children aged 12 to 23 months in Kebbi/Sokoto and 
Zamfara, respectively, fully vaccinated (BCG, measles, 
DPT3, and polio3) by the time of the survey inter-
view. The most important reason for not vaccinating 
the child was spousal opposition (33%) followed 
by distance to the health facility (14%) and fear of 
needles (11%). Across study areas, 73 percent of 
respondents reported that their spouses influence 
their decision about child vaccinations, making 
spousal opposition an important barrier to vaccine 
uptake. While respondents gave generally positive 
reports about their own vaccine knowledge and 
attitudes, more specific questions elicited a less rosy 
picture. Specifically, only about half (52%) of respon-
dents in Kebbi/Sokoto believed that health facilities 
frequently had vaccines available, as compared with 
61 percent in Zamfara. Only 47 percent of respon-
dents in Kebbi/Sokoto and 66 percent in Zamfara 
believed most respondents in their communities 
took children to facilities for routine vaccination. 
Approximately one in four respondents (26%) agreed 
that vaccines contain dangerous chemicals that could 
harm a child’s health. Few respondents knew when 
a child should first be vaccinated and the number 
of vaccinations children should receive by their first 
birthdays. Taken together, results suggest relatively 
low vaccine knowledge, common perceptions of fre-
quent vaccine stockouts at health facilities, spousal 
opposition to vaccine uptake, and the persistence of 
vaccine myths across the study area.
• Acute respiratory infections: While there were high 
rates of care-seeking for under-twos with cough, 
rapid breathing, and a chest-related problem, only 
49 percent and 33 percent of those who sought care 
were taken to a formal medical source in Kebbi/
Sokoto and Zamfara. Even fewer children with 
these respiratory symptoms were given antibiotics 
(41% and 26%). The most common reasons for 
choosing the source of care was nearby location 
(40%), provider trust (36%), family/friend recom-
mendation (30%), and effective treatment (27%), 
which underscores the importance to women of 
convenient and high-quality health care provision 
in their communities. The most important reasons 
for not seeking care were expense/cost (33%) and 
symptoms not perceived as severe or home care 
was provided (25%). Pediatric pneumonia knowledge 
was low across study areas. Only 28 percent and 37 
percent of respondents reported rapid or difficult 
breathing as a symptom of pediatric pneumonia, 45 
percent and 31 percent could not report any way to 
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help prevent a child from getting pneumonia, and 62 
percent and 56 percent could not report any effec-
tive medicine to treat pneumonia in Kebbi/Sokoto 
and Zamfara, respectively. These results point to the 
need to shift care-seeking from pharmacies to formal 
medical sources and to improve overall pneumonia 
knowledge in study areas.
• Diarrhea: Few children with diarrhea were given 
both ORS and zinc, although this proportion was 
higher in Zamfara (27%) than in Kebbi/Sokoto (13%). 
Among children with diarrhea, 36 percent and 56 
percent were given ORS alone in Kebbi/Sokoto and 
Zamfara, respectively. While there were high rates of 
care-seeking for children under 2 years with diar-
rhea, 34 percent and 56 percent of these children 
were taken to a pharmacy, where poor-quality care 
persists. The most important reasons for choosing 
the source of care were provider trust (39%), nearby 
location (29%), and effective treatment (24%), which 
underscores the importance to women of conve-
nient and high-quality health care provision in their 
communities. The most important reasons for not 
seeking care were expense/cost (32%), fatalism (“It’s 
up to God”) (29%), and symptoms not perceived 
as severe or care was provided at home (25%). 
Approximately one in four respondents (24%) had 
never heard of zinc across study areas. Across study 
areas, 63 percent of respondents reported that ORS 
replaces lost water in a child with diarrhea, while 
44 percent incorrectly noted that it stops diarrhea. 
These results point to the need to shift care-seeking 
from pharmacies to formal medical sources and to 
improve overall diarrhea knowledge in study areas.
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